{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "from __future__ import print_function, division"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['/Users/kelvin/anaconda3/lib/python3.7/site-packages/requests']"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# if needed: pip install requests or conda install requests\n",
    "import requests\n",
    "\n",
    "requests.__path__"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {},
   "outputs": [],
   "source": [
    "url = 'https://data.cdc.gov/resource/bi63-dtpu.json'\n",
    "\n",
    "response = requests.get(url)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "metadata": {},
   "outputs": [],
   "source": [
    "page = response.text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<html><body><p>[{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"21\",\"aadr\":\"2.6\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"30\",\"aadr\":\"3.7\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"30\",\"aadr\":\"3.8\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"23\",\"aadr\":\"3.8\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"325\",\"aadr\":\"4.1\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"29\",\"aadr\":\"4.4\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"49\",\"aadr\":\"4.5\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"39\",\"aadr\":\"4.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"37\",\"aadr\":\"4.5\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"374\",\"aadr\":\"4.9\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"34\",\"aadr\":\"4.9\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"279\",\"aadr\":\"5.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"30\",\"aadr\":\"5.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"278\",\"aadr\":\"5.2\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"40\",\"aadr\":\"5.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"30\",\"aadr\":\"5.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"31\",\"aadr\":\"5.2\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"304\",\"aadr\":\"5.3\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"43\",\"aadr\":\"5.4\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"39\",\"aadr\":\"5.4\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"306\",\"aadr\":\"5.4\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"293\",\"aadr\":\"5.4\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"33\",\"aadr\":\"5.4\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"458\",\"aadr\":\"5.5\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"33\",\"aadr\":\"5.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"395\",\"aadr\":\"5.6\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"58\",\"aadr\":\"5.6\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"37\",\"aadr\":\"5.6\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"487\",\"aadr\":\"5.7\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"414\",\"aadr\":\"5.7\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"38\",\"aadr\":\"5.7\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"37\",\"aadr\":\"5.7\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"225\",\"aadr\":\"5.8\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"55\",\"aadr\":\"5.8\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"64\",\"aadr\":\"5.9\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"474\",\"aadr\":\"5.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"348\",\"aadr\":\"5.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1169\",\"aadr\":\"5.9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1132\",\"aadr\":\"5.9\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"220\",\"aadr\":\"6.0\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"36\",\"aadr\":\"6.0\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"387\",\"aadr\":\"6.0\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1189\",\"aadr\":\"6.0\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1187\",\"aadr\":\"6.0\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"461\",\"aadr\":\"6.1\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"36\",\"aadr\":\"6.1\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"536\",\"aadr\":\"6.1\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"1785\",\"aadr\":\"6.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"50\",\"aadr\":\"6.2\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"481\",\"aadr\":\"6.2\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"557\",\"aadr\":\"6.2\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"56\",\"aadr\":\"6.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"553\",\"aadr\":\"6.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1228\",\"aadr\":\"6.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1196\",\"aadr\":\"6.3\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"71\",\"aadr\":\"6.3\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"250\",\"aadr\":\"6.4\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"226\",\"aadr\":\"6.4\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"55\",\"aadr\":\"6.4\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"62\",\"aadr\":\"6.4\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"425\",\"aadr\":\"6.4\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"241\",\"aadr\":\"6.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"72\",\"aadr\":\"6.5\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"40\",\"aadr\":\"6.5\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"433\",\"aadr\":\"6.5\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"426\",\"aadr\":\"6.5\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"585\",\"aadr\":\"6.5\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1253\",\"aadr\":\"6.5\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"59\",\"aadr\":\"6.6\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"56\",\"aadr\":\"6.6\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"532\",\"aadr\":\"6.6\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"482\",\"aadr\":\"6.6\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"436\",\"aadr\":\"6.6\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"560\",\"aadr\":\"6.6\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"563\",\"aadr\":\"6.6\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"50\",\"aadr\":\"6.7\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"423\",\"aadr\":\"6.7\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"450\",\"aadr\":\"6.7\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"431\",\"aadr\":\"6.7\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"596\",\"aadr\":\"6.7\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"588\",\"aadr\":\"6.7\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1326\",\"aadr\":\"6.7\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"21\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"1994\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"316\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"49\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"492\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"440\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"30\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"615\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"597\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"588\",\"aadr\":\"6.8\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"272\",\"aadr\":\"6.9\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"57\",\"aadr\":\"6.9\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"327\",\"aadr\":\"6.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"320\",\"aadr\":\"6.9\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"41\",\"aadr\":\"6.9\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"1357\",\"aadr\":\"7.0\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"59\",\"aadr\":\"7\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"52\",\"aadr\":\"7.0\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2599\",\"aadr\":\"7.0\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"86\",\"aadr\":\"7.0\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1417\",\"aadr\":\"7.0\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"23\",\"aadr\":\"7.1\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"261\",\"aadr\":\"7.1\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"471\",\"aadr\":\"7.1\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1409\",\"aadr\":\"7.1\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1396\",\"aadr\":\"7.1\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"75\",\"aadr\":\"7.1\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"24\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2840\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2728\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2164\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"44\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"266\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"266\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"480\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"687\",\"aadr\":\"7.2\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"260\",\"aadr\":\"7.3\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"74\",\"aadr\":\"7.3\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"271\",\"aadr\":\"7.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"260\",\"aadr\":\"7.3\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"43\",\"aadr\":\"7.3\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"295\",\"aadr\":\"7.4\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"79\",\"aadr\":\"7.4\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"52\",\"aadr\":\"7.4\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"683\",\"aadr\":\"7.4\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"509\",\"aadr\":\"7.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"450\",\"aadr\":\"7.5\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"272\",\"aadr\":\"7.5\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"509\",\"aadr\":\"7.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"689\",\"aadr\":\"7.5\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2373\",\"aadr\":\"7.6\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2334\",\"aadr\":\"7.6\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"313\",\"aadr\":\"7.6\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"302\",\"aadr\":\"7.6\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"90\",\"aadr\":\"7.6\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"54\",\"aadr\":\"7.6\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"85\",\"aadr\":\"7.6\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"3119\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2482\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"97\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"398\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"378\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"77\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"52\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"516\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"719\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1547\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"84\",\"aadr\":\"7.7\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"1539\",\"aadr\":\"7.8\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"529\",\"aadr\":\"7.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"503\",\"aadr\":\"7.8\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"316\",\"aadr\":\"7.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"304\",\"aadr\":\"7.8\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"District of Columbia\",\"deaths\":\"52\",\"aadr\":\"7.8\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"530\",\"aadr\":\"7.8\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1652\",\"aadr\":\"7.8\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"537\",\"aadr\":\"7.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"322\",\"aadr\":\"7.9\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"67\",\"aadr\":\"7.9\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"274\",\"aadr\":\"7.9\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1010\",\"aadr\":\"7.9\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"86\",\"aadr\":\"7.9\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"60\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2261\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"49\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"137\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"95\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"336\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"100\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"93\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"67\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"308\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Washington\",\"deaths\":\"552\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"292\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1011\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"757\",\"aadr\":\"8.0\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"382\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"323\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"306\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"53\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"295\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"283\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1028\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1003\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1679\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1700\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1687\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"88\",\"aadr\":\"8.1\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2676\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"110\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"96\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"409\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"295\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"294\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"107\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"596\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"572\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1658\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"90\",\"aadr\":\"8.2\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"578\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"546\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2854\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"352\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"53\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1020\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"502\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"435\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"789\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Jersey\",\"deaths\":\"786\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New York\",\"deaths\":\"1708\",\"aadr\":\"8.3\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Alaska\",\"deaths\":\"41\",\"aadr\":\"8.4\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"68\",\"aadr\":\"8.4\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"28\",\"aadr\":\"8.4\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"472\",\"aadr\":\"8.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"454\",\"aadr\":\"8.4\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"585\",\"aadr\":\"8.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"1705\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2338\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"528\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"2835\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"458\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"448\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"109\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"57\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"2831\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"316\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"315\",\"aadr\":\"8.5\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"3640\",\"aadr\":\"8.6\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"3557\",\"aadr\":\"8.6\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"3033\",\"aadr\":\"8.6\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"99\",\"aadr\":\"8.6\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"313\",\"aadr\":\"8.6\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1108\",\"aadr\":\"8.6\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1086\",\"aadr\":\"8.6\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"495\",\"aadr\":\"8.6\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"401\",\"aadr\":\"8.7\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"California\",\"deaths\":\"3112\",\"aadr\":\"8.7\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"154\",\"aadr\":\"8.7\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"330\",\"aadr\":\"8.7\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"507\",\"aadr\":\"8.7\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"604\",\"aadr\":\"8.7\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"54\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"148\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"148\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Iowa\",\"deaths\":\"369\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"588\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"104\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nevada\",\"deaths\":\"274\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"353\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"304\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"553\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"500\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"477\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"631\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"598\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"96\",\"aadr\":\"8.8\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"1803\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2676\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2259\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"452\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"491\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"428\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"1888\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"1846\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"400\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"387\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"116\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"491\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Massachusetts\",\"deaths\":\"642\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"440\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"101\",\"aadr\":\"8.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"1866\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"453\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"450\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"57\",\"aadr\":\"9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"106\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"111\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"120\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1178\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"518\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"474\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"437\",\"aadr\":\"9.0\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"1999\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"450\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"123\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"331\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"89\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"135\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3206\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"2969\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"74\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1177\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"96\",\"aadr\":\"9.1\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"417\",\"aadr\":\"9.2\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"113\",\"aadr\":\"9.2\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"56\",\"aadr\":\"9.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"43\",\"aadr\":\"9.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1145\",\"aadr\":\"9.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1139\",\"aadr\":\"9.2\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"569\",\"aadr\":\"9.2\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"558\",\"aadr\":\"9.2\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2808\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2453\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"74\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"77\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"565\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"121\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"152\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2245\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2207\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"45\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3334\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1226\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1198\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"551\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"170\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1074\",\"aadr\":\"9.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"109\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2021\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2300\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2246\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"729\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"134\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"130\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"161\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"397\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"135\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"118\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"56\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"353\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"586\",\"aadr\":\"9.4\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"District of Columbia\",\"deaths\":\"53\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"1989\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Arizona\",\"deaths\":\"775\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Arizona\",\"deaths\":\"683\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2662\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"44\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"450\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"220\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"133\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"120\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"583\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"166\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1088\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"105\",\"aadr\":\"9.5\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Colorado\",\"deaths\":\"533\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2719\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"426\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"312\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"123\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"92\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3228\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3077\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"480\",\"aadr\":\"9.6\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2065\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"595\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"154\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"639\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"125\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"214\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2285\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2197\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"135\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3368\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"83\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"133\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1102\",\"aadr\":\"9.7\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"122\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"638\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"110\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"217\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2385\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2240\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"142\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"379\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"370\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1292\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"289\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maryland\",\"deaths\":\"606\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"497\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"497\",\"aadr\":\"9.8\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2410\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"81\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"70\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"728\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"65\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"101\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"141\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"131\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"123\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"92\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"45\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3602\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3397\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"384\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"368\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1321\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"974\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"974\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"133\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"110\",\"aadr\":\"9.9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"118\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Alaska\",\"deaths\":\"52\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Arizona\",\"deaths\":\"779\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Arizona\",\"deaths\":\"690\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"85\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"815\",\"aadr\":\"10\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"53\",\"aadr\":\"10\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"50\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"60\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2252\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"222\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Vermont\",\"deaths\":\"62\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"66\",\"aadr\":\"10\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3893\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maine\",\"deaths\":\"137\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1176\",\"aadr\":\"10.0\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"768\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"734\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"45\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"49\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2172\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"162\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"102\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Connecticut\",\"deaths\":\"397\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"181\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"113\",\"aadr\":\"10.1\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"74\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"3144\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2265\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2201\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"653\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"167\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"161\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oregon\",\"deaths\":\"426\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"565\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"4025\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3823\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"131\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"304\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1029\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"524\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"176\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1276\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2053\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2005\",\"aadr\":\"10.2\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2303\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"618\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"447\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"136\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"190\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"130\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"109\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"108\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"172\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Texas\",\"deaths\":\"1669\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"177\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"4167\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3913\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3775\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"91\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"923\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1363\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"305\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"461\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"132\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"131\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1284\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2347\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Vermont\",\"deaths\":\"63\",\"aadr\":\"10.3\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"197\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2556\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Arizona\",\"deaths\":\"885\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Arizona\",\"deaths\":\"776\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"603\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"496\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"563\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"57\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"676\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"149\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"586\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"3996\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"82\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"981\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"628\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"193\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Dakota\",\"deaths\":\"68\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"29350\",\"aadr\":\"10.4\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"189\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2396\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2454\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"38\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"608\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2416\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"150\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"105\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nevada\",\"deaths\":\"316\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"85\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"4294\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"California\",\"deaths\":\"4214\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1398\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1051\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"547\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Mississippi\",\"deaths\":\"294\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"193\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"177\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"418\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2433\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"29199\",\"aadr\":\"10.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"674\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Jersey\",\"deaths\":\"1131\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"728\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"3076\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2912\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"95\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"924\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"554\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"191\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1219\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1340\",\"aadr\":\"10.6\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2639\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Delaware\",\"deaths\":\"132\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"680\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Jersey\",\"deaths\":\"1208\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"851\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"212\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"847\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Illinois\",\"deaths\":\"1415\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"322\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"314\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"468\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1341\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2300\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"30622\",\"aadr\":\"10.7\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2563\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"357\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"3203\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"202\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"669\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"149\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"97\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"56\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"584\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"572\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1396\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1356\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"118\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"440\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2552\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"31484\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"768\",\"aadr\":\"10.8\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"141\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2640\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"738\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"77\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"997\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"136\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Kansas\",\"deaths\":\"293\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"490\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1098\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"187\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"187\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2418\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2225\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"32637\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"828\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"808\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"799\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"590\",\"aadr\":\"10.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Colorado\",\"deaths\":\"525\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"630\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Jersey\",\"deaths\":\"1128\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Rhode Island\",\"deaths\":\"165\",\"aadr\":\"11\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"444\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"175\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2439\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"104\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"228\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"212\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"105\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"93\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"86\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"505\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maine\",\"deaths\":\"158\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1108\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Mississippi\",\"deaths\":\"304\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"884\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"33300\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"32439\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"31655\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"797\",\"aadr\":\"11.0\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Montana\",\"deaths\":\"147\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Texas\",\"deaths\":\"2860\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"40\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"544\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"406\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"3130\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"133\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2426\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2394\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"909\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"136\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1131\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1106\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Dakota\",\"deaths\":\"73\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Dakota\",\"deaths\":\"73\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1295\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1441\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1430\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1410\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"443\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2363\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2311\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"880\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"876\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"593\",\"aadr\":\"11.1\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"477\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Rhode Island\",\"deaths\":\"161\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"634\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2620\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"215\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"199\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"264\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2387\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2351\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"142\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Dakota\",\"deaths\":\"103\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"624\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"873\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"137\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"334\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"333\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Kansas\",\"deaths\":\"299\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"499\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"493\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1139\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"606\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"596\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"202\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"158\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"151\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"137\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"955\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1287\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"126\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"127\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"866\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"791\",\"aadr\":\"11.2\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"2616\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Delaware\",\"deaths\":\"121\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Idaho\",\"deaths\":\"207\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Idaho\",\"deaths\":\"200\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Idaho\",\"deaths\":\"189\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Jersey\",\"deaths\":\"1234\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"209\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"704\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"155\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"133\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"129\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"172\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"267\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"106\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"170\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"106\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"973\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"704\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"683\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"193\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1325\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"482\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"34598\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"627\",\"aadr\":\"11.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Connecticut\",\"deaths\":\"449\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Diabetes mellitus (E10-E14)\",\"cause_name\":\"Diabetes\",\"state\":\"Nevada\",\"deaths\":\"350\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Arizona\",\"deaths\":\"768\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"743\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"391\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"3012\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maine\",\"deaths\":\"211\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"737\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"696\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"194\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"165\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"136\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2360\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Texas\",\"deaths\":\"1870\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"521\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"512\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"94\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"935\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Mississippi\",\"deaths\":\"325\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1319\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"467\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Vermont\",\"deaths\":\"72\",\"aadr\":\"11.4\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"District of Columbia\",\"deaths\":\"78\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"District of Columbia\",\"deaths\":\"74\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Hampshire\",\"deaths\":\"194\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"483\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"409\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"201\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"751\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"583\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"265\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"104\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"149\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"178\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"535\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"514\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"119\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"343\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"492\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1169\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1009\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1341\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"476\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2896\",\"aadr\":\"11.5\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Iowa\",\"deaths\":\"504\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Maine\",\"deaths\":\"205\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"751\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"771\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"30\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"141\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2383\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"210\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"58\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"972\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Kentucky\",\"deaths\":\"470\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"220\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1077\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"530\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2809\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"36035\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"643\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"647\",\"aadr\":\"11.6\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Connecticut\",\"deaths\":\"572\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"507\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Rhode Island\",\"deaths\":\"176\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"176\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maine\",\"deaths\":\"223\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"293\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"680\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"184\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"54\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"541\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"107\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"1168\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"1157\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"1133\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"715\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Mississippi\",\"deaths\":\"328\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"223\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"3059\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"963\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"963\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"639\",\"aadr\":\"11.7\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Connecticut\",\"deaths\":\"558\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Hampshire\",\"deaths\":\"203\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"220\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"164\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"173\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"160\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"98\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"South Carolina\",\"deaths\":\"434\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"810\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"677\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"171\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maine\",\"deaths\":\"154\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1180\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Missouri\",\"deaths\":\"679\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"201\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"986\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1539\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"524\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"510\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"2891\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"36909\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"948\",\"aadr\":\"11.8\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Alaska\",\"deaths\":\"24\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"161\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Nebraska\",\"deaths\":\"266\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Wisconsin\",\"deaths\":\"888\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"622\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"417\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Connecticut\",\"deaths\":\"565\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"67\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"713\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2415\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Oklahoma\",\"deaths\":\"425\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"156\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wisconsin\",\"deaths\":\"677\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"57\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"109\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"1134\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"745\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"736\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"361\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"352\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"537\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"518\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Mississippi\",\"deaths\":\"336\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"166\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1027\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1576\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"3037\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Washington\",\"deaths\":\"712\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"662\",\"aadr\":\"11.9\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New Jersey\",\"deaths\":\"1041\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Colorado\",\"deaths\":\"606\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Maine\",\"deaths\":\"231\",\"aadr\":\"12\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"517\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"South Carolina\",\"deaths\":\"690\",\"aadr\":\"12\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maine\",\"deaths\":\"175\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"563\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"132\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Montana\",\"deaths\":\"116\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"150\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"268\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2302\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"110\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"163\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"719\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"220\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"1212\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"532\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"522\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"656\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"162\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"New Hampshire\",\"deaths\":\"158\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1174\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"997\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"971\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Carolina\",\"deaths\":\"565\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"670\",\"aadr\":\"12.0\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Connecticut\",\"deaths\":\"568\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"District of Columbia\",\"deaths\":\"76\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Jersey\",\"deaths\":\"1257\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"472\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Connecticut\",\"deaths\":\"570\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Connecticut\",\"deaths\":\"584\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Connecticut\",\"deaths\":\"457\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"68\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2946\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"186\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"823\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"593\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"605\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"258\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"232\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"174\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"743\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"372\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Kansas\",\"deaths\":\"337\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Kentucky\",\"deaths\":\"495\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maine\",\"deaths\":\"161\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"678\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Missouri\",\"deaths\":\"693\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"38364\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"West Virginia\",\"deaths\":\"229\",\"aadr\":\"12.1\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"171\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Connecticut\",\"deaths\":\"604\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Florida\",\"deaths\":\"2802\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Montana\",\"deaths\":\"155\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"614\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"68\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"3050\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Florida\",\"deaths\":\"2923\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"179\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2421\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"78\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Florida\",\"deaths\":\"2029\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Kansas\",\"deaths\":\"325\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1221\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"686\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Mississippi\",\"deaths\":\"350\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Mississippi\",\"deaths\":\"343\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1174\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1106\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1439\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1412\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1631\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"132\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Tennessee\",\"deaths\":\"711\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"3254\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Vermont\",\"deaths\":\"81\",\"aadr\":\"12.2\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Colorado\",\"deaths\":\"659\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Colorado\",\"deaths\":\"550\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Nebraska\",\"deaths\":\"266\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"834\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"669\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"654\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"249\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Nebraska\",\"deaths\":\"245\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"217\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2465\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"675\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"72\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"790\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"557\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1213\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1162\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2003\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Dakota\",\"deaths\":\"81\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1465\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Rhode Island\",\"deaths\":\"129\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Dakota\",\"deaths\":\"94\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"39518\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Vermont\",\"deaths\":\"77\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Washington\",\"deaths\":\"809\",\"aadr\":\"12.3\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"249\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"District of Columbia\",\"deaths\":\"73\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Idaho\",\"deaths\":\"218\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oklahoma\",\"deaths\":\"546\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Washington\",\"deaths\":\"738\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Connecticut\",\"deaths\":\"569\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Idaho\",\"deaths\":\"186\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maine\",\"deaths\":\"239\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"594\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Hampshire\",\"deaths\":\"174\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"174\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Utah\",\"deaths\":\"270\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"592\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"580\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Florida\",\"deaths\":\"2086\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"583\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"567\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maine\",\"deaths\":\"175\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maine\",\"deaths\":\"171\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Missouri\",\"deaths\":\"715\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Pennsylvania\",\"deaths\":\"1647\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Washington\",\"deaths\":\"727\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"723\",\"aadr\":\"12.4\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Alaska\",\"deaths\":\"61\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Alaska\",\"deaths\":\"51\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Minnesota\",\"deaths\":\"745\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Jersey\",\"deaths\":\"1402\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Mexico\",\"deaths\":\"281\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"53\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2001\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Arizona\",\"deaths\":\"644\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Colorado\",\"deaths\":\"470\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"District of Columbia\",\"deaths\":\"70\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Hawaii\",\"deaths\":\"197\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"669\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New York\",\"deaths\":\"2440\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"North Dakota\",\"deaths\":\"118\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Wyoming\",\"deaths\":\"69\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"555\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"122\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Florida\",\"deaths\":\"2347\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Hawaii\",\"deaths\":\"175\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Louisiana\",\"deaths\":\"573\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Maine\",\"deaths\":\"166\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1261\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Michigan\",\"deaths\":\"1263\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Minnesota\",\"deaths\":\"683\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Mississippi\",\"deaths\":\"380\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Missouri\",\"deaths\":\"727\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2000\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Missouri\",\"deaths\":\"699\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Nebraska\",\"deaths\":\"232\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"South Dakota\",\"deaths\":\"102\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"3403\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Vermont\",\"deaths\":\"78\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"1072\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Wisconsin\",\"deaths\":\"724\",\"aadr\":\"12.5\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"Hawaii\",\"deaths\":\"260\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Alzheimer's disease (G30)\",\"cause_name\":\"Alzheimer's disease\",\"state\":\"New York\",\"deaths\":\"3174\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Alaska\",\"deaths\":\"58\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Indiana\",\"deaths\":\"962\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2010\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Hampshire\",\"deaths\":\"191\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"New Jersey\",\"deaths\":\"1356\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Oregon\",\"deaths\":\"522\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Maryland\",\"deaths\":\"630\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Minnesota\",\"deaths\":\"649\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"285\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"New Mexico\",\"deaths\":\"227\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Rhode Island\",\"deaths\":\"167\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Tennessee\",\"deaths\":\"768\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Alabama\",\"deaths\":\"604\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Arkansas\",\"deaths\":\"336\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2015\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Delaware\",\"deaths\":\"122\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2006\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Florida\",\"deaths\":\"2440\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Georgia\",\"deaths\":\"1295\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Indiana\",\"deaths\":\"809\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2008\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Iowa\",\"deaths\":\"380\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"1999\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Missouri\",\"deaths\":\"700\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"North Carolina\",\"deaths\":\"1284\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2014\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Ohio\",\"deaths\":\"1491\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Texas\",\"deaths\":\"3488\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2013\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"41149\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"United States\",\"deaths\":\"40600\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2011\",\"_113_cause_name\":\"Intentional self-harm (suicide) (*U03,X60-X84,Y87.0)\",\"cause_name\":\"Suicide\",\"state\":\"Virginia\",\"deaths\":\"1054\",\"aadr\":\"12.6\"}\n",
       ",{\"year\":\"2005\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Alaska\",\"deaths\":\"44\",\"aadr\":\"12.7\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Delaware\",\"deaths\":\"117\",\"aadr\":\"12.7\"}\n",
       ",{\"year\":\"2007\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Hawaii\",\"deaths\":\"199\",\"aadr\":\"12.7\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Nebraska\",\"deaths\":\"291\",\"aadr\":\"12.7\"}\n",
       ",{\"year\":\"2004\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Vermont\",\"deaths\":\"86\",\"aadr\":\"12.7\"}\n",
       ",{\"year\":\"2016\",\"_113_cause_name\":\"Influenza and pneumonia (J09-J18)\",\"cause_name\":\"Influenza and pneumonia\",\"state\":\"Virginia\",\"deaths\":\"1177\",\"aadr\":\"12.7\"}\n",
       ",{\"year\":\"2009\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Alaska\",\"deaths\":\"47\",\"aadr\":\"12.7\"}\n",
       ",{\"year\":\"2012\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Delaware\",\"deaths\":\"139\",\"aadr\":\"12.7\"}\n",
       ",{\"year\":\"2002\",\"_113_cause_name\":\"Nephritis, nephrotic syndrome and nephrosis (N00-N07,N17-N19,N25-N27)\",\"cause_name\":\"Kidney disease\",\"state\":\"Texas\",\"deaths\":\"2166\",\"aadr\":\"12.7\"}]\n",
       "</p></body></html>"
      ]
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from bs4 import BeautifulSoup\n",
    "\n",
    "soup = BeautifulSoup(page, \"lxml\")\n",
    "soup"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "bs4.BeautifulSoup"
      ]
     },
     "execution_count": 68,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(soup)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pdfminer.pdfinterp import PDFResourceManager, PDFPageInterpreter\n",
    "from pdfminer.converter import TextConverter\n",
    "from pdfminer.layout import LAParams\n",
    "from pdfminer.pdfpage import PDFPage\n",
    "from io import StringIO\n",
    "\n",
    "def convert_pdf_to_txt(path):\n",
    "    rsrcmgr = PDFResourceManager()\n",
    "    retstr = StringIO()\n",
    "    codec = 'utf-8'\n",
    "    laparams = LAParams()\n",
    "    device = TextConverter(rsrcmgr, retstr, codec=codec, laparams=laparams)\n",
    "    fp = open(path, 'rb')\n",
    "    interpreter = PDFPageInterpreter(rsrcmgr, device)\n",
    "    password = \"\"\n",
    "    maxpages = 0\n",
    "    caching = True\n",
    "    pagenos=set()\n",
    "\n",
    "    for page in PDFPage.get_pages(fp, pagenos, maxpages=maxpages, password=password,caching=caching, check_extractable=True):\n",
    "        interpreter.process_page(page)\n",
    "\n",
    "    text = retstr.getvalue()\n",
    "\n",
    "    fp.close()\n",
    "    device.close()\n",
    "    retstr.close()\n",
    "    return text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "text = convert_pdf_to_txt(\"HIV-Epidemiology-Annual-Report-2018.pdf\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'HIV Epidemiology \\nAnnual Report\\n2018\\n\\nSan Francisco  \\nDepartment of Public Health \\nPopulation Health Division\\n\\n\\x0c\\x0cHIV Epidemiology \\n\\nSan Francisco  \\nDepartment of Public Health \\nPopulation Health Division\\nHIV Epidemiology Section\\nSeptember 2019\\n\\nAnnual Report2018\\x0cThe HIV Epidemiology Annual Report is published annually by the HIV Epidemiology Section. To \\nobtain a free copy of the report, please contact:\\n\\n \\n \\n \\n \\n\\n \\n \\n\\nSan Francisco Department of Public Health\\nHIV Epidemiology Section\\n25 Van Ness Avenue, Suite 500\\nSan Francisco, CA 94102 USA\\n\\nPhone   \\nFax   \\n \\n\\n(415) 437-6335\\n(415) 431-0353\\n\\nThe HIV Epidemiology Annual Report 2018 is available on the internet at:\\n \\n\\nhttps://www.sfdph.org/dph/comupg/oprograms/HIVepiSec/HIVepiSecReports.asp\\n\\n\\x0cAcknowledgments\\n\\nThis  report  was  prepared  by  the  Applied  Research,  Community  Health \\nEpidemiology, and Surveillance Branch’s HIV Epidemiology Section staff. \\nWe wish to thank our colleagues in the Center for Public Health Research \\nBranch, Disease Prevention and Control Branch, Community Health Equity \\nand  Promotion  Branch,  and  the  San  Francisco  STOP  AIDS  Project  for \\nproviding data and critical input in this report.\\n\\nIn addition, we wish to acknowledge the contribution of persons with HIV, \\nHIV health care providers, community groups, researchers, and members \\nof the community. Publication of this report would not have been possible \\nwithout their cooperation, dedication, and hard work.\\n\\n\\x0c  San Francisco Department of Public Health\\n \\n\\nDirector of Health  Grant Colfax, MD\\n\\n \\n \\n\\n \\n  \\n \\n \\n \\n \\n\\n \\n\\n \\n \\n \\n \\n \\n \\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n \\n\\n   Health Officer and\\nDirector of Population Health Division \\n\\nTomás Aragón, MD, DrPH\\n\\nApplied Research, Community Health\\nEpidemiology, and Surveillance Branch\\n\\nDirector  Wayne Enanoria, PhD, MPH \\n\\nHIV Epidemiology Section\\nDirector \\n\\nSusan Scheer, PhD, MPH \\n\\nDirector of HIV Case Surveillance \\n\\nLing Hsu, MPH\\n\\nProgram Coordinators  Anthony Buckman, MS\\n\\n   Viva Delgado, MPH\\n  Maree Kay Parisi\\n  Qianya Vinson, MFA\\n \\nLead Epidemiologist \\n\\nSharon Pipkin, MPH\\n\\nEpidemiologists  Miao-Jung Mia Chen, PhD, MPH\\n\\n \\nJennie CS Chin, MBA\\n  Anne Hirozawa, MPH\\n  Alison Hughes, PhD, MPH\\nCatherine Kazbour, MPH\\n \\nElise Mara, MPH\\n \\n \\nChris Toomey, MPH \\n  Annie Vu, MPH \\n \\nStaff \\n\\nFinn Black\\n\\nBella Jackson\\n\\nJoseluis Gonzalez, MPH\\nJohn Guigayoma, MPH\\n\\n  Aida Flandez\\n \\n \\n  Oliver Harrison Jr.\\n \\n  Wiley Kornbluh\\n  Melody Nasser\\n \\n \\n \\n \\n \\n\\nPatrick Norton, PhD, MA\\nJan Bing Rosario\\nRufina San Juan\\nBelinda Van\\n\\nResearchers  Nancy Hessol, MSPH\\n\\nSandra Schwarcz, MD, MPH\\n\\n \\n \\n\\n(In alphabetic order by last name)\\n\\n\\x0cC Contents\\n\\nContents  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . i\\nList of Figures and Tables  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .\\nii\\nAbbreviations  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . ix\\nExecutive Summary  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . xi\\n1 .  Overview of HIV in San Francisco   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 1\\n2 .  Trends in HIV Diagnoses  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 13\\n3 .  Spectrum of Engagement in HIV Prevention and Care  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 17\\n4 .  Survival among Persons with HIV Disease Stage 3 (AIDS)  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 36\\n5 .  Trends in HIV Mortality   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 41\\n6 .  Health Insurance Status at Time of HIV Diagnosis   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 53\\n7 .  HIV among Men who Have Sex with Men  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 57\\n8 .  HIV among People who Inject Drugs  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 62\\n9 .  HIV among Heterosexuals   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 64\\n10 . HIV among Women  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 66\\n11 . HIV among Children, Adolescents and Young Adults   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 68\\n12 . HIV among Persons Aged 50 Years and Older  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 70\\n13 . HIV among Trans Women   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 73\\n14 . Housing Status among Persons Living with HIV   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 74\\n15 . Persons Co-infected with HIV and Sexually Transmitted Diseases  .  .  .  .  .  .  .  .  .  . . 77\\n16 . Pre-Exposure Prophylaxis  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 79\\n17 . Stigma among Persons with HIV  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 82\\n18 . Geographic Distribution of Persons with HIV  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 84\\nTechnical Notes  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 90\\nData Tables   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 98\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\ni\\n\\n\\x0cL\\n\\nList of Figures and Tables\\n\\n1 .  Overview of  HIV in San Francisco\\nTable 1.1 \\n\\nFigure 1.1 \\nFigure 1.2 \\nTable 1.2 \\n\\nTable 1.3 \\n\\nFigure 1.3 \\n\\nTable 1.4 \\n\\nTable 1.5 \\nTable 1.6 \\n\\nTable 1.7 \\n\\nFigure 1.4 \\nTable 1.8 \\n\\nFigure 2.2 \\n\\nFigure 2.3 \\n\\nFigure 2.4 \\n\\nFigure 2.5 \\n\\nCharacteristics of  persons living with HIV and persons newly diagnosed with HIV in San \\nFrancisco, California and the United States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1\\nHIV disease stage 3 (AIDS) cases, deaths, and prevalence, 1980-2018, San Francisco . . . . . . 2\\nHIV diagnoses, deaths, and prevalence, 2006-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . 3\\nTrends in persons newly diagnosed with HIV by demographic and risk characteristics, 2009-\\n2018, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4\\nTrends in persons living with HIV by demographic and risk characteristics, 2014-2018, San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5\\nSan Francisco HIV cases and out-of-jurisdiction HIV cases diagnosed in San Francisco, 2009-\\n2018, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6\\nCharacteristics of  persons living with HIV as of  December 2018 by residence status, San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7\\nCharacteristics of  persons living with HIV as of  December 2018, San Francisco  . . . . . . . . . 8\\nStage of  HIV disease at diagnosis among persons newly diagnosed with HIV in 2014-2017, \\nSan Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9\\nLate diagnoses among persons newly diagnosed with HIV in 2013-2017 by demographic and \\nrisk characteristics, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10\\nEstimated number of  new HIV infections, 2013-2017, San Francisco . . . . . . . . . . . . . . . . . 11\\nEstimated rate of  new HIV infections per 100,000 population by demographic and risk char-\\nacteristics, 2013-2017, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12\\n\\nNumber  of   persons  newly  diagnosed  with  HIV  by  race/ethnicity,  2009-2018,  San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .13\\nAnnual rates of  men newly diagnosed with HIV per 100,000 population by race/ethnicity, \\n2009-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14\\nAnnual rates of  women newly diagnosed with HIV per 100,000 population by race/ethnicity, \\n2009-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14\\nNumber  of   men  newly  diagnosed  with  HIV  by  transmission  category,  2009-2018,  San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15\\nNumber of  women newly diagnosed with HIV by transmission category, 2009-2018, San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15\\n\\n2 .  Trends in HIV Diagnoses\\nFigure 2.1 \\n\\nii  \\n\\nLIST OF FIGURES AND TABLES\\n\\n\\x0cTable 2.1 \\n\\nNumber of  persons newly diagnosed with HIV by gender and age at diagnosis, 2014-2018, San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16\\n\\n3 .  Spectrum of  Engagement in HIV Prevention and Care\\nFigure 3.1 \\n\\nFigure 3.2 \\nFigure 3.3 \\n\\nTable 3.1 \\n\\nTable 3.2 \\n\\nTable 3.3 \\n\\nTable 3.4 \\n\\nTable 3.5 \\n\\nTable 3.6 \\n\\nTable 3.7 \\n\\nFigure 3.4 \\n\\nFigure 3.5 \\n\\nFigure 3.6 \\n\\nTable 3.8 \\n\\nFigure 3.7 \\n\\nContinuum  of   HIV  care  among  persons  newly  diagnosed  with  HIV,  2013-2018,  San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17\\nContinuum of  HIV care among persons living with HIV, 2017, San Francisco . . . . . . . . . . 18\\nContinuum of  HIV care among persons living with diagnosed or undiagnosed HIV infection, \\n2017, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19\\nCare and prevention indicators among persons newly diagnosed with HIV and living with HIV, \\n2013-2017, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20\\nCare indicators among persons newly diagnosed with HIV in 2017 by demographic and risk \\ncharacteristics, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21\\nCare indicators among persons living with HIV in 2017 who resided in San Francisco at diag-\\nnosis, by demographic and risk characteristics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22\\nCare indicators among persons living with HIV in 2017 who were known to reside in San Francisco \\nas of the end of 2017, by demographic and risk characteristics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .23\\nCare indicators among persons who accepted and completed LINCS services in 2017 by demo-\\ngraphic and risk characteristics, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24\\nComparison of  HIV prevention and care indicators for San Francisco, California, and the \\nUnited States . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25\\nEstimate of  ART use among persons living with HIV as of  December 2018 and diagnosed in \\n2017 by demographic and risk characteristics, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . 26\\nEstimate of  ART use among persons living with HIV and with chart review, by nadir CD4 \\nlevel, December 2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27\\nTrends in median CD4 count at time of  ART initiation by CD4 count at time of  diagnosis, \\n2008-2017, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28\\nTrends in median CD4 count at time of  diagnosis and at time of  ART initiation among persons \\nnewly diagnosed with HIV, 2008-2017, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29\\nTime from HIV diagnosis to ART initiation among persons diagnosed with HIV in 2013-2017 \\nby demographic and risk characteristics, San Francisco  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30\\nKaplan-Meier estimates of  time from HIV diagnosis to ART initiation among persons diag-\\nnosed with HIV by year of  diagnosis, 2013-2017, San Francisco. . . . . . . . . . . . . . . . . . . . . . 31\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\niii\\n\\n\\x0cFigure 3.8 \\n\\nFigure 3.9 \\n\\nFigure 3.10 \\n\\nTable 3.9 \\n\\nKaplan-Meier estimates of time from HIV diagnosis to viral suppression among persons diag-\\nnosed with HIV by year of diagnosis, 2013-2017, San Francisco . . . . . . . . . . . . . . . . . . . . . . . 32\\nPersons living with HIV in 2018 who resided in San Francisco at diagnosis by care and most \\nrecent residence status. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33\\nPersons living with HIV who received care in San Francisco in 2018 by residence at diagnosis \\nand most recent residence status  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34\\nCharacteristics of persons living with HIV who received care in San Francisco in 2018 by most \\nrecent residence status. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35\\n\\n4 .  Survival among Persons with HIV Disease Stage 3 (AIDS)\\nFigure 4.1 \\n\\nKaplan-Meier survival curves for persons diagnosed with stage 3 HIV (AIDS) in five time \\nperiods, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36\\nKaplan-Meier survival curves for persons diagnosed with stage 3 HIV (AIDS) between 2012 \\nand 2016 by racial/ethnic group, San Francisco  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37\\nKaplan-Meier survival curves for persons diagnosed with stage 3 HIV (AIDS) between 2012 \\nand 2016 by transmission category, San Francisco  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38\\nKaplan-Meier survival curves for persons diagnosed with stage 3 HIV (AIDS) between 2012 \\nand 2016 by gender, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39\\nThree-year survival probability after stage 3 HIV (AIDS) for persons diagnosed between 2012 \\nand 2016 by racial/ethnic group, transmission category, and gender, San Francisco  . . . . . . 40\\n\\n5 .  Trends in HIV Mortality\\nTable 5.1 \\n\\nDeaths among persons diagnosed with HIV, by demographic and risk characteristics, 2013-\\n2017, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41\\nCase-fatality rates per 1,000 due to HIV-related and non-HIV-related causes among persons diag-\\nnosed with HIV, 2008-2017, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42\\nAge-adjusted mortality rates among persons aged 18 and older with HIV per 100,000 by sex \\nand race/ethnicity, 2008-2017, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43\\nUnderlying  causes  of   death  among  persons  diagnosed  with  HIV,  2006-2017,  San \\nFrancisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44\\nUnderlying  causes  of   death  among  persons  diagnosed  with  HIV  by  sex,  2006-2017,  San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45\\nUnderlying causes of  death among persons diagnosed with HIV by race/ethnicity, 2006-2017, \\nSan Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46\\n\\nFigure 4.2 \\n\\nFigure 4.3 \\n\\nFigure 4.4 \\n\\nFigure 4.5 \\n\\nTable 5.2 \\n\\nFigure 5.1 \\n\\nTable 5.3 \\n\\nTable 5.4 \\n\\nTable 5.5 \\n\\niv  \\n\\nLIST OF FIGURES AND TABLES\\n\\n\\x0cTable 5.6 \\n\\nTable 5.7 \\n\\nTable 5.8 \\n\\nTable 5.9 \\n\\nTable 5.10 \\n\\nTable 5.11 \\n\\nUnderlying causes of  death among persons diagnosed with HIV by select transmission catego-\\nries , 2006-2017, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47\\nMultiple  causes  of   death  among  persons  diagnosed  with  HIV,  2006-2017,  San \\nFrancisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48\\nMultiple  causes  of   death  among  persons  diagnosed  with  HIV  by  sex,  2006-2017,  San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49\\nMultiple causes of  death among persons diagnosed with HIV by race/ethnicity, 2006-2017, \\nSan Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50\\nMultiple causes of  death among persons diagnosed with HIV by select transmission categories, \\n2006-2017, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51\\nMultiple causes of  death among persons diagnosed with HIV by housing status, 2006-2017, \\nSan Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52\\n\\n6 .  Health Insurance Status at Time of  HIV Diagnosis\\nFigure 6.1 \\n\\nHealth insurance status at time of  HIV diagnosis by race/ethnicity, gender, and year of  diag-\\nnosis, 2014-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53\\nTrends in health insurance status at time of HIV diagnosis by race/ethnicity, 2014-2018, San \\nFrancisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54\\nHealth  insurance  status  at  time  of   HIV  diagnosis  by  race/ethnicity,  2014-2018,  San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55\\nHealth insurance status at time of HIV diagnosis by gender, 2014-2018, San Francisco  . . . . . 56\\n\\nFigure 6.4 \\n7 .  HIV among Men who Have Sex with Men\\nFigure 7.1 \\n\\nNumber  of   MSM  newly  diagnosed  with  HIV  by  race/ethnicity,  2009-2018,  San \\nFrancisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57\\nPercent of  MSM reporting condomless anal intercourse in the last six months by self-reported \\nHIV status, the STOP AIDS Project, 2009-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . 58\\nMale rectal gonorrhea and male gonococcal proctitis among MSM by HIV serostatus, 2009-\\n2018, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59\\nEarly syphilis among MSM by HIV serostatus, 2009-2018, San Francisco  . . . . . . . . . . . . . . 60\\nSubstance use among MSM, the STOP AIDS Project, 2009-2018, San Francisco  . . . . . . . . 61\\n\\nFigure 6.2 \\n\\nFigure 6.3 \\n\\nFigure 7.2 \\n\\nFigure 7.3 \\n\\nFigure 7.4 \\nFigure 7.5 \\n8 .  HIV among People who Inject Drugs\\nFigure 8.1 \\n\\nNumber of  non-MSM PWID newly diagnosed with HIV by race/ethnicity, 2009-2018, San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\nv\\n\\n\\x0cFigure 8.2 \\n\\nNumber of  non-MSM PWID newly diagnosed with HIV by age group at HIV diagnosis, 2009-\\n2018, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63\\n\\n9 .  HIV among Heterosexuals\\nFigure 9.1 \\n\\nNumber  of   heterosexuals  newly  diagnosed  with  HIV  by  race/ethnicity,  2009-2018,  San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64\\nEarly syphilis among heterosexual men, 2009-2018, San Francisco . . . . . . . . . . . . . . . . . . . . 65\\nEarly syphilis among women, 2009-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65\\n\\nFigure 9.2 \\nFigure 9.3 \\n10 . HIV among Women\\nFigure 10.1  Number  of   women  newly  diagnosed  with  HIV  by  race/ethnicity,  2009-2018,  San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .66\\nFigure 10.2  Women living with HIV diagnosed through December 2018 and female population by race/\\nethnicity, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67\\nFigure 10.3  Women living with HIV diagnosed through December 2018 by transmission category, San \\nFrancisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67\\n\\n11 .  HIV among Children, Adolescents and Young Adults\\nTable 11.1 \\n\\nYoung adults living with HIV by transmission category, gender, and race/ethnicity, December \\n2018, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68\\nNumber of  adolescents and young adults newly diagnosed with HIV, 2014-2018, San Francisco \\nand the United States. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68\\nFigure 11.1  Number of  children diagnosed with HIV by time period of  HIV diagnosis, 1980-2018, San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .69\\n\\nTable 11.2 \\n\\n12 . HIV among Persons Aged 50 Years and Older\\nTable 12.1 \\n\\nCharacteristics  of   persons  living  with  HIV  by  age  group,  December  2018,  San \\nFrancisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 70\\nFigure 12.1  Number and percent of  persons newly diagnosed with HIV at age 50 years and older, 2009-\\n2018, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71\\nCharacteristics of  persons newly diagnosed with HIV in 2009-2018 by age at diagnosis, San \\nFrancisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72\\n\\nTable 12.2 \\n\\n13 . HIV among Trans Women\\nTable 13.1 \\n\\nTable 13.2 \\n\\nCharacteristics of  trans women compared to all persons newly diagnosed with HIV in 2009-\\n2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73\\nCharacteristics of  trans women living with HIV compared to all persons living with HIV, \\nDecember 2018, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73\\n\\nvi  \\n\\nLIST OF FIGURES AND TABLES\\n\\n\\x0c14 . Housing Status among Persons Living with HIV\\nFigure 14.1  Number and percent of  homeless persons newly diagnosed with HIV by year of  diagnosis, \\n2009-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74\\nCharacteristics of  homeless persons compared to all persons newly diagnosed with HIV in \\n2009-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75\\nCharacteristics of  persons who were homeless or lived in SRO facility during 2018 compared \\nto all PLWH  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76\\n\\nTable 14.1 \\n\\nTable 14.2 \\n\\n15 . Persons Co-infected with HIV and Sexually Transmitted Diseases\\nFigure 15.1  Number of  STD diagnoses among persons living with HIV by year of  STD diagnosis, 2013-\\n2017, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77\\nDemographic characteristics of  persons living with HIV who were diagnosed with STD, 2013-\\n2017, San Francisco. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78\\n\\nTable 15.1 \\n\\n16 . Pre-Exposure Prophylaxis\\nFigure 16.1 \\nFigure 16.2 \\n\\nPrEP Cascade among MSM and Trans women, 2016, San Francisco  . . . . . . . . . . . . . . . . . . . 79\\nProportion of  MSM currently on PrEP by race/ethnicity, San Francisco City Clinic patients, \\n2014-2018. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80\\nPrEP screening, appointments and PrEP initiation among clients being served by selected \\ncommunity based organizations, San Francisco, August 2016 - March 2019. . . . . . . . . . . . . 80\\nPrEP Cascade among clients being served by selected community based organizations, San \\nFrancisco, August 2016 - March 2019 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81\\n\\nFigure 16.3 \\n\\nFigure 16.4 \\n\\n17 . Stigma among Persons with HIV\\nTable 17.1 \\n\\nPrevalence of stigma measures by demographic factors, Medical Monitoring Project, 2015-2017, \\nSan Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 82\\nPrevalence of stigma measures by Medical Monitoring Project, 2015-2017, San Francisco. . . . . 83\\n\\nFigure 17.1 \\n18 . Geographic Distribution of  Persons with HIV\\nMap 18.1 \\n\\nGeographic distribution of persons living with HIV who resided in San Francisco as of December \\n2018. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84\\nHIV prevalence per 100,000 population by neighborhood, 2018, San Francisco . . . . . . . . . 85\\nGeographic distribution of  rates of  HIV diagnosis per 100,000 population per two years for \\npersons newly diagnosed in 2017-2018, San Francisco . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86\\nGeographic distribution of proportion of persons living with HIV as of December 2017 and diag-\\nnosed through 2016 who were virally suppressed in 2017, San Francisco . . . . . . . . . . . . . . . . . . . 87\\n\\nMap 18.2 \\nMap 18.3 \\n\\nMap 18.4 \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  vii\\n\\n\\x0cMap 18.5 \\n\\nMap 18.6 \\n\\nGeographic distribution of  proportion of  persons newly diagnosed with HIV in 2013-2017 \\nwho were linked to care within one month of  diagnosis, San Francisco . . . . . . . . . . . . . . . . 88\\nGeographic distribution of  proportion of  persons newly diagnosed with HIV in 2013-2017 \\nwho achieved viral suppression within 12 months of  diagnosis, San Francisco . . . . . . . . . . 89\\n\\nviii  \\n\\nLIST OF FIGURES AND TABLES\\n\\n\\x0cA\\n\\nAbbreviations\\n\\n \\n \\n \\n \\n\\nAntiretroviral therapy\\nCenters for Disease Control and Prevention\\nMedical Monitoring Project\\nMen who have sex with men\\n\\nART \\nCDC \\nMMP \\nMSM \\nMSM-PWID    Men who have sex with men and who also inject drugs\\nNHBS \\nOOJ \\nPLWH \\nPrEP \\nPWID \\nSFDPH \\nSRO \\nSTD \\nTWSM \\nTWSM-PWID \\n\\nNational HIV Behavioral Surveillance\\nOut-of-jurisdiction\\nPersons living with HIV\\nPre-exposure prophylaxis\\nPeople who inject drugs\\nSan Francisco Department of  Public Health\\nSingle-Room Occupancy\\nSexually transmitted diseases\\nTrans women who have sex with men\\nTrans women who have sex with men and who also inject drugs\\n\\n \\n \\n \\n \\n \\n \\n \\n \\n \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\nix\\n\\n\\x0c\\x0cE\\n\\nExecutive Summary\\n\\nThis is an exciting time in HIV prevention and care for the city of  San Francisco. Significant progress has been \\nmade and San Francisco is on track to meet its goal to be the first city in the United States to achieve zero new \\nHIV infection. There are many encouraging trends, although some disparities and areas for improvement are \\nevident in this 2018 report. Of  note, the number of  new diagnoses dropped below 200, to 197, the lowest \\nnumber ever recorded. \\nTrends and Successes\\n\\n67% of  PLWH in San Francisco were over the age of  50; 30% were over age 60.\\n\\n ▪ New HIV diagnoses declined 13% from 227 diagnoses in 2017 to 197 diagnoses in 2018.\\n ▪ Overall, 94% of  PLWH were aware of  their HIV diagnosis.\\n ▪\\n ▪ No children (age <13) were diagnosed with HIV since 2005.\\n ▪ The majority of  persons newly diagnosed with HIV continue to be MSM. \\n ▪ Most new diagnoses (31%) were among people aged 30-39 years. \\n ▪\\n ▪ Median time from diagnosis to first care visit declined from 8 days in 2013 to 4 days in 2017.\\n ▪ Median time from first care visit to initiation of  antiretroviral therapy declined from 27 days in 2013 \\n\\n91% of  new diagnoses in 2018 were linked to care within one month of  diagnosis.\\n\\nto 0 days in 2017.\\n\\n ▪ Median time from diagnosis to viral suppression has declined from 135 days in 2013 to 62 days is 2017. \\n\\nDisparities and Health Inequities\\n\\n ▪ New diagnoses increased among African American and Latinx persons. For the first time, the number \\n\\nand proportion of  new HIV diagnoses among Latinxs exceeded the number among whites. \\n\\n ▪ African American men and women had the highest HIV diagnosis rates by race, with rates per 100,000 \\n\\npopulation of  145 and 35, respectively, followed by Latinx men and women. \\n\\n ▪ Compared to the overall proportion of  viral suppression among PLWH (74%), viral suppression was \\nlower for women (66%), trans women (68%), African Americans (68%), PWID (65%), MSM-PWID \\n(68%), TWSM-PWID (64%), and was particularly low among homeless individuals (33%). \\n27% of  trans women, 23% of  men and 15% of  women had no insurance at time of  diagnosis.\\n\\n ▪\\n ▪ The number and proportion of  persons homeless at diagnosis has continued to rise; there were 40 \\n\\n(20%) new diagnoses in 2018 compared to 25 (11%) in 2016.\\n\\n ▪ The number and proportion of  diagnoses among PWID has continued to rise; there were 27 (14%) \\n\\nnew diagnoses in 2018 compared to 21 (9%) in 2016.\\n\\n ▪ Three-year survival following an AIDS diagnosis was lowest among African Americans (82%) compared \\n\\nto other races; and PWID (79%) compared to other transmission categories.\\n\\nThe overall decline in new HIV diagnoses and improvements in HIV care outcomes are encouraging. However, \\nthe disparities faced by our most vulnerable populations highlight the need to address and achieve the Getting \\nto Zero goal of zero stigma and discrimination if we are to reach zero new HIV transmissions among everyone. \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\nxi\\n\\n\\x0c\\x0c1\\n\\nOverview of HIV in San Francisco\\n\\n15,990 \\n\\nSan FranciSco reSidentS \\n\\nwere diagnoSed and \\nliving with hiv aS oF \\n\\n12/31/2018\\n\\n12% oF Plwh in \\n\\ncaliFornia\\n\\n2% \\n\\nStateS\\n\\noF Plwh in the United \\n\\n ▪\\n\\nSan Francisco living HIV cases were more likely to be men and white, \\nand men who have sex with men (MSM), including MSM who also inject \\ndrugs (MSM-PWID), compared to persons living with HIV (PLWH) in \\nCalifornia and the United States.\\n\\n ▪ Newly diagnosed people with HIV in San Francisco were more likely to \\nbe men, Latinx or Asian/Pacific Islander compared to persons newly \\ndiagnosed with HIV nationally.\\n\\n ▪ Newly diagnosed people with HIV in San Francisco were more likely to \\nbe PWID (MSM and non-MSM) compared to persons newly diagnosed \\nwith HIV in California and the United States.\\n\\n ▪ Newly diagnosed persons in San Francisco in 2018 had a greater proportion \\nof African Americans, Latinxs, and non-MSM PWID compared to all San \\nFranciscans living with HIV.\\n\\nLiving HIV Cases\\n\\nNewly Diagnosed HIV Cases\\n\\nSan Francisco1 \\n\\nCalifornia2 \\n\\nUnited States3 \\n\\nSan Francisco1 \\n\\nCalifornia2 \\n\\nUnited States3 \\n\\n2018\\n\\n2017\\n\\n2016\\n\\n(N = 15,990)\\n\\n(N = 135,082)\\n\\n(N =1,008,929)\\n\\n2018\\n\\n(N = 197)\\n\\n2017\\n\\n2017\\n\\n(N = 4,791)\\n\\n(N = 38,739)\\n\\n4\\n\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\n5\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\nMen\\nWomen\\nTrans Women\\nTrans Men\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nNative American\\nOther/Unknown\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n\\n92%\\n6%\\n2%\\n<1%\\n58%\\n12%\\n20%\\n6%\\n<1%\\n3%\\n73%\\n1%\\n6%\\n14%\\n1%\\n4%\\n2%\\n\\n87%\\n12%\\n1%\\n<1%\\n40%\\n18%\\n35%\\n4%\\n<1%\\n2%\\n67%\\n--\\n6%\\n7%\\n--\\n15%\\n5%\\n\\n76%\\n24%\\n--\\n--\\n30%\\n41%\\n23%\\n1%\\n<1%\\n4%\\n54%\\n--\\n13%\\n5%\\n--\\n26%\\n2%\\n\\n88%\\n9%\\n3%\\n1%\\n29%\\n21%\\n38%\\n8%\\n<1%\\n3%\\n63%\\n2%\\n14%\\n10%\\n1%\\n5%\\n6%\\n\\n87%\\n11%\\n2%\\n<1%\\n26%\\n17%\\n47%\\n8%\\n<1%\\n3%\\n63%\\n--\\n5%\\n3%\\n--\\n17%\\n11%\\n\\n81%\\n19%\\n--\\n--\\n26%\\n43%\\n26%\\n3%\\n<1%\\n2%\\n66%\\n--\\n6%\\n3%\\n--\\n24%\\n<1%\\n\\n1  San Francisco data are reported through April 12, 2019 for cases diagnosed through December 31, 2018. San Francisco 2018 new diagnoses may be revised \\n\\ndue to case reporting delay. Death reporting not complete for 2018; San Francisco PLWH may be revised downward.\\n\\n2  California data are reported through January 9, 2019 for cases diagnosed through December 31, 2017. California’s new diagnosis case count does not include \\n\\npersons with unreported race and ethnicity.\\n\\n3  U.S. data are reported through June 30, 2018 and reflect cases diagnosed through December 31, 2017. U.S. living cases available through December 31, 2016 \\ndue to delays in death reporting. U.S. data reflect unadjusted numbers for 50 states and 6 dependent areas and may be found in the Centers for Disease Control \\nand Prevention. HIV Surveillance Report, 2017; vol. 29. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published November 2018. Accessed \\n[May 1, 2019]. U.S. racial/ethnic group data for new diagnoses only reflect persons with racial/ethnic group information.\\n\\n4  Data on trans women and trans men are not reported by the United States.\\n5  U.S. transmission category data for adults and adolescents have been statistically adjusted for missing values. \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n1\\n\\nTable 1.1 Characteristics of persons living with HIV and persons newly diagnosed with HIV in San Francisco, California and the United States\\x0c ▪ The number of  San Francisco residents at time of  diagnosis with HIV stage 3 (AIDS) reached a peak in \\n\\n1992 and has declined in all subsequent years.\\n\\n ▪ Beginning in 1995, the number of  deaths among people ever classified as stage 3 has decreased dramatically \\n\\ndue to antiretroviral therapies (ART).\\nFrom 1999 the number of  new stage 3 diagnoses and the number of  deaths continued to decline but at a \\nslower rate than from 1995 to 1998.\\n\\n ▪\\n\\n ▪ There were 9,167 San Francisco residents at time of  diagnosis living with HIV ever classified as stage 3 \\n\\nby the end of  2018. \\n\\ns\\nh\\nt\\na\\ne\\nD\\ns\\ne\\ns\\na\\nC\\n\\n/\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n10,000\\n\\n8,000\\n\\n6,000\\n\\n4,000\\n\\n2,000\\n\\n0\\n\\nPersons living with HIV ever classified as stage 3\\nHIV disease stage 3 cases\\nHIV disease stage 3 deaths\\n\\n80\\n\\n82\\n\\n84\\n\\n86\\n\\n88\\n\\n90\\n\\n92\\n\\n98\\n\\n96\\n\\n94\\n04\\nYear of Diagnosis/Death\\n\\n00\\n\\n02\\n\\n06\\n\\n08\\n\\n10\\n\\n12\\n\\n14\\n\\n16\\n\\n18\\n\\n1  Death reporting for 2018 is not complete.\\n\\n2  \\n\\nOVERVIEW OF HIV IN SAN FRANCISCO\\n\\nFigure 1.1 HIV disease stage 3 (AIDS) cases, deaths, and prevalence, 1980-2018, San Francisco\\x0c ▪ The number of  new HIV diagnoses declined from 534 in 2006 to 197 in 2018.\\n ▪ The number of  deaths each year fluctuated but remained relatively stable from 2008 to 2017. \\n ▪ The number of  PLWH increased each year until deaths in PLWH began to exceed new diagnoses in 2016.\\n ▪ The provisional number of  PLWH at the end of  2018 is 15,990; this will be revised when death reporting \\n\\nfor 2018 is complete.\\n\\nLiving HIV cases\\nNew HIV diagnoses\\nDeaths\\n\\n2\\n\\n1\\n\\n14,415 14,624 14,881 15,101 15,324 15,513 15,742 15,880 15,961 15,986 15,985 15,960 15,990\\n\\n534\\n\\n533\\n\\n521\\n\\n472\\n\\n467\\n\\n465\\n\\n425\\n\\n399\\n\\n321\\n\\n264\\n\\n252\\n\\n244\\n\\n236\\n\\n236\\n\\n261\\n\\n240\\n\\n300\\n\\n326\\n\\n324\\n\\n281\\n\\n256\\n\\n235\\n\\n234\\n\\n252\\n\\n227\\n\\n5,000\\n\\n197\\n\\n20,000\\n\\n15,000\\n\\n10,000\\n\\ni\\n\\nN\\nu\\nm\\nb\\ne\\nr\\n \\no\\nf\\n \\nL\\nv\\nn\\ng\\nH\\nV\\nC\\na\\ns\\ne\\ns\\n\\ni\\n\\n \\n\\nI\\n\\n \\n\\n/\\n\\ns\\nh\\nt\\na\\ne\\nD\\ns\\ne\\ns\\no\\nn\\ng\\na\\nD\\nV\\nH\\nw\\ne\\nN\\n\\n \\n\\nI\\n\\n \\n\\ni\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n800\\n\\n700\\n\\n600\\n\\n500\\n\\n400\\n\\n200\\n\\n100\\n\\n0\\n\\n2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018\\n\\n0\\n\\nYear\\n\\n1  See Technical Notes “Date of  Initial HIV Diagnosis.”\\n2  Death data for 2018 not complete and not displayed.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n3\\n\\nFigure 1.2 HIV diagnoses, deaths, and prevalence, 2006-2018, San Francisco\\x0c ▪ The majority of  persons newly diagnosed with HIV between 2009 and 2018 were men and MSM.\\n ▪\\n\\nFrom 2012 to 2018, there have been increases in proportions of  African Americans and Latinxs and \\ndeclines in proportions of  whites. \\nFrom 2017 to 2018, the racial/ethnic group accounting for the largest proportion of  annual diagnosed \\npersons shifted from white to Latinx.\\n\\n ▪\\n\\n ▪ Over time, most new diagnoses are among people aged 30-39 years.\\n ▪ While the numbers are small, the proportion of  women diagnosed trended upward in 2015 through 2018, \\n\\ncompared to 2012 to 2014.\\n\\n ▪ No children (<13 years) were diagnosed with HIV during 2009 to 2018.\\n\\nTotal Number\\nMen\\nWomen\\nTrans Women\\nTrans Men\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nNative American\\nMulti-race\\nUnknown\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50+\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n\\n2009\\n472\\n89%\\n6%\\n5%\\n0%\\n48%\\n13%\\n24%\\n9%\\n<1%\\n5%\\n<1%\\n<1%\\n13%\\n14%\\n30%\\n26%\\n17%\\n67%\\n3%\\n5%\\n15%\\n2%\\n5%\\n3%\\n\\nYear of Initial HIV Diagnosis1\\n\\n2010\\n467\\n89%\\n8%\\n4%\\n0%\\n48%\\n13%\\n23%\\n9%\\n<1%\\n6%\\n<1%\\n1%\\n12%\\n14%\\n31%\\n28%\\n14%\\n63%\\n3%\\n8%\\n13%\\n1%\\n8%\\n4%\\n\\n2011\\n425\\n87%\\n10%\\n3%\\n0%\\n52%\\n15%\\n20%\\n8%\\n<1%\\n4%\\n<1%\\n0%\\n10%\\n16%\\n27%\\n31%\\n16%\\n69%\\n2%\\n7%\\n12%\\n1%\\n7%\\n2%\\n\\n2012\\n465\\n92%\\n5%\\n3%\\n0%\\n49%\\n11%\\n24%\\n11%\\n1%\\n3%\\n<1%\\n0%\\n14%\\n16%\\n30%\\n28%\\n12%\\n75%\\n2%\\n5%\\n11%\\n<1%\\n6%\\n2%\\n\\n2013\\n399\\n91%\\n6%\\n3%\\n0%\\n45%\\n12%\\n26%\\n12%\\n1%\\n4%\\n<1%\\n0%\\n15%\\n20%\\n29%\\n25%\\n12%\\n75%\\n3%\\n5%\\n12%\\n1%\\n4%\\n1%\\n\\n2014\\n321\\n93%\\n4%\\n3%\\n0%\\n42%\\n10%\\n29%\\n14%\\n<1%\\n4%\\n0%\\n<1%\\n12%\\n18%\\n29%\\n23%\\n17%\\n73%\\n2%\\n8%\\n12%\\n1%\\n3%\\n1%\\n\\n2015\\n281\\n88%\\n10%\\n2%\\n0%\\n40%\\n15%\\n27%\\n12%\\n<1%\\n5%\\n<1%\\n1%\\n14%\\n23%\\n30%\\n21%\\n11%\\n73%\\n2%\\n6%\\n9%\\n<1%\\n7%\\n2%\\n\\n2016\\n234\\n86%\\n10%\\n3%\\n<1%\\n38%\\n15%\\n29%\\n15%\\n0%\\n3%\\n0%\\n0%\\n14%\\n23%\\n32%\\n16%\\n15%\\n68%\\n2%\\n9%\\n9%\\n1%\\n7%\\n3%\\n\\n2017\\n227\\n85%\\n12%\\n3%\\n0%\\n36%\\n17%\\n29%\\n13%\\n1%\\n5%\\n0%\\n1%\\n10%\\n17%\\n35%\\n21%\\n16%\\n60%\\n1%\\n11%\\n12%\\n1%\\n7%\\n7%\\n\\n2018\\n197\\n88%\\n9%\\n3%\\n1%\\n29%\\n21%\\n38%\\n8%\\n1%\\n3%\\n0%\\n1%\\n15%\\n20%\\n31%\\n20%\\n13%\\n63%\\n2%\\n14%\\n10%\\n1%\\n5%\\n6%\\n\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\n\\ni\\n\\n \\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\nV\\nH\\n \\nt\\na\\ne\\ng\\nA\\n\\nI\\n\\n \\n\\n)\\ns\\nr\\na\\ne\\ny\\n(\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\nn\\no\\ni\\ns\\ns\\ni\\n\\n \\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\n1  Data include persons diagnosed with HIV in any stage and reported as of  April 12, 2019. Percentages may not add to 100 due to rounding. See Technical Notes \\n\\n“Date of  Initial HIV Diagnosis.”\\n\\n4  \\n\\nOVERVIEW OF HIV IN SAN FRANCISCO\\n\\nTable 1.2 Trends in persons newly diagnosed with HIV by demographic and risk characteristics, 2009-2018, San Francisco\\x0c ▪ Gender, racial/ethnic and risk distributions of  PLWH remained mostly stable between 2014 and 2018; \\n\\ncases were predominately men, white, and MSM (including MSM-PWID).\\nPersons living with HIV aged 40-49 years declined from 27% in 2014 to 20% in 2018.\\nPersons living with HIV continued to shift into older age groups with the largest proportion among \\npersons aged 50-59 years (36%) and a steady increase observed among persons aged 60-69 years (17% to \\n23% from 2014 to 2018).\\n\\n ▪\\n ▪\\n\\nTotal1\\nMen\\nWomen\\nTrans Women\\nTrans Men\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nNative American\\nMulti-race\\nUnknown\\n  0 - 12\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50 - 59\\n60 - 69\\n70+\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n\\n2014\\n\\n2015\\n\\n15,961\\n14,660 (92)\\n901 ( 6)\\n395 ( 2)\\n5 (<1)\\n9,506 ( 1)\\n1,938 (12)\\n3,019 (19)\\n900 ( 6)\\n62 (<1)\\n529 ( 3)\\n7 (<1)\\n3 (<1)\\n2 (<1)\\n141 ( 1)\\n491 ( 3)\\n1,897 (12)\\n4,330 (27)\\n5,744 (36)\\n2,781 (17)\\n572 ( 4)\\n11,525 (72)\\n219 ( 1)\\n940 ( 6)\\n2,318 (15)\\n173 ( 1)\\n547 ( 3)\\n239 ( 1)\\n\\n15,986\\n14,679 (92)\\n901 ( 6)\\n401 ( 3)\\n5 (<1)\\n9,473 (59)\\n1,931 (12)\\n3,063 (19)\\n927 ( 6)\\n63 (<1)\\n521 ( 3)\\n8 (<1)\\n3 (<1)\\n4 (<1)\\n137 ( 1)\\n467 ( 3)\\n1,850 (12)\\n3,942 (25)\\n5,837 (37)\\n3,067 (19)\\n679 ( 4)\\n11,592 (73)\\n224 ( 1)\\n914 ( 6)\\n2,280 (14)\\n174 ( 1)\\n561 ( 4)\\n241 ( 2)\\n\\n2016\\n\\nNumber (%)\\n15,985\\n14,683 (92)\\n898 ( 6)\\n398 ( 2)\\n6 (<1)\\n9,421 (59)\\n1,914 (12)\\n3,103 (19)\\n958 ( 6)\\n63 (<1)\\n518 ( 0)\\n8 (<1)\\n2 (<1)\\n3 (<1)\\n118 ( 1)\\n438 ( 3)\\n1,803 (11)\\n3,638 (23)\\n5,869 (37)\\n3,305 (21)\\n809 ( 5)\\n11,631 (73)\\n224 ( 1)\\n900 ( 6)\\n2,245 (14)\\n171 ( 1)\\n568 ( 4)\\n246 ( 2)\\n\\n2017\\n\\n2018\\n\\n15,960\\n14,655 (92)\\n904 ( 6)\\n395 ( 2)\\n6 (<1)\\n9,338 (59)\\n1,909 (12)\\n3,134 (20)\\n984 ( 6)\\n65 (<1)\\n522 ( 3)\\n8 (<1)\\n0 ( 0)\\n5 (<1)\\n103 ( 1)\\n398 ( 2)\\n1,773 (11)\\n3,360 (21)\\n5,866 (37)\\n3,504 (22)\\n951 ( 6)\\n11,638 (73)\\n222 ( 1)\\n888 ( 6)\\n2,210 (14)\\n170 ( 1)\\n575 ( 4)\\n257 ( 2)\\n\\n15,990\\n14,684 (92)\\n903 ( 6)\\n396 ( 2)\\n7 (<1)\\n9,314 (58)\\n1,908 (12)\\n3,184 (20)\\n993 ( 6)\\n67 (<1)\\n516 ( 3)\\n8 (<1)\\n0 ( 0)\\n4 (<1)\\n98 ( 1)\\n346 ( 2)\\n1,727 (11)\\n3,124 (20)\\n5,827 (36)\\n3,750 (23)\\n1,114 ( 7)\\n11,681 (73)\\n223 ( 1)\\n887 ( 6)\\n2,186 (14)\\n170 ( 1)\\n575 ( 4)\\n268 ( 2)\\n\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n \\n\\n)\\nr\\na\\ne\\ny\\nh\\nc\\na\\ne\\n \\nf\\no\\nd\\nn\\ne\\n \\nt\\na\\n(\\n\\n \\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\n1  Persons living with HIV at the end of  each year.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n5\\n\\nTable 1.3 Trends in persons living with HIV by demographic and risk characteristics, 2014-2018, San Francisco\\x0c ▪ The number and proportion of  out-of-jurisdiction (OOJ) residents diagnosed in San Francisco increased \\n\\nin 2018.\\n\\n ▪ Among all cases reported by the San Francisco Department of Public Health each year, 28% to 35% resided \\n\\noutside of  San Francisco at the time of diagnosis (blue bar).\\n\\nI\\n\\nV\\nH\\nh\\nt\\ni\\n\\n \\n\\n \\n\\ni\\n\\nw\\nd\\ne\\ns\\no\\nn\\ng\\na\\nd\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n650\\n600\\n550\\n500\\n450\\n400\\n350\\n300\\n250\\n200\\n150\\n100\\n50\\n0\\n\\nSan Francisco Residents\\n\\nOut-of-Jurisdiction Residents\\n\\n72%\\n472\\n\\n69%\\n467\\n\\n71%\\n465\\n\\n70%\\n425\\n\\n68%\\n399\\n\\n209\\n31%\\n\\n180\\n28%\\n\\n182\\n30%\\n\\n192\\n29%\\n\\n186\\n32%\\n\\n68%\\n321\\n\\n69%\\n281\\n\\n67%\\n234\\n\\n71%\\n227\\n\\n65%\\n197\\n\\n149\\n32%\\n\\n125\\n31%\\n\\n115\\n33%\\n\\n91\\n29%\\n\\n105\\n35%\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n100%\\n\\n90%\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\n \\n\\n%\\no\\nf\\n \\nt\\no\\nt\\na\\n\\nl\\n \\n\\ni\\n\\nd\\na\\ng\\nn\\no\\ns\\ne\\nd\\nw\\n\\n \\n\\n \\n\\ni\\nt\\nh\\nH\\nV\\n\\nI\\n\\n1  See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\nYear of HIV Diagnosis1\\n\\n6  \\n\\nOVERVIEW OF HIV IN SAN FRANCISCO\\n\\nFigure 1.3 San Francisco HIV cases and out-of-jurisdiction HIV cases diagnosed in San Francisco, 2009-2018, San Francisco\\x0c ▪ As of  December 31, 2018, 15,990 San Francisco residents at diagnosis were alive and 9,673 (60%) of  these \\n\\nresidents were still living in the city based on their most recent available address.\\n\\n ▪ More than 3,000 OOJ residents at diagnosis have a current San Francisco address and received care in San \\n\\nFrancisco at some point after their diagnosis.\\n\\n ▪ The total number of  PLWH with a current address of  San Francisco is 12,749.\\n ▪ Demographic and risk distributions of  San Francisco residents at diagnosis who were still living in San \\n\\nFrancisco were very similar to all living San Francisco residents at diagnosis.\\n\\n ▪ A greater proportion of OOJ residents at diagnosis now living in San Francisco were under 50 years and MSM.\\n \\n\\nPLWH who were SF \\nresidents at diagnosis\\n\\nPLWH who were SF residents based on most \\n\\nrecent address (N=12,749)\\n\\nSF residents at \\n\\ndiagnosis\\nNumber (%)\\n\\nOOJ residents at \\n\\ndiagnosis\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n2\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nNative American\\nOther/Unknown\\n  0 - 12\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50 - 59\\n60 - 69\\n70+\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n\\n15,990\\n14,684 (92)\\n903 ( 6)\\n396 ( 2)\\n9,314 (58)\\n1,908 (12)\\n3,184 (20)\\n993 ( 6)\\n67 (<1)\\n524 ( 3)\\n0 ( 0)\\n4 (<1)\\n98 ( 1)\\n346 ( 2)\\n1,727 (11)\\n3,124 (20)\\n5,827 (36)\\n3,750 (23)\\n1,114 ( 7)\\n11,681 (73)\\n223 ( 1)\\n887 ( 6)\\n2,186 (14)\\n170 ( 1)\\n575 ( 4)\\n268 ( 2)\\n1  See Technical Notes “Residence and Receipt of  Care for PLWH.” \\n2  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.”\\n\\n9,673\\n8,759 (91)\\n629 ( 7)\\n279 ( 3)\\n5,283 (55)\\n1,191 (12)\\n2,146 (22)\\n708 ( 7)\\n34 (<1)\\n311 ( 3)\\n0 ( 0)\\n2 (<1)\\n72 ( 1)\\n218 ( 2)\\n1,108 (11)\\n1,857 (19)\\n3,414 (35)\\n2,286 (24)\\n716 ( 7)\\n6,865 (71)\\n158 ( 2)\\n625 ( 6)\\n1,326 (14)\\n119 ( 1)\\n395 ( 4)\\n185 ( 2)\\n\\n)\\n8\\n1\\n0\\n2\\n/\\n1\\n3\\n/\\n2\\n1\\n \\nf\\no\\n \\ns\\na\\n(\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ne\\ng\\nA\\n\\ni\\n \\n\\n \\n\\n \\n\\n3,076\\n2,891 (94)\\n107 ( 3)\\n78 ( 3)\\n1,648 (54)\\n426 (14)\\n668 (22)\\n149 ( 5)\\n13 (<1)\\n172 ( 6)\\n0 ( 0)\\n0 ( 0)\\n39 ( 1)\\n169 ( 5)\\n716 (23)\\n720 (23)\\n975 (32)\\n388 (13)\\n69 ( 2)\\n2,365 (77)\\n49 ( 2)\\n125 ( 4)\\n353 (11)\\n29 ( 1)\\n82 ( 3)\\n73 ( 2)\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n7\\n\\nTable 1.4 Characteristics of persons living with HIV1 as of December 2018 by residence status, San Francisco\\x0c ▪ White MSM (non-PWID) comprised half  of  men living with HIV in San Francisco.\\n ▪ Among African American men, there was a higher proportion of  PWID and MSM-PWID.\\n ▪ White and African American men had similar age distributions at the end of  2018, while Latinx, Asian/\\nPacific Islander, Native American, and multi-racial men were younger than whites and African Americans.\\nInjection drug use was the predominant transmission category for white, African American, and multi-racial \\nwomen while heterosexual sex was the predominant transmission category for Latinx and Asian/Pacific \\nIslander and Native American women combined. \\nLatinxs and African Americans each accounted for 36% and 31%, respectively, of trans women living with HIV.\\n\\n ▪\\n\\n ▪\\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n)\\n8\\n1\\n0\\n2\\n/\\n1\\n3\\n/\\n2\\n1\\n \\nf\\no\\n \\ns\\na\\n(\\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n)\\n8\\n1\\n0\\n2\\n/\\n1\\n3\\n/\\n2\\n1\\n \\nf\\no\\n \\ns\\na\\n(\\n\\nWhite\\n\\n7,340 (82)\\n176 ( 2)\\n1388 (15)\\n32 (<1)\\n52 ( 1)\\n0 ( 0)\\n0 ( 0)\\n18 (<1)\\n89 ( 1)\\n625 ( 7)\\n1,473 (16)\\n3,481 (39)\\n2,479 (28)\\n823 ( 9)\\n\\n8,988\\n\\n146 (58)\\n\\n83 (33)\\n\\n24 ( 9)\\n0 ( 0)\\n0 ( 0)\\n3 ( 1)\\n4 ( 2)\\n26 (10)\\n57 (23)\\n100 (40)\\n50 (20)\\n13 ( 5)\\n253\\n71\\n\\nAfrican \\nAmerican\\n\\n869 (60)\\n190 (13)\\n279 (19)\\n71 ( 5)\\n37 ( 3)\\n0 ( 0)\\n0 ( 0)\\n17 ( 1)\\n57 ( 4)\\n152 (11)\\n234 (16)\\n484 (33)\\n415 (29)\\n87 ( 6)\\n\\n1,446\\n\\n166 (49)\\n\\n140 (41)\\n\\n32 ( 9)\\n0 ( 0)\\n1 (<1)\\n8 ( 2)\\n6 ( 2)\\n33 (10)\\n54 (16)\\n122 (36)\\n95 (28)\\n19 ( 6)\\n338\\n122\\n\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nOther/Unidentified\\n  0 - 12\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50 - 59\\n60 - 64\\n65+\\nMen Total\\n\\nPWID\\n\\nHeterosexual\\n\\nOther/Unidentified\\n  0 - 12\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50 - 59\\n60 - 64\\n65+\\nWomen Total\\nTrans Women Total\\n\\nAsian/Pacific Islander \\n\\nLatinx\\nNumber (%)\\n\\n& Native American\\n\\nMulti-Race\\n\\n2,332 (82)\\n68 ( 2)\\n338 (12)\\n53 ( 2)\\n47 ( 2)\\n0 ( 0)\\n1 (<1)\\n27 ( 1)\\n112 ( 4)\\n497 (18)\\n701 (25)\\n987 (35)\\n417 (15)\\n96 ( 3)\\n\\n2,838\\n\\n62 (31)\\n\\n111 (55)\\n\\n30 (15)\\n0 ( 0)\\n1 (<1)\\n5 ( 2)\\n9 ( 4)\\n36 (18)\\n44 (22)\\n56 (28)\\n39 (19)\\n13 ( 6)\\n203\\n141\\n\\n810 (86)\\n21 ( 2)\\n78 ( 8)\\n21 ( 2)\\n16 ( 2)\\n0 ( 0)\\n0 ( 0)\\n8 ( 1)\\n44 ( 5)\\n190 (20)\\n281 (30)\\n281 (30)\\n111 (12)\\n31 ( 3)\\n946\\n\\n13 (18)\\n\\n51 (70)\\n\\n9 (12)\\n0 ( 0)\\n0 ( 0)\\n0 ( 0)\\n2 ( 3)\\n10 (14)\\n23 (32)\\n24 (33)\\n12 (16)\\n2 ( 3)\\n73\\n41\\n\\n329 (72)\\n16 ( 3)\\n103 (22)\\n7 ( 2)\\n5 ( 1)\\n0 ( 0)\\n1 ( 0)\\n3 ( 1)\\n9 ( 2)\\n65 (14)\\n125 (27)\\n157 (34)\\n79 (17)\\n21 ( 5)\\n460\\n\\n24 (71)\\n\\n6 (18)\\n\\n4 (12)\\n0 ( 0)\\n0 ( 0)\\n4 (12)\\n0 ( 0)\\n4 (12)\\n9 (26)\\n12 (35)\\n4 (12)\\n1 ( 3)\\n34\\n21\\n\\nTotal \\nNumber1\\n11,681\\n471\\n2,186\\n184\\n162\\n0\\n2\\n73\\n311\\n1529\\n2,816\\n5,392\\n3,503\\n1,058\\n14,684\\n\\n411\\n\\n391\\n\\n101\\n0\\n2\\n20\\n21\\n109\\n188\\n314\\n201\\n48\\n903\\n396\\n\\nn\\ne\\nM\\n\\nn\\ne\\nm\\no\\nW\\n\\n1  Includes persons whose racial/ethnic information is not available. Data on trans men are not released separately due to small numbers. See Technical Notes \\n\\n“Gender Status.”\\n\\n8  \\n\\nOVERVIEW OF HIV IN SAN FRANCISCO\\n\\nTable 1.5 Characteristics of persons living with HIV as of December 2018, San Francisco\\x0cPersons diagnosed with HIV disease stage zero\\n\\n ▪ Of  the 1,135 San Francisco residents diagnosed with HIV in 2014 to 2017, 322 (28%) were diagnosed at \\nstage 0 (an indicator of  recent HIV acquisition), 708 (62%) at stage 1-3, and 105 (9%) could not be staged \\ndue to not having a documented CD4 T-lymphocyte test ≤ 3 months after HIV diagnosis.\\n\\n ▪ The proportion of  stage 0 diagnoses was higher among men, trans women, whites, Latinxs, persons with \\nother or unknown race/ethnicity, persons under age 30 years at time of  diagnosis, MSM (including MSM-\\nPWID) and persons with other or unidentified risk factor.\\n\\nNew \\n\\nDiagnoses1\\n\\nStage at diagnosis2\\n\\nStage 0\\n\\nStage 1-3\\n\\nUnknown\\n\\nNumber (%3)\\n\\nTotal\\n2014\\n2015\\n2016\\n2017\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n13-24\\n25-29\\n30-39\\n40-49\\n50+\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nOther/Unidentified5\\n\\n1,135\\n327\\n299\\n265\\n244\\n1,006\\n96\\n32\\n445\\n150\\n324\\n162\\n54\\n144\\n220\\n358\\n243\\n170\\n794\\n91\\n114\\n75\\n61\\n\\n322 (28)\\n98 (30)\\n83 (28)\\n79 (30)\\n62 (25)\\n291 (29)\\n18 (19)\\n13 (41)\\n139 (31)\\n26 (17)\\n96 (30)\\n42 (26)\\n19 (35)\\n61 (42)\\n76 (35)\\n95 (27)\\n59 (24)\\n31 (18)\\n241 (30)\\n16 (18)\\n34 (30)\\n10 (13)\\n21 (34)\\n\\n708 (62)\\n201 (61)\\n184 (62)\\n162 (61)\\n161 (66)\\n626 (62)\\n67 (70)\\n14 (44)\\n275 (62)\\n104 (69)\\n200 (62)\\n101 (62)\\n28 (52)\\n69 (48)\\n128 (58)\\n218 (61)\\n167 (69)\\n126 (74)\\n480 (60)\\n62 (68)\\n75 (66)\\n60 (80)\\n31 (51)\\n\\n105 ( 9)\\n28 ( 9)\\n32 (11)\\n24 ( 9)\\n21 ( 9)\\n89 ( 9)\\n11 (11)\\n5 (16)\\n31 ( 7)\\n20 (13)\\n28 ( 9)\\n19 (12)\\n7 (13)\\n14 (10)\\n16 ( 7)\\n45 (13)\\n17 ( 7)\\n13 ( 8)\\n73 ( 9)\\n13 (14)\\n5 ( 4)\\n5 ( 7)\\n9 (15)\\n\\n \\n\\nI\\n\\nV\\nH\\n \\nf\\no\\n \\nr\\na\\ne\\nY\\n\\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\n\\ni\\n\\n4\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\n\\nI\\n\\nV\\nH\\n \\nt\\na\\ne\\ng\\nA\\n\\n \\n\\n)\\ns\\nr\\na\\ne\\ny\\n(\\n \\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\n\\ni\\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\n1  Includes persons diagnosed in the time period based on a confirmed laboratory HIV test regardless of  whether \\n\\nthe patient had an earlier self-report of  HIV positive date. \\n\\n2  The surveillance case definition includes five HIV stages at diagnosis. See Technical Notes “Stage of  Disease at \\n\\nHIV Diagnosis.”\\n\\n3  Percent of  new diagnoses.\\n4  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.”\\n5  Includes TWSM, TWSM-PWID and persons with no identified risk factor. \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n9\\n\\nTable 1.6 Stage of HIV disease at diagnosis among persons newly diagnosed with HIV in 2014-2017, San Francisco\\x0cPersons diagnosed with late stage HIV disease\\n\\nLate HIV diagnosis is defined as have a stage 3 (AIDS) diagnosis within three months of HIV diagnosis.\\n ▪\\n ▪ The proportion of  persons newly diagnosed with HIV whose diagnosis occurred late in the stage of  HIV \\n\\ndisease decreased from 18% in 2013 to 11% in 2016 and increased to 19% in 2017.\\nIn 2017, the proportion of  new diagnoses that occurred late was higher among women, trans women, \\nAsians/Pacific Islanders, persons aged 40 years or older at time of  diagnosis, heterosexuals, and homeless \\npersons.\\n\\n ▪\\n\\nYear of diagnosis1\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\nNumber of new diagnoses (% of who had a late diagnosis2)\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n13-24\\n25-29\\n30-39\\n40-49\\n50+\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nOther/Unidentified4\\nHoused\\nHomeless\\nUnknown\\n\\n398 (18)\\n359 (18)\\n27 (22)\\n12 (17)\\n180 (17)\\n50 (20)\\n101 (14)\\n50 (30)\\n17 (12)\\n51 (10)\\n79 (11)\\n114 (17)\\n100 (24)\\n54 (28)\\n289 (16)\\n24 (25)\\n44 (16)\\n22 (41)\\n19 (16)\\n348 (19)\\n31 (13)\\n19 (16)\\n\\n327 (17)\\n302 (18)\\n14 ( 7)\\n11 ( 0)\\n141 (13)\\n35 (23)\\n94 (16)\\n41 (22)\\n16 (25)\\n35 ( 6)\\n54 ( 9)\\n98 (19)\\n80 (19)\\n60 (22)\\n241 (17)\\n23 (17)\\n36 ( 6)\\n13 (46)\\n14 ( 0)\\n276 (18)\\n36 ( 8)\\n15 ( 7)\\n\\n299 (17)\\n264 (16)\\n27 (22)\\n8 (13)\\n118 (18)\\n41 (12)\\n85 (19)\\n38 (11)\\n17 (24)\\n47 ( 6)\\n60 ( 7)\\n95 (16)\\n65 (26)\\n32 (34)\\n221 (15)\\n19 (32)\\n23 (17)\\n23 (22)\\n13 (15)\\n261 (16)\\n28 (21)\\n10 (10)\\n\\n265 (11)\\n228 (11)\\n28 (11)\\n8 ( 0)\\n96 (10)\\n38 (16)\\n73 ( 7)\\n51 (12)\\n7 (14)\\n34 ( 3)\\n60 (10)\\n86 (10)\\n45 (16)\\n40 (13)\\n180 (12)\\n22 ( 9)\\n25 ( 4)\\n23 (17)\\n15 ( 0)\\n230 (10)\\n27 (15)\\n8 ( 0)\\n\\n244 (19)\\n212 (19)\\n27 (22)\\n5 (20)\\n90 (18)\\n36 (17)\\n72 (19)\\n32 (25)\\n14 (21)\\n29 ( 7)\\n44 (16)\\n80 (11)\\n53 (34)\\n38 (29)\\n152 (17)\\n27 (19)\\n30 (17)\\n16 (31)\\n19 (32)\\n205 (18)\\n30 (30)\\n9 (11)\\n\\n3\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ni\\n\\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\n \\nt\\na\\ne\\ng\\nA\\n\\n \\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\n \\n\\ng\\nn\\ni\\ns\\nu\\no\\nH\\n\\ns\\nu\\nt\\na\\nt\\nS\\n\\n1  Date of  HIV diagnosis is based on a confirmed laboratory HIV test and does not take into account patient self-report of  HIV positive.\\n2  Percent of  new diagnoses in the year who developed AIDS within 3 months of  HIV diagnosis.\\n3  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.”\\n4  Includes TWSM, TWSM-PWID and persons with no identified risk factor.\\n\\n10  \\n\\nOVERVIEW OF HIV IN SAN FRANCISCO\\n\\nTable 1.7 Late diagnoses among persons newly diagnosed with HIV in 2013-2017 by demographic and risk characteristics, San Francisco\\x0cHIV incidence estimates\\n\\n ▪ Estimates of  new HIV infections track the leading edge of  the HIV epidemic and are critical for allocating \\nresources and evaluating effectiveness of prevention programs. The SFDPH adopted the CD4-based model \\n(see Technical Notes “CD4-based Model”), developed by the Centers for Disease Control and Prevention \\n(CDC), to estimate new infections during 2013-2017 in San Francisco.\\n\\n ▪ Overall, the estimated number of  new HIV infections has declined since 2013, however, the confidence \\n\\nintervals overlap from year to year indicating a relatively stable trend.\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nt\\nn\\ne\\nd\\nc\\nn\\n\\ni\\n\\nI\\n \\n\\nd\\ne\\nt\\na\\nm\\n\\ni\\nt\\ns\\nE\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n500\\n\\n450\\n\\n400\\n\\n350\\n\\n300\\n\\n250\\n\\n200\\n\\n150\\n\\n100\\n\\n50\\n\\n0\\n\\n420\\n\\n330\\n\\n240\\n\\n300\\n\\n200\\n\\n2013\\n\\n2014\\n\\n400\\n\\n390\\n\\n95% CI (Upper and Lower)\\nHIV Incidence Estimate\\n\\n340\\n\\n220\\n\\n100\\n\\n2016\\n\\n320\\n\\n190\\n\\n60\\n\\n2017\\n\\n280\\n\\n170\\n\\n2015\\nYear\\n\\nCI: Confidence Interval.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n11\\n\\nFigure 1.4 Estimated number of new HIV infections, 2013-2017, San Francisco\\x0c ▪ The rate of  new infections among MSM and MSM-PWID is disproportionately high: 405 infections per \\n\\n100,000 MSM in 2015 compared to an overall rate of  36 in San Francisco.\\n\\n ▪ With caution given to the large margin of  error, the data suggest higher incidence among Latinx individuals \\n\\ncompared to whites for the years we are able to provide an estimate.\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\nOverall\\n\\nMale\\n\\nFemale\\n\\n13-24\\n\\n25-34\\n\\n35-44\\n\\n45-54\\n\\n55+\\nWhite\\n\\nAfrican American\\n\\nLatinx\\n\\nOther\\n\\n \\nt\\na\\n\\n \\n\\nx\\ne\\nS\\n\\nh\\nt\\nr\\ni\\nB\\n\\n)\\ns\\nr\\na\\ne\\ny\\n(\\n \\n\\ne\\ng\\nA\\n\\ny\\nt\\ni\\n\\ni\\n\\nc\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\nRate per 100,000\\n\\n(95% Confidence Interval)\\n\\n44\\n\\n39\\n\\n36\\n\\n29\\n\\n(32 - 56)\\n\\n(26 - 53)\\n\\n(22 - 51)\\n\\n(13 - 44)\\n\\n81\\n\\n73\\n\\n63\\n\\n50\\n\\n(58 - 103)\\n\\n(48 - 98)\\n\\n(63- 90)\\n\\n(21 - 78)\\n\\n**\\n\\n81\\n\\n(35 - 127)\\n\\n88\\n\\n**\\n\\n**\\n\\n78\\n\\n**\\n\\n**\\n\\n77\\n\\n(53 - 123)\\n\\n(39 - 116)\\n\\n(32 - 122)\\n\\n71\\n\\n(36 - 106)\\n\\n**\\n\\n**\\n43\\n\\n**\\n\\n**\\n\\n**\\n35\\n\\n(25 - 60)\\n\\n(17 - 52)\\n\\n**\\n\\n84\\n\\n**\\n\\n88\\n\\n(39 - 129)\\n\\n(37 - 140)\\n\\n**\\n\\n**\\n\\n449\\n\\n**\\n\\n**\\n\\n**\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n405\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n24\\n\\n(7 - 41)\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\n**\\n\\nMSM & MSM-PWID\\n\\n488\\n\\n(346 - 630)\\n\\n(290 - 607)\\n\\n(230 - 579)\\n\\nNon-MSM\\n\\n**\\n\\n**\\n\\n**\\n\\n1  The population data by year, sex, race/ethnicity, and age are obtained from California Department of  Finance. Demographic \\nResearch Unit. 2017. State and county population projections 2010-2060 [P-3: State and County Projections Dataset]. Sacramento: \\nCalifornia Department of  Finance. February 2, 2017. Revised June 20, 2017. The MSM population data are obtained from Hughes \\nAJ, Chen YH, Scheer S, et al. A novel modeling approach for estimating patterns of  migration into and out of  San Francisco by \\nHIV status and race among men who have sex with men. J Urban Health (2017). doi:10.1007/s11524-017-0145-2.\\n\\n** Incidence estimate with the relative standard error (RSE)>=30% is not displayed due to high estimation error. \\n\\n12  \\n\\nOVERVIEW OF HIV IN SAN FRANCISCO\\n\\nTable 1.8 Estimated rate of new HIV infections per 100,000 population1 by demographic and risk characteristics, 2013-2017, San Francisco\\x0c2\\n\\nRace/ethnicity\\n\\nTrends in HIV Diagnoses\\n\\nWhites\\n\\naccoUnted For the largeSt \\nnUmber oF newly diagnoSed \\ncaSeS From 2009-2017\\n\\n ▪ Diagnoses among whites were stable from 2009 to 2012 and declined \\n\\nfrom 2013 through 2018.\\n\\n ▪ Overall, diagnoses among African Americans and Latinxs declined from \\n\\n2009 to 2016 but slightly increased between 2017 and 2018.\\n\\n ▪ Diagnoses among Asians/Pacific Islanders have been declining slightly \\n\\nstarting in 2013.\\n\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown1\\n\\nLatinx\\n\\ndiagnoSeS SUrPaSSed\\n\\ndiagnoSeS For whiteS in \\n\\n2018\\n\\n400\\n\\n350\\n\\n300\\n\\n250\\n\\n200\\n\\n150\\n\\n100\\n\\n50\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1  Cases in the “Other/Unknown” racial/ethnic category include 9% Native Americans, 87% multi-race, and 3% unknown.\\n2  See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\nYear of HIV Diagnosis2\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n13\\n\\nFigure 2.1 Number of persons newly diagnosed with HIV by race/ethnicity, 2009-2018, San Francisco\\x0c ▪ Among  men,  annual  population-\\nspecific  rates  of   HIV  diagnosis \\ndeclined  for  most  racial/ethnic \\ngroups from 2009 through 2018; \\nthe decline was most sustained for \\nwhites. \\n\\n ▪ African  American  men  had  the \\nhighest annual HIV diagnosis rates, \\nfollowed by Latino men, between \\n2013 and 2018.\\n\\n ▪ Both African American and Latino \\nmen’s  diagnosis  rates  increased \\nin 2018 (145 and 89 per 100,000, \\nrespectively).\\nFrom  2009  through  2018,  Asian \\nand Pacific Islander men had a peak \\ndiagnosis rate of  40 per 100,000 in \\n2012; the diagnosis rate dipped to \\n11 per 100,000 in 2018.\\n\\n ▪\\n\\n ▪\\n\\nFrom  2009  through  2018,  the \\nannual population-specific rates of  \\nHIV diagnosis were substantially \\nlower  for  women  in  all  racial/\\nethnic groups, compared to men.\\n ▪ Except for 2014, the annual rates \\nof   HIV  diagnosis  were  higher \\nfor  African  American  women \\ncompared to all other racial/ethnic \\ngroups.\\n\\n400\\n\\n350\\n\\n300\\n\\n250\\n\\n200\\n\\n150\\n\\n100\\n\\n50\\n\\n,\\n\\n0\\n0\\n0\\n0\\n0\\n1\\n \\nr\\ne\\np\\n \\ne\\nt\\na\\nR\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\nWhite\\nAfrican American\\nLatino\\nAsian/Pacific Islander\\n\\n2013\\n\\n2012\\n2015\\nYear of HIV Diagnosis\\n\\n2014\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1  See Technical Notes “HIV Case Rates and HIV Mortality Rates.” Includes persons with HIV by year \\nof  their initial HIV diagnosis. Excludes transfemale cases. Rates for Native American and multi-racial \\ncases are not calculated due to small numbers. \\n\\n90\\n\\n80\\n\\n70\\n\\n60\\n\\n50\\n\\n40\\n\\n30\\n\\n20\\n\\n10\\n\\n0\\n0\\n0\\n,\\n0\\n0\\n1\\n \\nr\\ne\\np\\n \\ne\\nt\\na\\nR\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\nWhite\\nAfrican American\\nLatina\\nAsian/Pacific Islander\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n2012\\n\\n2013\\n\\n2015\\nYear of HIV Diagnosis\\n\\n2014\\n\\n1  See Technical Notes “HIV Case Rates and HIV Mortality Rates.” Includes persons with HIV by year \\nof  their initial HIV diagnosis. Excludes transmale cases. Rates for Native American and multi-racial \\ncases are not calculated due to small numbers. \\n\\n14  \\n\\nTRENDS IN HIV DIAGNOSES\\n\\nFigure 2.2 Annual rates1 of men newly diagnosed with HIV per 100,000 population by race/ethnicity, 2009-2018, San FranciscoFigure 2.3 Annual rates1 of women newly diagnosed with HIV per 100,000 population by race/ethnicity, 2009-2018, San Francisco\\x0cTransmission category\\n\\n ▪ The  majority  of   men  newly \\ndiagnosed with HIV during 2009 \\nthrough  2018  were  MSM  (non-\\nPWID),  and  while  the  annual \\nnumber  fluctuated,  the  overall \\ntrend declined.\\n\\n ▪ The  annual  number  of   MSM-\\nPWID  diagnoses  also  declined \\noverall. \\n\\n ▪ Diagnoses  among  heterosexual \\nPWID  have  been  increasing  in \\nrecent years starting in 2016.\\n\\n ▪ Annual diagnoses among men due \\nto heterosexual contact have been \\nlow  and  fairly  stable  during  this \\ntime period.\\n\\n ▪ The  number  of   women  newly \\ndiagnosed  with  HIV  due  to \\nheterosexual  contact  was  similar \\nto that for female PWID.\\n\\n ▪ The  number  of   diagnoses  each \\nyear among female PWID has been \\nstable from 2013 to 2017.\\n\\n1\\ns\\ne\\ns\\na\\nC\\ne\\na\\nM\\n\\nl\\n\\n \\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n400\\n\\n350\\n\\n300\\n\\n250\\n\\n200\\n\\n150\\n\\n100\\n\\n50\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nUnknown\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n2012\\n\\n2014\\n\\n2013\\n\\n2015\\nYear of HIV Diagnosis\\n\\n1  Excludes trans women diagnosed with HIV. Includes persons with HIV by year of  their initial HIV \\n\\ndiagnosis.\\n\\n40\\n\\n35\\n\\n30\\n\\n25\\n\\n20\\n\\n15\\n\\n10\\n\\n5\\n\\n1\\ns\\ne\\ns\\na\\nC\\n \\ne\\nl\\na\\nm\\ne\\nF\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\nPWID\\nHeterosexual\\nUnknown\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n2012\\n\\n2014\\n\\n2013\\n\\n2015\\nYear of HIV Diagnosis\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n15\\n\\n1  Excludes trans men diagnosed with HIV. Includes persons with HIV by year of  their initial HIV \\n\\ndiagnosis. \\n\\nFigure 2.4 Number of men newly diagnosed with HIV by transmission category, 2009-2018, San FranciscoFigure 2.5 Number of women newly diagnosed with HIV by transmission category, 2009-2018, San Francisco\\x0cAge\\n\\n ▪ The annual number of  men diagnosed declined from 297 in 2014 to 174 in 2018, while the number of  \\n\\nwomen was small and fluctuated.\\nIn this time period, among men, the 30-39 age group had the highest number of  new diagnoses, followed \\nby men 25-29 years of age.\\n\\n ▪\\n\\n ▪ During this time period there were no new diagnoses among those under 13 years of age.\\n\\nYear of Initial HIV Diagnosis2\\n\\n2016\\n\\nNumber (%)\\n\\n  0 - 12\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50+\\nMen Total\\n  0 - 12\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50+\\nWomen Total\\n\\n2014\\n\\n0 ( 0)\\n0 ( 0)\\n35 (12)\\n54 (18)\\n90 (30)\\n70 (24)\\n48 (16)\\n297\\n\\n0 ( 0)\\n0 ( 0)\\n2 (15)\\n1 ( 8)\\n1 ( 8)\\n4 (31)\\n5 (38)\\n13\\n\\nn\\ne\\nM\\n\\n)\\ns\\nr\\na\\ne\\ny\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n(\\n\\nn\\ne\\nm\\no\\nW\\n\\n)\\ns\\nr\\na\\ne\\ny\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n(\\n\\n2015\\n\\n0 ( 0)\\n2 ( 1)\\n36 (15)\\n60 (24)\\n71 (29)\\n52 (21)\\n26 (11)\\n247\\n\\n0 ( 0)\\n1 ( 4)\\n1 ( 4)\\n5 (19)\\n11 (41)\\n4 (15)\\n5 (19)\\n27\\n\\n0 ( 0)\\n0 ( 0)\\n29 (14)\\n46 (23)\\n66 (33)\\n33 (16)\\n27 (13)\\n201\\n\\n0 ( 0)\\n0 ( 0)\\n2 ( 8)\\n5 (21)\\n6 (25)\\n4 (17)\\n7 (29)\\n24\\n\\n2107\\n\\n0 ( 0)\\n1 ( 1)\\n19 (10)\\n37 (19)\\n72 (37)\\n36 (19)\\n29 (15)\\n194\\n\\n0 ( 0)\\n2 ( 7)\\n3 (11)\\n1 ( 4)\\n5 (19)\\n9 (33)\\n7 (26)\\n27\\n\\n2018\\n\\n0 ( 0)\\n1 ( 1)\\n26 (15)\\n40 (23)\\n50 (29)\\n36 (21)\\n21 (12)\\n174\\n\\n0 ( 0)\\n0 ( 0)\\n2 (12)\\n0 ( 0)\\n7 (41)\\n3 (18)\\n5 (29)\\n17\\n\\n1  Data on trans women and trans men by age are not presented due to small numbers and potential small population.\\n2  See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\n16  \\n\\nTRENDS IN HIV DIAGNOSES\\n\\nTable 2.1 Number of persons newly diagnosed with HIV by gender1 and age at diagnosis, 2014-2018, San Francisco\\x0c3 \\n\\nSpectrum of Engagement in HIV \\nPrevention and Care\\n\\nContinuum of HIV care among persons newly diagnosed with HIV\\n\\n ▪ Between  2013  through  2018,  the  proportion  of   newly  diagnosed \\npersons who entered care within one month increased between 73% \\nand 91%.\\n\\n ▪ Not all persons who entered care continued to receive care; 58%-72% \\nof  persons diagnosed in 2013 to 2017 remained in care three to nine \\nmonths after initial linkage to care.\\n\\n ▪ The  proportion  of   newly  diagnosed  persons  who  achieved  viral \\nsuppression within 12 months showed an overall upward trend between \\n2013 and 2017 with the highest proportion virally suppressed among \\npersons diagnosed in 2016 (85%). \\n\\n91% \\n\\noF PerSonS newly diagnoSed \\nin 2018 entered care within \\n\\none month\\n\\n78% \\n\\noF PerSonS newly diagnoSed \\nin 2017 achieved viral SUP-\\nPreSSion within 12 monthS\\n\\n100%\\n\\n90%\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n100%\\n\\n100%\\n100%\\n398 327 299\\n\\n100%\\n265\\n\\n100%\\n244\\n\\n100%\\n240\\n\\n91%\\n219\\n\\n85%\\n278\\n\\n83%\\n220\\n\\n81%\\n198\\n\\n81%\\n242\\n\\n73%\\n291\\n\\n2013 Diagnoses\\n2016 Diagnoses\\n\\n2014 Diagnoses\\n2017 Diagnoses\\n\\n2015 Diagnoses\\n2018 Diagnoses\\n\\n3\\n\\n85%\\n224\\n\\n78%\\n191\\n\\n77%\\n231\\n\\n76%\\n247\\n\\n72%\\n190\\n\\n69%\\n224\\n\\n65%\\n194\\n\\n64%\\n155\\n\\n65%\\n260\\n\\n58%\\n229\\n\\nNew diagnoses\\n\\n1\\n\\nLinked to care within 1\\n\\nmonth of diagnosis\\n\\nRetained in care for 3-9\\n\\nmonths after linkage within\\n\\n1 month of diagnosis\\n\\nViral suppression   within 12\\n\\n2\\n\\nmonths among all new\\n\\ndiagnoses\\n\\n1  Number of  new diagnoses shown each year is based on evidence of  a confirmed HIV test and does not take into account patient self-report of  HIV infection.\\n2  Defined as the latest viral load test within 12 months of  HIV diagnosis <200 copies/mL. See Technical Notes “HIV Care Outcomes and Definitions.”\\n3  Retention in care and viral suppression data are not available yet for persons diagnosed in 2018.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n17\\n\\nFigure 3.1 Continuum of HIV care among persons newly diagnosed with HIV, 2013-2018, San Francisco\\x0cContinuum of HIV care among persons living with HIV\\n\\n ▪ As of December 31, 2017 there were 15,040 persons living with HIV (PLWH) who were diagnosed through \\nthe end of  2016 and who resided in San Francisco at time of  diagnosis. Of  these, 73% had at least one \\nCD4, viral load or genotype test (received care), 54% had two or more laboratory tests at least three months \\napart (retained in care), and 67% were virally suppressed in 2017.\\n\\n ▪ Of the 12,778 PLWH who resided in San Francisco based on their most recent address (9,722 San Francisco \\nresidents at diagnosis and still in San Francisco, 3,056 out-of-jurisdiction (OOJ) residents at diagnosis who \\nmoved to San Francisco after diagnosis), 81% received care, 60% were retained in care and 74% were \\nvirally suppressed in 2017. \\n\\n100%\\n\\n100%\\n\\n100%\\n\\n1\\nPLWH who resided in San Francisco at diagnosis (N=15,040  )\\n\\nPLWH who were last known to reside in San Francisco as of 12/31/2017\\n2\\nregardless of where they were diagnosed (N=12,778  )\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n80%\\n\\n60%\\n\\n40%\\n\\n20%\\n\\n0%\\n\\n81%\\n\\n73%\\n\\n74%\\n\\n67%\\n\\n60%\\n\\n54%\\n\\nTotal living with HIV\\n\\n in 2017\\n\\n3\\n\\nHad  ≥1 lab test\\n\\nin 2017\\n\\nHad  ≥2 lab tests\\n\\nin 2017\\n\\nVirally suppressed\\n\\n in 2017\\n\\n4\\n\\n1  Excludes persons who were non-San Francisco residents at time of  HIV diagnosis but San Francisco residents at stage 3 HIV (AIDS) diagnosis.\\n2  See Technical Notes “Residence and Receipt of  Care for PLWH.”\\n3  Includes persons living with HIV at the end of  2017 (≥ 13 years old) and diagnosed by the end of  2016. \\n4  Defined as the latest viral load in 2017 <200 copies/mL.\\n\\n18  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nFigure 3.2 Continuum of HIV care among persons living with HIV, 2017, San Francisco\\x0c ▪ Among all persons with HIV (diagnosed and undiagnosed), it is estimated that 94% were aware of  their \\n\\nHIV diagnosis, 76% received care, 56% were retained in care, and 70% were virally suppressed in 2017.\\n\\n100%\\n\\n100%\\n\\n94%\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\nd\\ne\\nt\\na\\nm\\n\\n \\n\\ni\\nt\\ns\\nE\\n\\n80%\\n\\n60%\\n\\n40%\\n\\n20%\\n\\n0%\\n\\n76%\\n\\n70%\\n\\n56%\\n\\nInfected\\n\\nDiagnosed/ Aware\\n1\\n\\nReceived care\\n\\n2\\n\\nRetained in care\\n\\n2\\n\\nVirally suppressed\\n\\n2\\n\\n1  The estimated percent aware of  HIV diagnosis for San Francisco was derived from the CD4 depletion model. See Technical Notes “CD4-based Model.” \\n2  The estimated percent received care, retained in care, and virally suppressed among all infected was derived by applying the 94% diagnosed/aware to the 81% \\nwho had ≥1 lab tests, 60% who had ≥2 lab tests, and 74% who were virally suppressed among persons living with HIV who were last known to reside in San \\nFrancisco as shown in Figure 3.2, respectively.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO \\n\\n19\\n\\nFigure 3.3 Continuum of HIV care among persons living with diagnosed or undiagnosed HIV infection, 2017, San Francisco\\x0cHIV care and prevention indicators\\n\\n ▪ The proportion of  late stage HIV diagnosis, defined as a new case who developed HIV disease stage 3 \\n(AIDS) within three months of  HIV diagnosis decreased from 18% in 2013 to 11% in 2016 and then \\nincreased in 2017 to 19%.\\n\\n ▪ The median time from HIV diagnosis to viral suppression shortened from 135 days in 2013 to 62 days in 2017.\\n ▪ All care indicators from diagnosis to viral suppression improved over time including time from HIV \\ndiagnosis to first care (from 8 days in 2013 to 4 days in 2017), time from receipt of  care to antiretroviral \\ntherapy (ART) initiation (from 27 days in 2013 to 0 day in 2017) and time from ART initiation to viral \\nsuppression (from 76 days in 2013 to 46 days in 2017).\\n\\n ▪ Among PLWH who resided in San Francisco based on their last known address at the end of  each year, \\nthe proportion of  those received care (81-82%), as well as the proportion of  those were virally suppressed \\n(74%), remained relatively stable in recent years.\\n\\ns\\nr\\no\\nt\\na\\nc\\ni\\nd\\nn\\n\\nI\\n\\nNew HIV diagnoses1\\nProportion developed AIDS within 3 months of diagnosis\\nProportion linked to care within 1 month of diagnosis\\nProportion virally suppressed2 within 12 months of diagnosis\\nMedian time (days) from HIV diagnosis to first viral suppression\\n    Median time (days) from HIV diagnosis to first care\\n    Median time (days) from first care to ART initiation3\\n    Median time (days) from ART initiation to first viral suppresssion3\\nMedian CD4 count (cells/µL) at treatment initiation among those \\ndiagnosed with a CD4 count>500 cells/µL\\nLiving HIV cases4 (≥13 years old)\\nProportion of cases who had ≥1 CD4/viral load test\\n    Proportion received ≥2 tests among those with ≥1 test\\nProportion virally suppressed2 among living cases\\n    Proportion virally suppressed among those with ≥1 viral load test  \\n\\n2013\\nN=398\\n18%\\n73%\\n65%\\n135\\n8\\n27\\n76\\n\\n675\\n\\n2014\\nN=327\\n17%\\n85%\\n76%\\n94\\n7\\n19\\n54\\n\\n660\\n\\nYear\\n2015\\nN=299\\n17%\\n81%\\n77%\\n79\\n7\\n7\\n53\\n\\n672\\n\\n2016\\nN=265\\n11%\\n83%\\n85%\\n65\\n5\\n1\\n42\\n\\n688\\n\\n2017\\nN=244\\n19%\\n81%\\n78%\\n62\\n4\\n0\\n46\\n\\n702\\n\\nN=14,227 N=13,242 N=13,717 N=13,054 N=12,778\\n\\n76%\\n\\n79%\\n\\n66%\\n\\n89%\\n\\n82%\\n\\n76%\\n\\n72%\\n\\n90%\\n\\n82%\\n\\n76%\\n\\n74%\\n\\n91%\\n\\n82%\\n\\n76%\\n\\n74%\\n\\n92%\\n\\n81%\\n\\n74%\\n\\n74%\\n\\n92%\\n\\n1  Includes persons diagnosed each year based on a confirmed HIV test and does not take into account patient self-report of  HIV infection.\\n2  Defined as the latest viral load test within 12 months of  HIV diagnosis <200 copies/mL. For living cases viral suppression is measured using the latest test in \\n\\n3  Calculation is limited to persons diagnosed with HIV who were known to have started ART. See Technical Notes “Estimate of  ART Use.”\\n4  Includes PLWH who were alive and resided in San Francisco as of  the end of  each year and diagnosed as of  the previous year. See Technical Notes “Residence \\n\\nthe year.\\n\\nand Receipt of  Care for PLWH.”\\n\\n20  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nTable 3.1 Care and prevention indicators among persons newly diagnosed with HIV and living with HIV, 2013-2017, San Francisco\\x0cCare indicators among persons with HIV by demographic and risk characteristics\\n\\n ▪ There  are  noticeable  differences  in  care  outcomes  among  persons  diagnosed  with  HIV  in  2017  by \\n\\ndemographic and risk characteristics.\\n\\n ▪ African Americans had a lower proportion of  linkage to care and viral suppression.\\n ▪\\n\\nLinkage to care, retention in care, and viral suppression were lower among persons who inject drugs (PWID), \\nhomeless persons, and persons born in the U.S. \\n\\nNumber of \\ndiagnoses2\\n\\n% Linked to care within 1 \\n\\nmonth of diagnosis3\\n\\n% Retained in care 3-9 \\nmonths after linkage3\\n\\n% Virally suppressed within \\n\\n12 months of diagnosis3\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n13-24\\n25-29\\n30-39\\n40-49\\n50+\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nOther/Unidentified5\\nHoused\\nHomeless\\nUnknown\\nUS\\nNon-US\\nUnknown\\n\\n244\\n212\\n27\\n5\\n90\\n36\\n72\\n32\\n14\\n29\\n44\\n80\\n53\\n38\\n152\\n27\\n30\\n16\\n19\\n205\\n30\\n9\\n91\\n72\\n81\\n\\n81%\\n81%\\n81%\\n80%\\n80%\\n75%\\n81%\\n94%\\n79%\\n76%\\n91%\\n79%\\n77%\\n84%\\n84%\\n63%\\n80%\\n88%\\n84%\\n83%\\n73%\\n67%\\n74%\\n86%\\n85%\\n\\n64%\\n62%\\n74%\\n80%\\n54%\\n64%\\n65%\\n81%\\n71%\\n72%\\n64%\\n63%\\n62%\\n61%\\n65%\\n37%\\n60%\\n75%\\n84%\\n68%\\n40%\\n44%\\n56%\\n74%\\n63%\\n\\n78%\\n79%\\n70%\\n80%\\n80%\\n69%\\n75%\\n91%\\n79%\\n79%\\n84%\\n79%\\n74%\\n76%\\n86%\\n48%\\n67%\\n75%\\n84%\\n83%\\n53%\\n44%\\n76%\\n85%\\n75%\\n\\n4\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ni\\n\\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\n \\nt\\na\\ne\\ng\\nA\\n\\n \\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\n \\n\\ng\\nn\\ni\\ns\\nu\\no\\nH\\n\\n \\nt\\na\\n \\ns\\nu\\nt\\na\\nt\\nS\\n\\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\n\\ni\\n\\n \\n\\ny\\nr\\nt\\nn\\nu\\no\\nC\\n\\nh\\nt\\nr\\ni\\nB\\n \\nf\\no\\n\\n1  See Technical Notes “HIV Care Outcomes and Definitions.”\\n2  Includes persons diagnosed in 2017 based on a confirmed HIV test and does not take into account patient self-report of  HIV infection.\\n3  Percent of  total diagnoses.\\n4  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.”\\n5  Includes TWSM, TWSM-PWID and persons with no identified risk factor.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  21\\n\\nTable 3.2 Care indicators1 among persons newly diagnosed with HIV in 2017 by demographic and risk characteristics, San Francisco\\x0c ▪ Among PLWH in 2017 who were San Francisco residents at the time of  diagnosis, 67% were virally \\n\\nsuppressed; among those who received care in 2017, 92% were virally suppressed.\\n\\n ▪ The proportion who were virally suppressed was lower among women, trans women, African Americans, \\n\\npersons younger than 50 years, PWID, and homeless persons.\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n13-24\\n25-29\\n30-39\\n40-49\\n50-59\\n60-69\\n70+\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\nHoused\\n\\nHomeless\\nUS\\nNon-US\\nUnknown\\n\\nNumber of \\nliving cases1\\n\\n15,040\\n13,839\\n845\\n351\\n8,916\\n1,760\\n2,919\\n917\\n528\\n75\\n329\\n1,555\\n3,113\\n5,617\\n3,412\\n939\\n11,064\\n198\\n825\\n2,024\\n151\\n542\\n236\\n14,736\\n\\n304\\n11,432\\n2,415\\n1,193\\n\\n3\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\nf\\no\\n \\ns\\na\\n(\\n \\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n)\\n7\\n1\\n0\\n2\\n/\\n1\\n3\\n/\\n2\\n1\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\nn\\no\\ni\\ns\\ns\\ni\\n\\n \\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\n \\n\\ng\\nn\\ni\\ns\\nu\\no\\nH\\n\\n \\n,\\ns\\nu\\nt\\na\\nt\\nS\\n\\n \\nt\\ns\\no\\nM\\n\\n \\nt\\nn\\ne\\nc\\ne\\nR\\n\\n \\n\\n \\nf\\no\\ny\\nr\\nt\\nn\\nu\\no\\nC\\n\\nh\\nt\\nr\\ni\\nB\\n\\n% with >= 1 \\n\\n% with >= 2 \\n\\nlaboratory test \\n\\nlaboratory tests \\n\\nin 20172\\n\\nin 20172\\n\\n% Virally suppressed \\n\\n(most recent viral load test in 2017 <200 copies/mL)\\namong those with >= 1 \\nlaboratory test in 2017\\n\\namong all living cases\\n\\n73%\\n73%\\n78%\\n79%\\n73%\\n74%\\n71%\\n75%\\n78%\\n76%\\n74%\\n69%\\n69%\\n72%\\n78%\\n79%\\n73%\\n83%\\n75%\\n75%\\n73%\\n78%\\n53%\\n74%\\n\\n53%\\n74%\\n68%\\n78%\\n\\n54%\\n53%\\n58%\\n58%\\n53%\\n57%\\n53%\\n54%\\n54%\\n61%\\n50%\\n46%\\n47%\\n53%\\n62%\\n67%\\n53%\\n63%\\n57%\\n55%\\n50%\\n56%\\n37%\\n54%\\n\\n38%\\n54%\\n52%\\n55%\\n\\n67%\\n67%\\n65%\\n65%\\n68%\\n64%\\n64%\\n71%\\n71%\\n68%\\n64%\\n59%\\n61%\\n67%\\n74%\\n76%\\n68%\\n69%\\n61%\\n64%\\n60%\\n69%\\n48%\\n68%\\n\\n35%\\n67%\\n64%\\n72%\\n\\n92%\\n92%\\n84%\\n82%\\n93%\\n86%\\n90%\\n94%\\n91%\\n89%\\n86%\\n85%\\n88%\\n92%\\n95%\\n96%\\n94%\\n82%\\n82%\\n86%\\n82%\\n88%\\n91%\\n92%\\n\\n66%\\n91%\\n94%\\n92%\\n\\n1  Includes San Francisco residents at diagnosis living with HIV at the end of  2017 (≥13 years old) and diagnosed by the end of  2016. Excludes persons who were \\nnon-San Francisco residents at time of  HIV diagnosis but San Francisco residents at stage 3 HIV (AIDS) diagnosis. See Technical Notes “Residence and Receipt \\nof  Care for PLWH.”\\n\\n2  Percent of  total living cases.\\n3  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.”\\n22  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nTable 3.3 Care indicators among persons living with HIV in 2017 who resided in San Francisco at diagnosis, by demographic and risk characteristics\\x0c ▪ Among PLWH who were San Francisco residents as of  the end of  2017, 74% were virally suppressed; \\n\\namong those who received care in 2017, 91% were virally suppressed.\\n\\n ▪ The proportion who were virally suppressed was lower among women, trans women, African Americans, \\n\\npersons younger than 50 years, PWID, and homeless persons.\\n\\nNumber of \\nliving cases1\\n\\n% with >= 1 \\n\\n% with >= 2 \\n\\nlaboratory test \\n\\nlaboratory tests \\n\\nin 20172\\n\\nin 20172\\n\\n(most recent viral load test in 2017 <200 copies/mL)\\namong those with >= 1 \\nlaboratory test in 2017\\n\\namong all living cases\\n\\n% Virally suppressed\\n\\n12,778\\n11,688\\n725\\n360\\n7,095\\n1,606\\n2,742\\n815\\n520\\n83\\n382\\n1,715\\n2,804\\n4,542\\n2,548\\n704\\n9,263\\n207\\n745\\n1,719\\n151\\n470\\n223\\n\\n12,447\\n\\n331\\n\\n9,321\\n2,201\\n1,256\\n\\n81%\\n81%\\n81%\\n84%\\n81%\\n81%\\n78%\\n81%\\n84%\\n87%\\n80%\\n77%\\n77%\\n81%\\n86%\\n85%\\n81%\\n88%\\n82%\\n81%\\n78%\\n81%\\n56%\\n\\n81%\\n\\n51%\\n\\n82%\\n73%\\n83%\\n\\n60%\\n60%\\n60%\\n64%\\n60%\\n62%\\n58%\\n61%\\n60%\\n66%\\n51%\\n53%\\n53%\\n60%\\n70%\\n73%\\n60%\\n67%\\n62%\\n61%\\n60%\\n59%\\n42%\\n\\n60%\\n\\n38%\\n\\n61%\\n57%\\n59%\\n\\n74%\\n74%\\n66%\\n68%\\n76%\\n68%\\n70%\\n77%\\n74%\\n80%\\n69%\\n67%\\n67%\\n75%\\n81%\\n83%\\n76%\\n71%\\n65%\\n68%\\n64%\\n70%\\n51%\\n\\n75%\\n\\n33%\\n\\n75%\\n69%\\n76%\\n\\n91%\\n92%\\n82%\\n81%\\n93%\\n84%\\n91%\\n95%\\n89%\\n92%\\n87%\\n87%\\n88%\\n92%\\n95%\\n97%\\n94%\\n81%\\n80%\\n85%\\n81%\\n87%\\n92%\\n\\n92%\\n\\n64%\\n\\n91%\\n94%\\n91%\\n\\n3\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n)\\n7\\n1\\n0\\n2\\n/\\n1\\n3\\n/\\n2\\n1\\n \\nf\\no\\n \\ns\\na\\n(\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\nn\\no\\ni\\ns\\ns\\ni\\n\\n \\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n13-24\\n25-29\\n30-39\\n40-49\\n50-59\\n60-69\\n70+\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n\\n \\n\\ng\\nn\\ni\\ns\\nu\\no\\nH\\n\\n \\n,\\ns\\nu\\nt\\na\\nt\\nS\\n\\n \\nt\\ns\\no\\nM\\n\\nt\\nn\\ne\\nc\\ne\\nR\\n\\n \\n\\ny\\nr\\nt\\nn\\nu\\no\\nC\\n\\nh\\nt\\nr\\ni\\nB\\n \\nf\\no\\n\\nHoused\\n\\nHomeless\\n\\nUS\\nNon-US\\nUnknown\\n\\n1  Includes San Francisco residents living with HIV as of  the end of  2017 (≥13 years old) and diagnosed by the end of  2016. See Technical Notes “Residence and \\n\\nReceipt of  Care for PLWH.”  \\n\\n2  Percent of  total living cases.\\n3  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.”\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  23\\n\\nTable 3.4 Care indicators among persons living with HIV in 2017 who were known to reside in San Francisco as of the end of 2017, by demographic and risk characteristics\\x0c ▪\\n\\n ▪\\n\\n ▪\\n\\n ▪\\n\\nFrom January 1, 2017 through December 31, 2017, 120 PLWH were referred, accepted, and completed \\nLinkage Integration Navigation Comprehensive Services (LINCS; see Technical Notes “Linkage Integration \\nNavigation Comprehensive Services”).\\n85% of  those who completed LINCS had a viral load, CD4 test or genotyping test within three months \\nof  LINCS initiation.\\n62% of  persons who completed LINCS had additional testing in the three to nine months after linkage, \\nindicating retention in care.\\n58% of  persons who completed LINCS showed evidence of  viral suppression at their most recent viral \\nload in the 12 month period after they began the LINCS program.\\n\\n ▪ By  age,  persons  30-39  years  old  who  completed  LINCS  had  the  highest  proportion  achieving  viral \\nsuppression;  by  transmission  category,  MSM  non-PWID  had  the  highest  proportion  achieving  viral \\nsuppression.\\n\\nNumber of accepted \\nand completed LINCS\\n\\n% Linked to care \\nwithin 3 months of \\nLINCS initiation1\\n\\n% Retained in care \\n3-9 months after \\n\\nlinkage1\\n\\n% Virally suppressed at most \\nrecent test in 12 months after \\n\\nLINCS initiation1\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n13-24\\n25-29\\n30-39\\n40-49\\n50+\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nHoused\\n\\nHomeless\\n\\n120\\n95\\n14\\n11\\n46\\n32\\n29\\n8\\n5\\n2\\n15\\n37\\n33\\n33\\n51\\n22\\n38\\n9\\n68\\n\\n52\\n\\n85%\\n86%\\n71%\\n91%\\n85%\\n84%\\n83%\\n88%\\n100%\\n100%\\n100%\\n84%\\n82%\\n82%\\n90%\\n77%\\n87%\\n67%\\n84%\\n\\n87%\\n\\n62%\\n61%\\n64%\\n64%\\n61%\\n66%\\n55%\\n75%\\n60%\\n50%\\n87%\\n65%\\n52%\\n58%\\n63%\\n55%\\n66%\\n56%\\n62%\\n\\n62%\\n\\n58%\\n59%\\n57%\\n55%\\n57%\\n59%\\n52%\\n88%\\n60%\\n50%\\n60%\\n73%\\n39%\\n61%\\n69%\\n55%\\n50%\\n44%\\n60%\\n\\n56%\\n\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n)\\n7\\n1\\n\\n/\\n\\n1\\n3\\n\\n/\\n\\n2\\n1\\n\\n \\n\\n \\nf\\no\\ns\\na\\n(\\n\\ni\\n\\ni\\n\\nn\\no\\ns\\ns\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\ng\\nn\\ni\\ns\\nu\\no\\nH\\n\\ns\\nu\\nt\\na\\nt\\nS\\n\\n1  Percent of  persons who accepted and completed LINCS.\\n\\n24  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nTable 3.5 Care indicators among persons who accepted and completed LINCS services in 2017 by demographic and risk characteristics, San Francisco\\x0cComparison of HIV prevention and care indicators in San Francisco to California and \\nthe United States\\n\\n ▪ Awareness of  HIV status in San Francisco is high (94%) compared to all of  California and the U.S. (86%).\\n ▪ The proportions of  PLWH who received care and were virally suppressed were higher in San Francisco \\n\\nthan in California and the U.S. \\n\\n ▪ The death rates per 1,000 persons with HIV or stage 3 HIV (AIDS) in San Francisco were slightly higher \\n\\nthan that in California but lower than in the U.S.\\n\\nAwareness of HIV status1\\nEstimated % persons living with HIV who know their serostatus\\n\\nLate HIV diagnosis \\n\\ns\\nr\\no\\nt\\na\\nc\\ni\\nd\\nn\\n\\nI\\n\\n% persons diagnosed with AIDS within 3 months of HIV diagnosis\\nHIV care access and outcome3 \\n% newly diagnosed persons linked to care within 1 month of HIV diagnosis\\n% PLWH who are in care (≥1 laboratory tests)\\n% PLWH who are retained in care (≥2 laboratory tests)\\n% PLWH who are virally suppressed\\n% PLWH aged 13-24 years who are virally suppressed\\n% PLWH PWID who are virally suppressed\\n\\nHIV mortality \\n  Death rate per 1,000 persons with HIV (including AIDS) diagnosis\\n  Death rate per 1,000 persons with AIDS diagnosis\\n\\nSan Francisco\\n\\nCalifornia2 United States2\\n\\n94% (2017)\\n\\n86% (2016)\\n\\n86% (2016)\\n\\n19% (2017)\\n\\n19% (2017)\\n\\n21% (2017)\\n\\n81% (2017)\\n81% (2017)\\n60% (2017)\\n74% (2017)\\n80% (2017)\\n65% (2017)\\n\\n75% (2017)\\n76% (2016)\\n58% (2016)\\n66% (2016)\\n\\nNA\\nNA\\n\\n78% (2017)\\n74% (2016)\\n58% (2016)\\n62% (2016)\\n54% (2016)\\n54% (2016)\\n\\n14.9 (2017)\\n21.8 (2017)\\n\\n13.9 (2016)\\n20.4 (2016)\\n\\n16.3 (2016)\\n24.1 (2016)\\n\\n1  The estimated percent aware of  HIV infection for San Francisco was derived using the CD4 depletion model. See Technical Notes “CD4-based Model.” Reference \\nfor California and U.S. estimates: CDC HIV Surveillance Supplemental Report 2019;24(No. 1). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. \\nPublished February 2019.\\n\\n2  CDC HIV Surveillance Supplemental Report 2019;24(No. 3). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Published June 2019.  \\n3  The percentages of  persons living with HIV diagnosis who are in care, retained in care, and virally suppressed are calculated among those diagnosed and last \\n\\nknown to be living in San Francisco and California, respectively. See Technical Notes “Residence and Receipt of  Care for PLWH.”\\n\\nNA: Not Available.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  25\\n\\nTable 3.6 Comparison of HIV prevention and care indicators for San Francisco, California, and the United States\\x0cUse of antiretroviral therapy\\n\\n ▪\\n\\nPersons with a medical record indicating that they were prescribed ART were assumed to have received \\nand used it (See Technical Notes “Estimate of  ART Use”). Overall, 91%-98% of  PLWH received ART. \\nART use was lower among women, African Americans, persons under 30 years, PWID, and the homeless. \\n ▪ Among 244 persons newly diagnosed with HIV in 2017, 86% received ART. ART use was lower among \\nwomen, whites and African Americans, persons aged 40 or older, PWID, heterosexuals, the homeless, and \\npersons who were publicly insured at time of diagnosis. \\n\\nPersons living with HIV1, December 2018\\n\\nPersons newly diagnosed with HIV1, 2017\\n\\nPercent receiving ART, ever \\n\\nPercent receiving ART\\n\\nLower level estimate  Upper level estimate  \\n\\n(N=15,327)\\n\\n(N=6,658)\\n\\n(N=244)\\n\\n2\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n3\\ne\\ng\\nA\\n\\n \\n\\ni\\n\\ni\\n\\nn\\no\\ns\\ns\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\n \\n\\ni\\n\\ng\\nn\\ns\\nu\\no\\nH\\n\\n4\\ns\\nu\\nt\\na\\nt\\nS\\n\\n \\n\\ne\\nc\\nn\\na\\nr\\nu\\ns\\nn\\n\\nI\\n\\n \\nt\\na\\n\\ns\\n\\ni\\n\\ns\\no\\nn\\ng\\na\\nD\\n\\ni\\n\\nOverall\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n13 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50 +\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\n\\nHoused\\n\\n91%\\n91%\\n91%\\n91%\\n92%\\n88%\\n90%\\n89%\\n89%\\n90%\\n86%\\n84%\\n87%\\n93%\\n91%\\n91%\\n86%\\n91%\\n92%\\n94%\\n\\n91%\\n\\n98%\\n99%\\n95%\\n99%\\n99%\\n96%\\n98%\\n99%\\n99%\\n92%\\n95%\\n97%\\n97%\\n99%\\n99%\\n99%\\n95%\\n99%\\n99%\\n97%\\n\\n99%\\n\\n86%\\n87%\\n78%\\n100%\\n82%\\n81%\\n86%\\n97%\\n100%\\n92%\\n88%\\n89%\\n80%\\n84%\\n88%\\n100%\\n67%\\n90%\\n100%\\n81%\\n\\n86%\\n\\nHomeless\\nPrivate\\nPublic\\nNone\\n\\n79%\\n95%\\n92%\\n87%\\n\\n93%\\n99%\\n97%\\n98%\\n\\n84%\\n93%\\n83%\\n88%\\n\\n1  Excludes persons who did not reside in San Francisco at time of  HIV diagnosis but reside in San Francisco at time of  HIV stage 3 (AIDS) diagnosis.  \\n2  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.” \\n3  Age as of  December 31, 2018 for PLWH. Age at HIV diagnosis for persons newly diagnosed with HIV.\\n4  Housing status is based on the most recent residence for PLWH and the residence at HIV diagnosis for persons newly diagnosed with HIV.\\n\\n26  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nTable 3.7 Estimate of ART use among persons living with HIV as of December 2018 and diagnosed in 2017 by demographic and risk characteristics, San Francisco\\x0c ▪ The proportion receiving ART was slighter higher among persons with a lower CD4 count: 99% of  cases \\nwith a nadir CD4 count below 200 cells/µL, 99% with a nadir CD4 count between 200-350 cells/µL, 98% \\nwith a nadir CD4 count between 351-500 cells/µL, and 97% with a nadir CD4 count above 500 cells/µL \\nreceived ART.\\n\\n \\n\\ni\\n\\nT\\nR\\nA\\ng\\nn\\nv\\ne\\nc\\ne\\nR\\n%\\n\\n \\n\\ni\\n\\n100%\\n\\n99%\\n\\n99%\\n\\n98%\\n\\n97%\\n\\n80%\\n\\n60%\\n\\n40%\\n\\n20%\\n\\n0%\\n\\n<200\\n\\n200-350\\n\\n351-500\\n\\n>500\\n\\nCD4 Count (cells/μL)\\n\\n1  See Technical Notes “Estimate of  ART Use.” \\n2  Excludes persons who did not reside in San Francisco at time of  HIV diagnosis but reside in San Francisco at time of  HIV stage 3 (AIDS) diagnosis. \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  27\\n\\nFigure 3.4 Estimate of ART use1 among persons living with HIV2 and with chart review, by nadir CD4 level, December 2018, San Francisco\\x0c ▪ Among persons newly diagnosed with HIV between 2008 and 2017 whose CD4 count at diagnosis was \\n>500 cells/µL, the median CD4 count at ART initiation increased from 553 cells/µL in 2008 to 702 cells/\\nµL in 2017.\\n\\n ▪ Among persons whose CD4 count at diagnosis was between 200 and 500 cells/µL, the median CD4 count \\n\\nat ART initiation remained relatively stable over time.\\n\\n ▪ The median CD4 count at ART initiation among persons whose CD4 count at diagnosis <200 cells/µL \\n\\nfluctuated between 79 and 147 cells/µL during 2008 and 2017. \\n\\nCD4 count at diagnosis, >500\\nCD4 count at diagnosis, 351-500\\nCD4 count at diagnosis, 200-350\\nCD4 count at diagnosis, <200\\n\\n651\\n\\n629\\n\\n675\\n\\n660\\n\\n672\\n\\n688\\n\\n702\\n\\n553\\n\\n558\\n\\n565\\n\\n428\\n\\n297\\n\\n419\\n\\n280\\n\\n430\\n\\n437\\n\\n419\\n\\n430\\n\\n418\\n\\n418\\n\\n292\\n\\n292\\n\\n271\\n\\n285\\n\\n286\\n\\n290\\n\\n412\\n\\n278\\n\\n79\\n\\n103\\n\\n85\\n\\n116\\n\\n82\\n\\n111\\n\\n107\\n\\n147\\n\\n119\\n\\n900\\n\\n800\\n\\n700\\n\\n600\\n\\n500\\n\\n400\\n\\n300\\n\\n200\\n\\n100\\n\\n0\\n\\n)\\nL\\nu\\n/\\ns\\nl\\nl\\ne\\nc\\n(\\n \\nT\\nR\\nA\\n\\n \\nt\\na\\n \\nt\\nn\\nu\\no\\nC\\n \\n4\\nD\\nC\\nn\\na\\ni\\nd\\ne\\nM\\n\\n \\n\\n387\\n\\n282\\n\\n102\\n\\n2008\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\nYear of HIV Diagnosis\\n\\n1  Median CD4 count at ART initiation was calculated among persons who started ART and whose CD4 count at HIV diagnosis and CD4 count at ART initiation \\n\\nwere available (N=2,732).\\n\\n28  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nFigure 3.5 Trends in median CD4 count at time of ART initiation1 by CD4 count at time of diagnosis, 2008-2017, San Francisco\\x0c ▪ Among persons newly diagnosed with HIV between 2008 and 2017, the median CD4 count at HIV diagnosis \\nincreased from 394 cells/µL in 2008 to 466 cells/µL in 2015 and then decreased to 409 cells/µL in 2017.\\n ▪ Among those newly diagnosed who started ART, the median CD4 count at ART initiation followed a similar \\ntrend as the median CD4 count at HIV diagnosis; increased from 336 cells/µL in 2008 to 434 cells/µL in \\n2015 and then decreased to 406 cells/µL in 2017.\\n\\n ▪ The increasing CD4 count at diagnosis and a smaller difference between the CD4 count at diagnosis and \\nCD4 count at ART initiation suggest a trend towards earlier HIV diagnosis and timely ART initiation \\nbetween 2008 and 2017.\\n\\n)\\nL\\nµ\\ns\\n\\n/\\n\\nl\\nl\\n\\ne\\nC\\n\\n(\\n \\nt\\nn\\nu\\no\\nC\\n4\\nD\\nC\\n\\n \\n\\n500\\n\\nCD4 at HIV diagnosis\\nCD4 at ART initiation\\n2\\n\\n1\\n\\n400\\n\\n394\\n\\n406\\n\\n411\\n\\n383\\n\\n336\\n\\n322\\n\\n442\\n\\n415\\n\\n418\\n\\n404\\n\\n440\\n\\n428\\n\\n433\\n\\n415\\n\\n466\\n\\n434\\n\\n459\\n\\n426\\n\\n409\\n\\n406\\n\\n300\\n\\n200\\n\\n100\\n\\n0\\n\\n2008\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\nYear of HIV Diagnosis\\n\\n1  Median CD4 count at HIV diagnosis was calculated among persons whose CD4 count at HIV diagnosis was available (N=3,350).\\n2  Median CD4 count at ART initiation was calculated among persons who started ART and whose CD4 count at HIV diagnosis and CD4 count at ART initiation \\n\\nwere available (N=2,732).\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  29\\n\\nFigure 3.6 Trends in median CD4 count at time of diagnosis and at time of ART initiation among persons newly diagnosed with HIV, 2008-2017, San Francisco\\x0c ▪\\n\\nSan Francisco launched a pilot RAPID (Rapid ART Program Initiative for HIV Diagnoses) program in \\n2013 and adopted a citywide RAPID protocol in 2015 with the goal to link persons newly diagnosed with \\nHIV to care within 5 working days (or 7 calendar days) of  diagnosis and start ART at the first care visit.\\n\\n ▪ Among persons diagnosed with HIV between 2013 and 2017, the proportion who started ART within 7 \\n\\ndays of  diagnosis (rapid ART initiation) increased from 8% in 2013 to 44% in 2017.\\n\\n ▪ A higher proportion of  rapid ART initiation was observed among Latinx (29%), persons 13-24 years \\n(28%), heterosexuals (29%), persons born outside the U.S. (27%), and those with public insurance (27%). \\n ▪ Trans women had the lowest proportion of  rapid ART initiation (7%) although the number of  new \\n\\ndiagnoses among trans women is small.\\n\\n1  Includes persons diagnosed with HIV who were in care. Excludes 106 persons with an invalid ART initiation date.\\n2  Includes TWSM, TWSM-PWID and persons with no identified risk factor.\\n\\n30  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nNumber of diagnoses1% Started ART within 7 days of diagnosis% Started ART 8-30 days after diagnosis% Started ART > 30 days after diagnosis or not known to have started ARTTotal1,37423%27%50%20133618%23%70%201430016%28%55%201527425%30%45%201622635%29%35%201721344%26%30%Men1,22424%27%49%Women10822%24%54%Trans Women417%29%63%White58421%27%52%African American18522%22%56%Latinx36629%26%45%Asian/Pacific Islander17421%30%48%Other/Unknown6522%32%46%13-2417828%28%45%25-2926922%28%50%30-3942025%27%49%40-4930322%26%51%50+20420%27%53%MSM96624%28%48%PWID10521%20%59%MSM-PWID14920%24%56%Heterosexual8529%27%44%Other/Unidentified26917%26%57%Housed1,16623%28%50%Homeless13024%20%56%Unknown7828%31%41%US71920%26%54%Non-US36527%31%42%Unknown29027%24%49%Private52122%30%48%Public40227%26%48%None32924%24%52%Unknown 12216%27%57%Country of BirthInsurance at DiagnosisYear of DiagnosisGenderRace/EthnicityAge at DiagnosisTransmission CategoryHousing Status at Diagnosis Table 3.8 Time from HIV diagnosis to ART initiation among persons diagnosed with HIV in 2013-2017 by demographic and risk characteristics, San Francisco\\x0cTrends in time from HIV diagnosis to ART initiation\\n\\n ▪ Among persons diagnosed with HIV between 2013 and 2017 who were in care, the median time from \\n\\ndiagnosis to ART initiation significantly decreased from 50 days in 2013 to 11 days in 2017. \\n\\nMedian time between \\ndiagnosis and ART \\n\\ninitiation \\n\\n(months/days)\\n\\nTotal cases \\nincluded1\\n\\nNo. initiated ART as \\n\\nof 04/12/2019\\n\\nNo. (%) censored at the \\n\\nlast follow-up date\\n\\n2013\\n2014\\n2015\\n2016\\n2017\\n\\n1 / 50\\n1 / 34\\n<1 / 22\\n<1 / 14\\n<1 / 11\\n\\n361\\n300\\n274\\n226\\n213\\n\\n306\\n269\\n247\\n214\\n186\\n\\n55 (15%)\\n31 (10%)\\n27 (10%)\\n12 (  5%)\\n27 (13%)\\n\\n1  Includes persons diagnosed with HIV who were in care. Excludes 106 persons with an invalid ART initiation date. Time between HIV diagnosis and ART \\n\\ninitiation was calculated using full dates (month, day, year).  \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  31\\n\\nFigure 3.7 Kaplan-Meier estimates of time from HIV diagnosis to ART initiation among persons diagnosed with HIV by year of diagnosis, 2013-2017, San Francisco\\x0cTrends in time from HIV diagnosis to viral suppression\\n\\n ▪ Among persons diagnosed with HIV who were in care, the median time from diagnosis to viral suppression \\n(HIV viral load less than 200 copies/mL) steadily decreased from four months in 2013 to two months in \\n2015 and remained relatively stable thereafter.\\n\\nMedian time between \\ndiagnosis and viral \\n\\nsuppression\\n (months/days)\\n\\nTotal cases \\nincluded1\\n\\nNo. virally suppressed \\n\\nas of 4/12/2019\\n\\nNo. (%) censored at the \\n\\nlast lab test date\\n\\n2013\\n2014\\n2015\\n2016\\n2017\\n\\n4 / 145\\n3 / 102\\n2 / 83\\n2 / 66\\n2 / 71\\n\\n372\\n319\\n292\\n260\\n237\\n\\n335\\n298\\n272\\n248\\n209\\n\\n37 (10%)\\n21 (  7%)\\n20 (  7%)\\n12 (  5%)\\n28 (12%)\\n\\n1  Includes persons diagnosed with HIV who were in care. Time between HIV diagnosis and viral suppression was calculated using full dates (month, day, year).    \\n\\n32  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nFigure 3.8 Kaplan-Meier estimates of time from HIV diagnosis to viral suppression among persons diagnosed with HIV by year of diagnosis, 2013-2017, San Francisco\\x0cReceipt of HIV care among persons living with HIV by residence status\\n\\n ▪ Among 15,990 PLWH in 2018 who resided in San Francisco at time of  diagnosis, 72% were known to \\nreceive HIV care in 2018 (55% received care in San Francisco, 17% received care outside of  San Francisco) \\nand 28% did not receive HIV care. \\n\\n ▪ Of the 28% not known to be in care, 12% had a San Francisco current address and should be a high priority \\n\\nto be reengaged back into care.\\n\\nN=15,9901\\n\\nNot known to be \\nin care (N=4435)\\n\\n28%\\n\\nReceived care \\n\\nelsewhere \\n(N=2755)\\n\\n17%\\n\\nMost recent \\naddress, OOJ,\\n\\n16%\\n\\nMost recent \\naddress, SF,\\n\\n12%\\n\\nMost recent \\naddress, SF, 1%\\n\\nMost recent \\naddress, OOJ,\\n\\n16%\\n\\nMost recent \\naddress, OOJ,\\n\\n8%\\n\\nMost recent \\naddress, SF,\\n\\n47%\\n\\nReceived care in \\n\\nSF (N=8800)\\n\\n55%\\n\\n1  Includes persons who resided in San Francisco at diagnosis and were alive as of  December 2018 to assess where they live based on the most recent available \\n\\naddress and where they receive care in 2018. See Technical Notes “Residence and Receipt of  Care for PLWH.”\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  33\\n\\nFigure 3.9 Persons living with HIV in 2018 who resided in San Francisco at diagnosis by care and most recent residence status\\x0c ▪ Of the 12,925 PLWH who received care in San Francisco in 2018, 32% were originally diagnosed elsewhere \\n\\nand 27% currently reside outside of San Francisco.\\n\\nN=12,9251\\nMost recent \\naddress, OOJ\\n\\n2\\n\\n14%\\n\\nMost recent \\naddress, SF\\n2\\n\\n18%\\n\\nOOJ at \\ndiagnosis \\n(N=4125),\\n\\n32%\\n\\nSF at \\n\\ndiagnosis \\n(N=8800),\\n\\n68%\\n\\nMost recent \\naddress, OOJ\\n\\n9%\\n\\nMost recent \\naddress, SF\\n\\n59%\\n\\n1  Includes persons who received HIV care in San Francisco in 2018 regardless of  where they were initially diagnosed with HIV. Receipt of  care in San Francisco \\nis defined as having at least one CD4, viral load, or genotype test ordered by San Francisco HIV providers. See Technical Notes “Residence and Receipt of  Care \\nfor PLWH.”\\n\\n2  Most recent address for OOJ residents at diagnosis is less complete because the update on address information is not conducted regularly or consistently.\\n\\n34  \\n\\nSPECTRUM OF ENGAGEMENT IN HIV PREVENTION AND CARE\\n\\nFigure 3.10 Persons living with HIV who received care in San Francisco in 2018 by residence at diagnosis and most recent residence status\\x0c ▪ The majority of  PLWH who received care in 2018 in San Francisco were male, white, over 50 years old, \\n\\nand men who have sex with men.\\n\\n ▪ The distribution of  characteristics among those currently known to live in San Francisco and those known \\n\\nto live in another jurisdiction was similar.\\n\\nPersons receiving HIV care in San Francisco1\\n\\nTotal cases receiving \\n\\ncare in 2018\\n\\nMost recent residence in \\n\\nSan Francisco2\\nNumber (%)\\n\\nMost recent residence \\noutside San Francisco2\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n 0-12\\n13-24\\n25-29\\n30-39\\n40-49\\n50-59\\n60-69\\n70+\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n\\n12,925 (100)\\n11,815 ( 91)\\n762 ( 6)\\n340 ( 3)\\n7,125 ( 55)\\n1,741 ( 13)\\n2,663 ( 21)\\n849 ( 7)\\n547 ( 4)\\n3 (  <1)\\n152 ( 1)\\n431 ( 3)\\n1,759 ( 14)\\n2,479 ( 19)\\n4,405 ( 34)\\n2,881 ( 22)\\n815 ( 6)\\n9,466 ( 73)\\n206 ( 2)\\n706 ( 5)\\n1,632 ( 13)\\n131 ( 1)\\n511 ( 4)\\n273 ( 2)\\n\\n9,919 (100)\\n9,041 ( 91)\\n593 ( 6)\\n280 ( 3)\\n5,442 ( 55)\\n1,294 ( 13)\\n2,111 ( 21)\\n654 ( 7)\\n418 ( 4)\\n0 ( 0)\\n91 ( 1)\\n296 ( 3)\\n1,347 ( 14)\\n1,873 ( 19)\\n3,424 ( 35)\\n2,242 ( 23)\\n646 ( 7)\\n7,196 ( 73)\\n167 ( 2)\\n587 ( 6)\\n1,333 ( 13)\\n111 ( 1)\\n376 ( 4)\\n149 ( 2)\\n\\n3,006 (100)\\n2,774 ( 92)\\n169 ( 6)\\n60 ( 2)\\n1,683 ( 56)\\n447 ( 15)\\n552 ( 18)\\n195 ( 6)\\n129 ( 4)\\n3 (  <1)\\n61 ( 2)\\n135 ( 4)\\n412 ( 14)\\n606 ( 20)\\n981 ( 33)\\n639 ( 21)\\n169 ( 6)\\n2,270 ( 76)\\n39 ( 1)\\n119 ( 4)\\n299 ( 10)\\n20 ( 1)\\n135 ( 4)\\n124 ( 4)\\n\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n)\\n8\\n1\\n0\\n2\\n/\\n1\\n3\\n/\\n2\\n1\\n \\nf\\no\\n \\ns\\na\\n(\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\nn\\no\\ni\\ns\\ns\\ni\\n\\n \\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\n1  Includes persons living with HIV at end of  2018 who received care in San Francisco in 2018 regardless of  where they were initially diagnosed \\nwith HIV. Receipt of  care in San Francisco is defined as having at least one CD4, viral load, or genotype test ordered by San Francisco HIV \\nproviders. See Technical Notes “Residence and Receipt of  Care for PLWH.”\\n\\n2  Based on most recent available address.\\n3  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.” \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  35\\n\\nTable 3.9 Characteristics of persons living with HIV who received care in San Francisco in 2018 by most recent residence status\\x0c4\\n\\n ▪\\n\\nSurvival among Persons with HIV \\nDisease Stage 3 (AIDS)\\n\\nStage 3 HIV (AIDS) survival time was poor for persons diagnosed in the first ten years of  the epidemic \\n(1980-1989) with a median survival time of  18 months after stage 3 HIV diagnosis.\\n\\n ▪ The median survival time increased to 39 months for persons diagnosed between 1990 and 1995.\\n ▪ The median stage 3 HIV survival time has not yet been reached for those diagnosed in the more recent \\n\\ntime periods (1996-2000, 2001-2005, and 2006-2011, 2012-2016).\\n\\n ▪ The survival probability at three years among persons diagnosed with stage 3 HIV increased from 23% \\nin the period 1980-1989 to 52% in the period 1990-1995 followed by an increase to 85% in the period \\n1996-2000 and smaller but continued increase in more recent years’ diagnoses (87% in 2001-2005, 90% in \\n2006-2011, and 89% in 2012-2016).\\n\\n23%\\n\\noF hiv Stage 3 caSeS \\ndiagnoSed in 1980-1989 \\nSUrvived For three yearS\\n\\n\\uf0ec\\n\\n89%\\n\\noF hiv Stage 3 caSeS \\ndiagnoSed in 2012-2016 \\nSUrvived For three yearS\\n\\n1  See Technical Notes “HIV Disease Stage 3 (AIDS) Survival.”\\n\\n36  \\n\\nSURVIVAL AMONG PERSONS WITH HIV DISEASE STAGE 3 (AIDS)\\n\\nFigure 4.1 Kaplan-Meier survival curves for persons diagnosed with stage 3 HIV (AIDS) in five time periods, San Francisco\\x0c ▪ Among persons diagnosed with stage 3 HIV (AIDS) in the years 2012-2016, survival probability at three \\n\\nyears was lower among African Americans compared to whites, Latinxs, and Asians/Pacific Islanders.\\n\\n ▪ The three-year survival probability for African Americans after HIV stage 3 diagnosis was 82%, compared \\n\\nto 88% among whites, 94% among Latinx individuals, and 95% among Asians/Pacific Islanders. \\n\\n1  See Technical Notes “HIV Disease Stage 3 (AIDS) Survival.”\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  37\\n\\nFigure 4.2 Kaplan-Meier survival curves for persons diagnosed with stage 3 HIV (AIDS) between 2012 and 2016 by racial/ethnic group, San Francisco\\x0c ▪ Among persons diagnosed with stage 3 HIV (AIDS) between 2012 through 2016, the three-year survival \\nprobability after stage 3 HIV diagnosis was highest for men who have sex with men (91%) and lowest for \\nheterosexual persons who inject drugs (79%).\\n\\n1  See Technical Notes “HIV Disease Stage 3 (AIDS) Survival.”\\n\\n38  \\n\\nSURVIVAL AMONG PERSONS WITH HIV DISEASE STAGE 3 (AIDS)\\n\\nFigure 4.3 Kaplan-Meier survival curves for persons diagnosed with stage 3 HIV (AIDS) between 2012 and 2016 by transmission category, San Francisco\\x0c ▪\\n\\nFrom 2012 through 2016, survival time among women with a stage 3 HIV (AIDS) diagnosis was shorter \\nthan survival among men and trans women.\\n\\n ▪ The three-year survival probability among women was 88% compared to 89% among men and 98% among \\n\\ntrans women. \\n\\n1  See Technical Notes “HIV Disease Stage 3 (AIDS) Survival.” \\n2  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.” \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  39\\n\\nFigure 4.4 Kaplan-Meier survival curves for persons diagnosed with stage 3 HIV (AIDS) between 2012 and 2016 by gender, San Francisco\\x0c ▪ Overall three-year survival probability (Kaplan-Meier method) after stage 3 HIV (AIDS) for persons \\n\\ndiagnosed during 2012 to 2016 was 89%.\\n\\n ▪ African Americans (82%), PWID (79%), and women (88%) had lower three-year survival probabilities \\n\\ncompared to other groups.\\n\\nRace\\n\\nTransmission Category\\n\\nGender\\n\\nOverall\\n\\n94% 95%\\n\\n91%\\n\\n88%\\n\\n82%\\n\\n79%\\n\\n90%\\n\\n88%\\n\\n89% 88%\\n\\n89%\\n\\n98%\\n\\n0%\\n\\n100%\\n\\n90%\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\n2\\ny\\nt\\ni\\nl\\ni\\n\\nb\\na\\nb\\no\\nr\\nP\\n\\n \\nl\\n\\ni\\n\\na\\nv\\nv\\nr\\nu\\nS\\n \\nr\\na\\ne\\ny\\n-\\n3\\n\\n1  Native American, multi-racial, trans men data are not released separately due to small numbers. \\n2  Calculated from Kaplan-Meier method.\\n\\n40  \\n\\nSURVIVAL AMONG PERSONS WITH HIV DISEASE STAGE 3 (AIDS)\\n\\nFigure 4.5 Three-year survival probability after stage 3 HIV (AIDS) for persons diagnosed between 2012 and 2016 by racial/ethnic group1, transmission category, and gender1, San Francisco\\x0c5\\n\\nTrends in HIV Mortality\\n\\n ▪ As of December 31, 2017, the cumulative number of deaths among San Francisco \\n\\nHIV cases was 21,289.\\nFrom 2013 to 2017 the proportions of death by gender were relatively stable and \\nthe proportions of death in whites and men who have sex with men and who also \\ninject drugs (MSM-PWID) increased.\\n\\n ▪\\n\\n ▪ The majority of  deaths occurred among persons aged 50 years and older (72% \\nto 79%) with an increase in both number and proportion of  death in persons \\naged 70 years and older in 2017.\\n\\n33% \\n\\noF deathS in 2017 \\nwere dUe to hiv-\\nrelated caUSeS\\n\\n1\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n2013\\n\\n2014\\n\\n222 (85)\\n29 (11)\\n10 ( 4)\\n147 (56)\\n49 (19)\\n40 (15)\\n9 ( 3)\\n\\n208 (87)\\n20 ( 8)\\n12 ( 5)\\n138 (58)\\n53 (22)\\n35 (15)\\n4 ( 2)\\n\\nYear of Death\\n\\n2015\\n\\nNumber (%)\\n228 (89)\\n27 (11)\\n1 (<1)\\n146 (57)\\n48 (19)\\n31 (12)\\n8 ( 3)\\n\\n2016\\n\\n2017\\n\\n197 (84)\\n27 (11)\\n11 ( 5)\\n142 (60)\\n51 (22)\\n29 (12)\\n4 ( 2)\\n\\n222 (88)\\n21 ( 8)\\n9 ( 4)\\n165 (65)\\n43 (17)\\n34 (13)\\n3 ( 1)\\n\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander/ \\nNative American\\nMulti-Race\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nOther/Unidentified2\\n  0 - 29\\n30 - 39\\n40 - 49\\n50 - 59\\n60 - 69\\n70+\\nStage 0, 1, 2, or unknown\\nStage 3 (AIDS)\\nHIV/AIDS-related\\nNon-HIV/AIDS-related\\nUnknown\\nTotal\\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\n)\\ns\\nr\\na\\ne\\ny\\n(\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\nh\\nt\\na\\ne\\nD\\n \\nt\\na\\ne\\ng\\nA\\n\\n9 ( 4)\\n121 (51)\\n35 (15)\\n57 (24)\\n9 ( 4)\\n13 ( 6)\\n1 ( 0)\\n11 ( 5)\\n39 (17)\\n76 (32)\\n78 (33)\\n30 (13)\\n38 (16)\\n197 (84)\\n76 (32)\\n156 (66)\\n3 ( 1)\\n235 (100)\\n1  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.”\\n2  Includes TWSM, TWSM-PWID and persons with no identified risk factor. \\n3  Underlying cause of  death obtained from the NDI is available through 2017. See Technical Notes “Death Ascertainment.”\\n\\n16 ( 6)\\n145 (56)\\n49 (19)\\n49 (19)\\n5 ( 2)\\n13 ( 5)\\n3 ( 1)\\n12 ( 5)\\n57 (22)\\n101 (39)\\n66 (25)\\n22 ( 8)\\n55 (21)\\n206 (79)\\n103 (39)\\n150 (57)\\n8 ( 3)\\n261 (100)\\n\\n10 ( 4)\\n137 (57)\\n39 (16)\\n44 (18)\\n8 ( 3)\\n12 ( 5)\\n4 ( 2)\\n11 ( 5)\\n36 (15)\\n90 (38)\\n70 (29)\\n29 (12)\\n41 (17)\\n199 (83)\\n105 (44)\\n132 (55)\\n3 ( 1)\\n240 (100)\\n\\n23 ( 9)\\n139 (54)\\n43 (17)\\n62 (24)\\n6 ( 2)\\n6 ( 2)\\n7 ( 3)\\n15 ( 6)\\n37 (14)\\n100 (39)\\n66 (26)\\n31 (12)\\n42 (16)\\n214 (84)\\n102 (40)\\n149 (58)\\n5 ( 2)\\n256 (100)\\n\\n7 ( 3)\\n129 (51)\\n38 (15)\\n63 (25)\\n9 ( 4)\\n13 ( 5)\\n4 ( 2)\\n12 ( 5)\\n38 (15)\\n83 (33)\\n66 (26)\\n49 (19)\\n40 (16)\\n212 (84)\\n83 (33)\\n159 (63)\\n10 ( 4)\\n252 (100)\\n\\nf\\no\\ne\\ns\\nu\\na\\nC\\n\\n3\\nh\\nt\\na\\ne\\nD\\n\\ne\\ns\\na\\ne\\ns\\ni\\nD\\n\\ne\\ng\\na\\nt\\nS\\n\\nV\\nH\\n\\nI\\n\\n \\n\\n \\n\\n \\n\\n \\n\\nCumulative \\nTotals as of \\n12/31/2017\\n\\n20,132\\n878\\n279\\n15,468\\n2,730\\n2,244\\n547\\n\\n300\\n15,370\\n1,775\\n3,299\\n245\\n600\\n1,112\\n7,354\\n7,671\\n3,482\\n1,283\\n387\\n583\\n20,706\\n--\\n--\\n--\\n21,289\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  41\\n\\nTable 5.1 Deaths among persons diagnosed with HIV, by demographic and risk characteristics, 2013-2017, San Francisco\\x0c ▪ The case-fatality rate due to underlying HIV-related causes among persons with HIV stage 3 diagnosis \\n\\ndeclined from 13.01 per 1,000 persons in 2008 to 7.87 per 1,000 persons for 2017.\\n\\n ▪ Non-HIV-related causes of  death among persons with HIV stage 3 diagnosis fluctuated during this time \\n\\nperiod and increased to the highest annual rate of  13.93 deaths per 1,000 persons in 2017.\\n\\n ▪ When deaths in all stages of  HIV disease were evaluated, case-fatality rates for HIV-related causes declined \\nfrom 8.72 per 1,000 persons in 2008 to 5.12 per 1,000 persons in 2017 and the case-fatality rates for non-\\nHIV causes increased slightly to near 10 deaths per 1,000 persons in both 2016 and 2017.\\n\\nPersons with HIV (all stages)\\n\\nPersons with HIV Stage 3 (AIDS)\\n\\nHIV-related cause of death Non-HIV-related cause of death HIV-related cause of death Non-HIV-related cause of death\\n\\nCase-fatality rate1 per 1,000\\n\\nr\\na\\ne\\nY\\n\\n2008\\n2009\\n2010\\n2011\\n2012\\n2013\\n2014\\n2015\\n2016\\n2017\\n\\n8.72\\n8.08\\n6.68\\n6.41\\n5.19\\n6.38\\n6.48\\n6.28\\n4.69\\n5.12\\n\\n8.32\\n8.01\\n8.61\\n7.87\\n9.39\\n9.29\\n8.15\\n9.17\\n9.62\\n9.81\\n\\n13.01\\n12.46\\n9.62\\n9.87\\n7.96\\n9.30\\n9.76\\n9.83\\n7.51\\n7.87\\n\\n11.41\\n10.35\\n11.29\\n10.19\\n11.99\\n11.26\\n10.70\\n12.23\\n13.00\\n13.93\\n\\n1  Case-fatality rates are calculated as the number of  persons with HIV stage 3 (AIDS), or all HIV disease stages, who died each year divided by the number of  \\n\\ntotal HIV stage 3 (AIDS), or HIV disease all stage, cases alive during that year. See Technical Notes for “Death Ascertainment.” \\n\\n42  \\n\\nTRENDS IN HIV MORTALITY\\n\\nTable 5.2 Case-fatality rates per 1,000 due to HIV-related and non-HIV-related causes among persons diagnosed with HIV, 2008-2017, San Francisco\\x0c ▪ The age-adjusted HIV mortality rate among African American men dropped 24% from 194 per 100,000 \\n\\nin 2008 to 148 per 100,000 in 2017.\\n\\n ▪ The mortality rate among African American men in 2017 rate was 1.6 times higher than white men (94 per \\n\\n100,000) and 2.3 times higher than Latino men (65 per 100,000). \\n\\n ▪ HIV mortality rates for women were much lower than the rates for men.\\n ▪ African American women experience not only higher HIV mortality rates but also a larger magnitude \\n\\ndifference compared to white women and Latina women.\\nIn 2017, African American women had a mortality rate of  43 deaths per 100,000, which was 4.3 times \\nhigher than Latina women and 7.2 times higher than white women.  \\n\\n ▪\\n\\n,\\n\\n0\\n0\\n0\\n0\\n0\\n1\\n \\nr\\ne\\np\\n1\\ne\\nt\\na\\nR\\ny\\nt\\ni\\nl\\n\\n \\n\\n \\n\\na\\nt\\nr\\no\\nM\\nd\\ne\\nt\\ns\\nu\\nd\\nA\\n-\\ne\\ng\\nA\\n\\nj\\n\\n300\\n280\\n260\\n240\\n220\\n200\\n180\\n160\\n140\\n120\\n100\\n80\\n60\\n40\\n20\\n0\\n2008\\n\\nWhite men\\nAfrican American men\\nLatino men\\n\\nWhite women\\nAfrican American women\\nLatina women\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\nYear\\n\\n1  Age-adjusted mortality rates are calculated for persons 18 and over. For each race/ethnicity and sex group, the number of  HIV cases who died each year was \\ndivided by projected San Francisco population estimates across seven age groups (18-29, 30-39, 40-49,50-59,60-69,70-79, 80+) to generate crude rates applied \\nto the standard population, defined using the California population estimates from the Department of  Finance. See Technical Notes for “HIV Case Rates and \\nHIV Mortality Rates.”\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  43\\n\\nFigure 5.1 Age-adjusted mortality rates among persons aged 18 and older with HIV per 100,000 by sex and race/ethnicity, 2008-2017, San Francisco\\x0c ▪ HIV as the underlying cause of  death declined from 51.7% in 2006-2009 to 38.0% of  deaths in 2014-2017. \\n ▪ Non-AIDS cancers continued to account for the second most frequent underlying cause of death in persons \\n\\nwith HIV with lung cancer as the most frequently occurring non-AIDS cancer cause.\\n\\n ▪ Accidents, including drug overdose, and other traumatic injury deaths (suicide and assault) are preventable  \\n\\nand relatively frequent causes of death among people with HIV. \\n\\nHIV\\nNon-AIDS cancer\\n    Lung cancer\\n    Liver cancer\\n    Anal cancer\\n    Colon cancer\\n    Pancreatic cancer\\n    Rectal cancer\\n    Hodgkins lymphoma\\n    Leukemia\\nAccidents\\n\\nDrug overdose\\n\\nHeart disease\\n    Coronary heart disease\\n    Cardiomyopathy\\nSuicide\\nLiver disease\\n    Alcoholic liver disease\\n    Liver cirrhosis\\nChronic obstructive pulmonary disease\\nAssault\\nCerebrovascular disease\\nDiabetes\\nMental disorders due to substance use\\nViral hepatitis\\nRenal disease\\nPneumonitis\\nSepticemia\\nDiseases of arteries\\nHyperlipidemia\\nUndetermined intent\\n\\n2006-2009\\nN=1,143\\n\\n591 (51.7 )\\n123 (10.8 )\\n47 ( 4.1 )\\n18 ( 1.6 )\\n5 ( 0.4 )\\n9 ( 0.8 )\\n4 ( 0.3 )\\n4 ( 0.3 )\\n2 ( 0.2 )\\n0 ( 0.0 )\\n121 (10.6 )\\n93 ( 8.1 )\\n87 ( 7.6 )\\n45 ( 3.9 )\\n6 ( 0.5 )\\n50 ( 4.4 )\\n27 ( 2.4 )\\n11 ( 1.0 )\\n14 ( 1.2 )\\n25 ( 2.2 )\\n8 ( 0.7 )\\n8 ( 0.7 )\\n1 ( 0.1 )\\n22 ( 1.9 )\\n10 ( 0.9 )\\n9 ( 0.8 )\\n2 ( 0.2 )\\n2 ( 0.2 )\\n2 ( 0.2 )\\n2 ( 0.2 )\\n4 ( 0.3 )\\n\\nYear of Death\\n2010-2013\\n\\nN=949\\n\\nNumber (%)\\n391 (41.2 )\\n136 (14.3 )\\n31 ( 3.3 )\\n22 ( 2.3 )\\n9 ( 0.9 )\\n5 ( 0.5 )\\n8 ( 0.8 )\\n4 ( 0.4 )\\n2 ( 0.2 )\\n6 ( 0.6 )\\n112 (11.8 )\\n97 (10.2 )\\n83 ( 8.7 )\\n42 ( 4.4 )\\n4 ( 0.4 )\\n37 ( 3.9 )\\n21 ( 2.2 )\\n6 ( 0.6 )\\n14 ( 1.5 )\\n17 ( 1.8 )\\n9 ( 0.9 )\\n10 ( 1.1 )\\n11 ( 1.2 )\\n10 ( 1.1 )\\n7 ( 0.7 )\\n3 ( 0.3 )\\n2 ( 0.2 )\\n2 ( 0.2 )\\n3 ( 0.3 )\\n2 ( 0.2 )\\n6 ( 0.6 )\\n\\n2014-2017\\n\\nN=962\\n\\n366 (38.0 )\\n144 (15.0 )\\n34 ( 3.5 )\\n14 ( 1.5 )\\n12 ( 1.2 )\\n6 ( 0.6 )\\n6 ( 0.6 )\\n3 ( 0.3 )\\n1 ( 0.1 )\\n1 ( 0.1 )\\n120 (12.5 )\\n100 (10.4 )\\n103 (10.7 )\\n49 ( 5.1 )\\n7 ( 0.7 )\\n32 ( 3.3 )\\n25 ( 2.6 )\\n15 ( 1.6 )\\n7 ( 0.7 )\\n23 ( 2.4 )\\n14 ( 1.5 )\\n13 ( 1.4 )\\n11 ( 1.1 )\\n11 ( 1.1 )\\n7 ( 0.7 )\\n7 ( 0.7 )\\n5 ( 0.5 )\\n5 ( 0.5 )\\n4 ( 0.4 )\\n4 ( 0.4 )\\n0 ( 0.0 )\\n\\n \\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\ne\\ns\\nu\\na\\nC\\ng\\nn\\ni\\ny\\nl\\nr\\ne\\nd\\nn\\nU\\n\\n \\n\\n1  See Technical Notes “Death Ascertainment.” Deceased HIV cases that lack cause of  death information are not represented in \\n\\nthis table.\\n\\n44  \\n\\nTRENDS IN HIV MORTALITY\\n\\nTable 5.3 Underlying causes of death among persons diagnosed with HIV, 2006-2017, San Francisco\\x0c ▪ The most frequent, yet declining, underlying cause of death for males and females was HIV.\\n ▪\\n\\nIn 2006-2009 and 2010-2013, men with HIV had a higher proportion of  deaths due to non-AIDS cancers \\nthan women.\\nIn all three time periods, men had a higher proportion of  deaths due to heart disease and suicide as the \\nunderlying cause and women had a higher proportion of  underlying causes of  death due to accidents and \\nchronic obstructive pulmonary disease than did men.\\n\\n ▪\\n\\n2006-2009\\n\\nFemale\\n\\nMale\\n\\nYear of Death\\n2010-2013\\n\\nMale\\n\\nFemale\\n\\n2014-2017\\n\\nFemale\\n\\nMale\\n\\n \\n\\n1,024\\n\\nTotal\\nHIV\\nNon-AIDS cancer\\nAccidents\\nHeart disease\\nSuicide\\nLiver disease\\nChronic obstructive pulmonary disease\\nAssault\\nCerebrovascular disease\\nDiabetes\\nMental disorders due to substance use\\n\\n870\\n327 (37.6)\\n130 (14.9)\\n106 (12.2)\\n99 (11.4)\\n32 ( 3.7)\\n23 ( 2.6)\\n19 ( 2.2)\\n12 ( 1.4)\\n12 ( 1.4)\\n10 ( 1.1)\\n10 ( 1.1)\\n1  See Technical Notes “Death Ascertainment.” Deceased HIV cases that lack cause of  death information are not represented in this table.\\n\\nNumber (%)\\n87\\n34 (39.1)\\n5 ( 5.7)\\n18 (20.7)\\n7 ( 8.0)\\n0 ( 0.0)\\n2 ( 2.3)\\n3 ( 3.4)\\n1 ( 1.1)\\n2 ( 2.3)\\n1 ( 1.1)\\n1 ( 1.1)\\n\\n862\\n357 (41.4)\\n131 (15.2)\\n94 (10.9)\\n76 ( 8.8)\\n37 ( 4.3)\\n19 ( 2.2)\\n14 ( 1.6)\\n8 ( 0.9)\\n8 ( 0.9)\\n10 ( 1.2)\\n9 ( 1.0)\\n\\n119\\n61 (51.3)\\n5 ( 4.2)\\n17 (14.3)\\n6 ( 5.0)\\n2 ( 1.7)\\n5 ( 4.2)\\n7 ( 5.9)\\n0 ( 0.0)\\n0 ( 0.0)\\n0 ( 0.0)\\n6 ( 5.0)\\n\\n530 (51.8)\\n118 (11.5)\\n104 (10.2)\\n81 ( 7.9)\\n48 ( 4.7)\\n22 ( 2.1)\\n18 ( 1.8)\\n8 ( 0.8)\\n8 ( 0.8)\\n1 ( 0.1)\\n16 ( 1.6)\\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\ne\\ns\\nu\\na\\nC\\ng\\nn\\ni\\ny\\nl\\nr\\ne\\nd\\nn\\nU\\n\\n \\n\\n92\\n39 (42.4)\\n14 (15.2)\\n14 (15.2)\\n4 ( 4.3)\\n0 ( 0.0)\\n2 ( 2.2)\\n4 ( 4.3)\\n2 ( 2.2)\\n1 ( 1.1)\\n1 ( 1.1)\\n1 ( 1.1)\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  45\\n\\nTable 5.4 Underlying causes of death among persons diagnosed with HIV by sex, 2006-2017, San Francisco\\x0c ▪\\n\\nLatinx decedents had the highest proportion of  deaths due to HIV as the underlying cause, compared to \\nAfrican Americans and whites, and the proportion of  deaths where HIV was the underlying cause declined \\nacross time periods among Latinxs, African Americans and whites.\\n\\n ▪ The proportion of deaths due to non-AIDS cancers increased across all time periods for African Americans.\\n ▪ The proportion of deaths due to heart disease increased among Latinxs and whites. \\n ▪ The proportion of deaths due to accidents decreased slightly among African Americans yet increased among \\n\\nLatinxs and whites.\\n\\n2006-2009\\nAfrican \\nAmerican\\n\\nLatinx\\n\\nWhite\\n\\nLatinx\\n\\nWhite\\n\\nLatinx\\n\\n2014-2017\\nAfrican \\nAmerican\\n\\nWhite\\n\\nTotal\\nHIV\\nNon-AIDS cancer\\nAccidents\\nHeart disease\\nSuicide\\nChronic obstructive pulmonary disease\\nLiver disease\\nCerebrovascular disease\\nMental disorders due to substance use\\nAssault\\nDiabetes\\n\\n \\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\ne\\ns\\nu\\na\\nC\\ng\\nn\\ni\\ny\\nl\\nr\\ne\\nd\\nn\\nU\\n\\n \\n\\n131\\n89 (67.9)\\n5 ( 3.8)\\n4 ( 3.1)\\n6 ( 4.6)\\n8 ( 6.1)\\n1 ( 0.8)\\n3 ( 2.3)\\n2 ( 1.5)\\n3 ( 2.3)\\n0 ( 0.0)\\n0 ( 0.0)\\n\\n244\\n119 (49.2)\\n21 ( 8.7)\\n33 (13.6)\\n17 ( 7.0)\\n2 ( 0.8)\\n7 ( 2.9)\\n7 ( 2.9)\\n3 ( 1.2)\\n9 ( 3.7)\\n1 ( 0.4)\\n0 ( 0.0)\\n\\n695\\n341 (49.1)\\n88 (12.7)\\n78 (11.2)\\n57 ( 8.2)\\n36 ( 5.2)\\n17 ( 2.4)\\n16 ( 2.3)\\n2 ( 0.3)\\n9 ( 1.3)\\n7 ( 1.0)\\n1 ( 0.1)\\n\\n123\\n66 (53.7)\\n14 (11.4)\\n11 ( 8.9)\\n8 ( 6.5)\\n3 ( 2.4)\\n3 ( 2.4)\\n3 ( 2.4)\\n1 ( 0.8)\\n1 ( 0.8)\\n1 ( 0.8)\\n1 ( 0.8)\\n\\n559\\n212 (37.9)\\n91 (16.3)\\n64 (11.4)\\n54 ( 9.7)\\n29 ( 5.2)\\n9 ( 1.6)\\n13 ( 2.3)\\n6 ( 1.1)\\n7 ( 1.3)\\n5 ( 0.9)\\n4 ( 0.7)\\n\\n125\\n57 (45.6)\\n13 (10.4)\\n13 (10.4)\\n10 ( 8.0)\\n4 ( 3.2)\\n1 ( 0.8)\\n6 ( 4.8)\\n2 ( 1.6)\\n2 ( 1.6)\\n2 ( 1.6)\\n3 ( 2.4)\\n\\n191\\n75 (39.3)\\n38 (19.9)\\n22 (11.5)\\n14 ( 7.3)\\n1 ( 0.5)\\n5 ( 2.6)\\n4 ( 2.1)\\n2 ( 1.0)\\n2 ( 1.0)\\n6 ( 3.1)\\n2 ( 1.0)\\n\\n579\\n204 (35.2)\\n86 (14.9)\\n76 (13.1)\\n73 (12.6)\\n23 ( 4.0)\\n17 ( 2.9)\\n13 ( 2.2)\\n9 ( 1.6)\\n6 ( 1.0)\\n5 ( 0.9)\\n5 ( 0.9)\\n\\n1  See Technical Notes “Death Ascertainment.” Deceased HIV cases that lack cause of  death information are not represented in this table. Asian, Pacific Islander, \\n\\nNative American, and multi-racial decedents were not displayed due to small cell sizes.\\n\\nYear of Death\\n2010-2013\\nAfrican \\nAmerican\\nNumber (%)\\n190\\n79 (41.6)\\n24 (12.6)\\n25 (13.2)\\n17 ( 8.9)\\n2 ( 1.1)\\n5 ( 2.6)\\n2 ( 1.1)\\n2 ( 1.1)\\n1 ( 0.5)\\n2 ( 1.1)\\n6 ( 3.2)\\n\\n46  \\n\\nTRENDS IN HIV MORTALITY\\n\\nTable 5.5 Underlying causes of death among persons diagnosed with HIV by race/ethnicity, 2006-2017, San Francisco\\x0c ▪ The proportion of  deaths where HIV was the underlying cause of  death declined for MSM, PWID, and \\n\\nMSM-PWID across three time periods.\\n\\n ▪ The proportion of  deaths where heart disease was the underlying cause of  death increased for MSM, \\n\\nPWID, and MSM-PWID across three time periods. \\n\\n ▪ The proportion of  deaths due to accidents was higher among PWID and MSM-PWID compared to MSM \\nin all time periods; the proportion of  deaths due to accidents among MSM-PWID increased across all \\ntime periods.\\n\\n ▪ The majority of  deaths due to accidents in each transmission group were due to drug overdoses.\\n\\n2006-2009\\n\\nMSM\\n\\nPWID\\n\\nMSM-\\nPWID\\n\\nYear of Death\\n2010-2013\\n\\n2014-2017\\n\\nMSM\\n\\nPWID\\n\\nMSM-\\nPWID\\n\\nMSM\\n\\nPWID\\n\\nTotal\\nHIV\\nNon-AIDS cancer\\nHeart disease\\nAccidents\\n\\nDrug overdose\\n\\nSuicide\\nLiver disease\\nChronic obstructive lung disease\\nMental disorders due to substance use\\nAssault\\nCerebrovascular disease\\nDiabetes\\n\\n591\\n298 (50.4)\\n85 (14.4)\\n55 ( 9.3)\\n45 ( 7.6)\\n31 ( 5.3)\\n34 ( 5.8)\\n16 ( 2.7)\\n7 ( 1.2)\\n4 ( 0.7)\\n4 ( 0.7)\\n4 ( 0.7)\\n1 ( 0.2)\\n\\n509\\n\\n257\\n\\n189\\n89 (47.1) 140 (54.5) 213 (41.8)\\n96 (18.9)\\n11 ( 5.8)\\n51 (10.0)\\n9 ( 4.8)\\n31 (16.4)\\n38 ( 7.5)\\n29 ( 5.7)\\n27 (14.3)\\n23 ( 4.5)\\n3 ( 1.6)\\n5 ( 2.6)\\n11 ( 2.2)\\n11 ( 2.2)\\n9 ( 4.8)\\n4 ( 0.8)\\n11 ( 5.8)\\n5 ( 1.0)\\n1 ( 0.5)\\n2 ( 1.1)\\n6 ( 1.2)\\n6 ( 1.2)\\n0 ( 0.0)\\n\\n22 ( 8.6)\\n17 ( 6.6)\\n35 (13.6)\\n29 (11.3)\\n11 ( 4.3)\\n4 ( 1.6)\\n7 ( 2.7)\\n4 ( 1.6)\\n2 ( 0.8)\\n0 ( 0.0)\\n0 ( 0.0)\\n\\nNumber (%)\\n161\\n62 (38.5)\\n14 ( 8.7)\\n12 ( 7.5)\\n29 (18.0)\\n27 (16.8)\\n2 ( 1.2)\\n4 ( 2.5)\\n4 ( 2.5)\\n1 ( 0.6)\\n1 ( 0.6)\\n3 ( 1.9)\\n2 ( 1.2)\\n\\n516\\n\\n206\\n78 (37.9) 194 (37.6)\\n91 (17.6)\\n19 ( 9.2)\\n60 (11.6)\\n16 ( 7.8)\\n37 (18.0)\\n38 ( 7.4)\\n29 ( 5.6)\\n35 (17.0)\\n21 ( 4.1)\\n11 ( 5.3)\\n5 ( 2.4)\\n17 ( 3.3)\\n13 ( 2.5)\\n1 ( 0.5)\\n9 ( 1.7)\\n4 ( 1.9)\\n8 ( 1.6)\\n2 ( 1.0)\\n0 ( 0.0)\\n7 ( 1.4)\\n6 ( 1.2)\\n2 ( 1.0)\\n\\n150\\n55 (36.7)\\n23 (15.3)\\n17 (11.3)\\n24 (16.0)\\n21 (14.0)\\n0 ( 0.0)\\n3 ( 2.0)\\n6 ( 4.0)\\n1 ( 0.7)\\n4 ( 2.7)\\n1 ( 0.7)\\n1 ( 0.7)\\n\\nMSM-\\nPWID\\n\\n223\\n79 (35.4)\\n25 (11.2)\\n22 ( 9.9)\\n46 (20.6)\\n42 (18.9)\\n11 ( 4.9)\\n4 ( 1.8)\\n3 ( 1.3)\\n1 ( 0.4)\\n1 ( 0.4)\\n4 ( 1.8)\\n2 ( 0.9)\\n\\n \\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\ne\\ns\\nu\\na\\nC\\ng\\nn\\ni\\ny\\nl\\nr\\ne\\nd\\nn\\nU\\n\\n \\n\\n1  See Technical Notes “Death Ascertainment.” Deceased HIV cases that lack cause of  death information are not represented in this table. \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  47\\n\\nTable 5.6 Underlying causes of death among persons diagnosed with HIV by select transmission categories, 2006-2017, San Francisco\\x0c ▪ The proportion of  deaths in which HIV was either the underlying or contributory cause declined from \\n69.6% in the period 2006-2009 to 63.1% during 2010 to 2013, and then to 59.8% in the years 2014-2017.\\n ▪ Heart disease was the second most common cause of  death when underlying and contributory causes \\n\\nwere considered.\\n\\n ▪ Non-AIDS cancers remained a frequent cause of death; lung, liver, and anal cancers were the most common. \\n\\n2006-2009\\nN=1,143\\n\\nYear of Death\\n\\n2010-2013\\n\\nN=949\\n\\n2014-2017\\n\\nN=962\\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\n \\ns\\ne\\ns\\nu\\na\\nC\\ne\\np\\ni\\nt\\nl\\nu\\nM\\n\\nl\\n\\n \\n\\nHIV\\nHeart disease\\n    Coronary heart disease\\n    Cardiomyopathy\\nNon-AIDS cancer\\n    Lung cancer\\n    Anal cancer\\n    Liver cancer\\n    Colon cancer\\n    Pancreatic cancer\\n    Rectal cancer\\n    Leukemia\\n    Hodgkin lymphoma\\nAccidents\\n    Drug overdose\\nLiver disease\\n    Liver cirrhosis\\n    Alcoholic liver disease\\nRenal disease\\nViral hepatitis\\nSepticemia\\nMental disorders due to substance use\\nChronic obstructive pulmonary disease\\nCerebrovascular disease\\nDiabetes\\nSuicide\\nPneumonitis\\nDiseases of arteries\\nAssault\\nHyperlipidemia\\nUndetermined intent\\n\\n796 (69.6)\\n264 (23.1)\\n76 ( 6.6)\\n18 ( 1.6)\\n168 (14.7)\\n50 ( 4.4)\\n7 ( 0.6)\\n24 ( 2.1)\\n10 ( 0.9)\\n5 ( 0.4)\\n6 ( 0.5)\\n3 ( 0.3)\\n9 ( 0.8)\\n134 (11.7)\\n101 ( 8.8)\\n146 (12.8)\\n65 ( 5.7)\\n12 ( 1.0)\\n113 ( 9.9)\\n132 (11.5)\\n110 ( 9.6)\\n108 ( 9.4)\\n78 ( 6.8)\\n38 ( 3.3)\\n41 ( 3.6)\\n50 ( 4.4)\\n14 ( 1.2)\\n12 ( 1.0)\\n8 ( 0.7)\\n7 ( 0.6)\\n4 ( 0.3)\\n\\nNumber (%)\\n599 (63.1)\\n262 (27.6)\\n85 ( 9.0)\\n22 ( 2.3)\\n182 (19.2)\\n37 ( 3.9)\\n12 ( 1.3)\\n29 ( 3.1)\\n5 ( 0.5)\\n10 ( 1.1)\\n5 ( 0.5)\\n9 ( 0.9)\\n6 ( 0.6)\\n116 (12.2)\\n98 (10.3)\\n119 (12.5)\\n70 ( 7.4)\\n6 ( 0.6)\\n94 ( 9.9)\\n121 (12.8)\\n94 ( 9.9)\\n92 ( 9.7)\\n62 ( 6.5)\\n28 ( 3.0)\\n56 ( 5.9)\\n37 ( 3.9)\\n10 ( 1.1)\\n9 ( 0.9)\\n9 ( 0.9)\\n8 ( 0.8)\\n7 ( 0.7)\\n\\n575 (59.8)\\n295 (30.7)\\n90 ( 9.4)\\n29 ( 3.0)\\n200 (20.8)\\n42 ( 4.4)\\n16 ( 1.7)\\n16 ( 1.7)\\n9 ( 0.9)\\n7 ( 0.7)\\n7 ( 0.7)\\n5 ( 0.5)\\n3 ( 0.3)\\n131 (13.6)\\n103 (10.7)\\n112 (11.6)\\n65 ( 6.8)\\n17 ( 1.8)\\n112 (11.6)\\n105 (10.9)\\n96 (10.0)\\n95 ( 9.9)\\n68 ( 7.1)\\n52 ( 5.4)\\n45 ( 4.7)\\n32 ( 3.3)\\n19 ( 2.0)\\n14 ( 1.5)\\n14 ( 1.5)\\n14 ( 1.5)\\n0 ( 0.0)\\n\\n1  Includes underlying and contributory causes of  death. Individuals may have more than one cause of  death. See Technical \\nNotes “Death Ascertainment.” Deceased HIV cases that lack cause of death information are not represented in this table. \\n\\n48  \\n\\nTRENDS IN HIV MORTALITY\\n\\nTable 5.7 Multiple causes of death among persons diagnosed with HIV, 2006-2017, San Francisco\\x0c ▪ Among both women and men, HIV was the most frequent underlying or contributory cause of  death in \\nall time periods, however the proportions of  deaths attributed to HIV declined over the three time periods \\nfor males but not females.\\n\\n ▪ Heart disease was the second most frequent underlying or contributory cause of  death in both women \\n\\nand men, and increased from 22.9% of  deaths in 2006-2009 to 31.3% of deaths in 2014-2017 for men. \\n\\n ▪ Deaths from non-AIDS cancers accounted for a greater proportion of deaths in men than in women during \\nthe first two time periods but accounted for similar proportions of  deaths in both sexes by the third time \\nperiod; the proportion of  female deaths due to non-AIDS cancers increased over the three time periods.\\n\\n ▪ All accident-related deaths in females in 2014-2017 were due to drug overdoses.\\n ▪ The proportion of  deaths from mental disorders due to substance use declined for females across three \\n\\ntime periods but increased for males.\\nIn the most recent time period, HIV, drug overdose, renal disease, viral hepatitis, septicemia, and chronic \\nobstructive pulmonary disease accounted for a higher proportion of  deaths in women than in men.\\n\\n ▪\\n\\n2006-2009\\n\\nYear of Death\\n2010-2013\\n\\n2014-2017\\n\\nMale\\n\\nFemale\\n\\nMale\\n\\nFemale\\n\\nMale\\n\\nFemale\\n\\n1,024\\n\\n713 (69.6)\\n235 (22.9)\\n160 (15.6)\\n114 (11.1)\\n85 ( 8.3)\\n125 (12.2)\\n99 ( 9.7)\\n117 (11.4)\\n88 ( 8.6)\\n97 ( 9.5)\\n63 ( 6.2)\\n30 ( 2.9)\\n\\n118\\n83 (69.7)\\n29 (24.4)\\n8 ( 6.7)\\n20 (16.8)\\n16 (13.4)\\n21 (17.6)\\n14 (11.8)\\n15 (12.6)\\n20 (16.8)\\n13 (10.9)\\n15 (12.6)\\n8 ( 6.7)\\n\\nNumber (%)\\n87\\n53 (60.9)\\n31 (35.6)\\n7 ( 8.0)\\n18 (20.7)\\n15 (17.2)\\n11 (12.6)\\n12 (13.8)\\n18 (20.7)\\n12 (13.8)\\n9 (10.3)\\n12 (13.8)\\n5 ( 5.8)\\n\\n862\\n546 (63.3)\\n231 (26.8)\\n175 (20.3)\\n98 (11.4)\\n83 ( 9.6)\\n108 (12.5)\\n82 ( 9.5)\\n103 (11.9)\\n80 ( 9.3)\\n85 ( 9.9)\\n50 ( 5.8)\\n23 ( 2.7)\\n\\n870\\n511 (58.7)\\n272 (31.3)\\n181 (20.8)\\n116 (13.3)\\n88 (10.1)\\n102 (11.7)\\n94 (10.8)\\n92 (10.6)\\n86 ( 9.9)\\n85 ( 9.8)\\n57 ( 6.6)\\n47 ( 5.4)\\n\\n92\\n64 (69.6)\\n23 (25.0)\\n19 (20.7)\\n15 (16.3)\\n15 (16.3)\\n10 (10.9)\\n18 (19.6)\\n13 (14.1)\\n9 ( 9.8)\\n11 (12.0)\\n11 (12.0)\\n5 ( 5.4)\\n\\nTotal\\nHIV\\nHeart disease\\nNon-AIDS cancer\\nAccidents\\n\\nDrug overdose\\n\\nLiver disease\\nRenal disease\\nViral hepatitis\\nMental disorders due to substance use\\nSepticemia\\nChronic obstructive pulmonary disease\\nCerebrovascular disease\\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\n \\ns\\ne\\ns\\nu\\na\\nC\\ne\\np\\ni\\nt\\nl\\nu\\nM\\n\\nl\\n\\n \\n\\n1  Includes underlying and contributory causes of  death. Individuals may have more than one cause of  death. See Technical Notes “Death Ascertainment.” Deceased \\n\\nHIV cases that lack cause of  death information are not represented in this table.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  49\\n\\nTable 5.8 Multiple causes of death among persons diagnosed with HIV by sex, 2006-2017, San Francisco\\x0c ▪ When multiple causes of  death were compared for Latinx, African American, and white decedents, HIV \\n\\ncontributed to more than half  of  deaths in each racial/ethnic group for all time periods.\\n\\n ▪ African American decedents were also more likely to die from renal disease, chronic obstructive pulmonary \\n\\ndisease, and cerebrovascular disease than were Latinx and white decedents.\\n\\n2006-2009\\nAfrican \\nAmerican\\n\\nLatinx\\n\\nWhite\\n\\nLatinx\\n\\nWhite\\n\\nLatinx\\n\\n2014-2017\\nAfrican \\nAmerican\\n\\nWhite\\n\\nYear of Death\\n2010-2013\\nAfrican \\nAmerican\\nNumber (%)\\n190\\n\\n579\\n\\n191\\n\\n559\\n\\n695\\n\\n242\\n\\nDrug overdose\\n\\nTotal\\nHIV\\nHeart disease\\nNon-AIDS cancer\\nAccidents\\n\\n125\\n80 (64.0) 122 (63.9) 333 (57.5)\\n33 (26.4)\\n61 (31.9) 182 (31.4)\\n47 (24.6) 121 (20.9)\\n21 (16.8)\\n82 (14.2)\\n23 (12.0)\\n17 (13.6)\\n65 (11.2)\\n20 (10.5)\\n10 ( 8.0)\\n21 (16.8)\\n17 ( 8.9)\\n64 (11.1)\\n56 ( 9.7)\\n12 ( 6.3)\\n18 (14.4)\\n54 ( 9.3)\\n22 (11.5)\\n17 (13.6)\\n13 (10.4)\\n38 (19.9)\\n53 ( 9.2)\\n52 ( 9.0)\\n19 ( 9.9)\\n17 (13.6)\\n43 ( 7.4)\\n18 ( 9.4)\\n4 ( 3.2)\\n8 ( 6.4)\\n14 ( 7.3)\\n28 ( 4.8)\\n1  Includes underlying and contributory causes of  death. Individuals may have more than one cause of  death. See Technical Notes “Death Ascertainment.” Deceased \\n\\n131\\n100 (76.3) 170 (70.2) 473 (68.1)\\n26 (19.8)\\n73 (30.2) 145 (20.9)\\n29 (12.0) 115 (16.5)\\n10 ( 7.6)\\n85 (12.2)\\n37 (15.3)\\n5 ( 3.8)\\n65 ( 9.4)\\n28 (11.6)\\n4 ( 3.1)\\n23 (17.6)\\n32 (13.2)\\n84 (12.1)\\n63 ( 9.1)\\n33 (13.6)\\n9 ( 6.9)\\n83 (11.9)\\n24 ( 9.9)\\n16 (12.2)\\n11 ( 8.4)\\n47 (19.4)\\n48 ( 6.9)\\n54 ( 7.8)\\n23 ( 9.5)\\n25 (19.1)\\n48 ( 6.9)\\n25 (10.3)\\n2 ( 1.5)\\n6 ( 4.6)\\n13 ( 5.4)\\n16 ( 2.3)\\n\\n123\\n92 (74.8) 129 (67.9) 332 (59.4)\\n28 (22.8)\\n64 (33.7) 152 (27.2)\\n35 (18.4) 118 (21.1)\\n17 (13.8)\\n66 (11.8)\\n26 (13.7)\\n11 ( 8.9)\\n52 ( 9.3)\\n23 (12.1)\\n11 ( 8.9)\\n24 (19.5)\\n25 (13.2)\\n63 (11.3)\\n58 (10.4)\\n23 (12.1)\\n6 ( 4.9)\\n53 ( 9.5)\\n41 (21.6)\\n17 (13.8)\\n11 ( 8.9)\\n33 (17.4)\\n43 ( 7.7)\\n45 ( 8.1)\\n18 ( 9.5)\\n20 (16.3)\\n37 ( 6.6)\\n20 (10.5)\\n4 ( 3.3)\\n3 ( 2.4)\\n7 ( 3.7)\\n16 ( 2.9)\\n\\nLiver disease\\nMental disorders due to substance use\\nViral hepatitis\\nRenal disease\\nSepticemia\\nChronic obstructive lung disease\\nCerebrovascular disease\\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\n \\ns\\ne\\ns\\nu\\na\\nC\\ne\\np\\ni\\nt\\nl\\nu\\nM\\n\\nl\\n\\n \\n\\nHIV cases that lack cause of  death information are not represented in this table. \\n\\n50  \\n\\nTRENDS IN HIV MORTALITY\\n\\nTable 5.9 Multiple causes of death among persons diagnosed with HIV by race/ethnicity, 2006-2017, San Francisco\\x0c ▪ When multiple causes of  death were considered for decedents who were MSM, PWID, or MSM-PWID, \\n\\nheart disease was the second most frequent underlying or contributory cause of death, behind HIV.\\n\\n ▪ Compared to MSM, PWID and MSM-PWID had higher proportions of  deaths from liver disease, mental \\n\\ndisorders due to substance use, septicemia, and accidents (including drug overdoses).\\n\\n2006-2009\\n\\nMSM\\n\\nPWID\\n\\nMSM-\\nPWID\\n\\nYear of Death\\n2010-2013\\n\\nMSM\\n\\nPWID\\n\\nMSM-\\nPWID\\n\\n2014-2017\\n\\nMSM\\n\\nPWID\\n\\nMSM-\\nPWID\\n\\n223\\n\\n150\\n\\n516\\n\\n206\\n\\n509\\n\\n257\\n\\n189\\n\\nTotal\\nHIV\\nHeart disease\\nNon-AIDS cancer\\nRenal disease\\nLiver disease\\nMental disorders due to substance use\\nSepticemia\\nAccidents\\n\\nNumber (%)\\n161\\n97 (60.2) 119 (57.8) 305 (59.1) 101 (67.3) 119 (53.4)\\n43 (26.7)\\n67 (30.0)\\n39 (17.5)\\n20 (12.4)\\n19 ( 8.5)\\n28 (17.4)\\n29 (18.0)\\n35 (15.7)\\n30 (13.5)\\n21 (13.0)\\n24 (10.8)\\n21 (13.0)\\n51 (22.9)\\n31 (19.3)\\n27 (16.8)\\n44 (19.7)\\n13 ( 5.8)\\n23 (14.3)\\n9 ( 4.0)\\n9 ( 5.6)\\n7 ( 4.3)\\n8 ( 3.6)\\n1  Includes underlying and contributory causes of  death. Individuals may have more than one cause of  death. See Technical Notes “Death Ascertainment.” Deceased \\n\\n591\\n409 (69.2) 124 (65.6) 183 (71.2) 332 (65.2)\\n135 (22.8)\\n63 (24.5) 139 (27.3)\\n33 (12.8) 123 (24.2)\\n113 (19.1)\\n42 ( 8.3)\\n27 (10.5)\\n51 ( 8.6)\\n53 ( 9.0)\\n46 (17.9)\\n48 ( 9.4)\\n38 ( 7.5)\\n25 ( 9.7)\\n42 ( 7.1)\\n43 ( 8.4)\\n24 ( 9.3)\\n51 ( 8.6)\\n38 ( 7.5)\\n38 (14.8)\\n51 ( 8.6)\\n34 ( 5.8)\\n32 (12.5)\\n29 ( 5.7)\\n26 ( 5.1)\\n23 ( 8.9)\\n25 ( 4.2)\\n15 ( 2.9)\\n5 ( 1.9)\\n17 ( 2.9)\\n17 ( 2.9)\\n10 ( 3.9)\\n38 ( 7.5)\\n\\n52 (25.2) 158 (30.6)\\n25 (12.1) 121 (23.4)\\n55 (10.7)\\n18 ( 8.7)\\n36 (17.5)\\n51 ( 9.9)\\n45 ( 8.7)\\n27 (13.1)\\n44 ( 8.5)\\n21 (10.2)\\n42 ( 8.1)\\n38 (18.4)\\n35 (17.0)\\n29 ( 5.6)\\n33 ( 6.4)\\n11 ( 5.3)\\n30 ( 5.8)\\n2 ( 1.0)\\n7 ( 3.4)\\n27 ( 5.2)\\n\\n42 (28.0)\\n32 (21.3)\\n21 (14.0)\\n19 (12.7)\\n16 (10.7)\\n18 (12.0)\\n25 (16.7)\\n22 (14.7)\\n17 (11.3)\\n10 ( 6.7)\\n5 ( 3.3)\\n\\n42 (22.2)\\n15 ( 7.9)\\n23 (12.2)\\n32 (16.9)\\n31 (16.4)\\n22 (11.6)\\n34 (18.0)\\n29 (15.3)\\n22 (11.6)\\n7 ( 3.7)\\n9 ( 4.8)\\n\\nChronic obstructive lung disease\\nCerebrovascular disease\\nDiabetes\\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\n \\ns\\ne\\ns\\nu\\na\\nC\\ne\\np\\ni\\nt\\nl\\nu\\nM\\n\\nDrug overdose\\n\\nl\\n\\n \\n\\nHIV cases that lack cause of  death information are not represented in this table. \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  51\\n\\nTable 5.10 Multiple causes of death among persons diagnosed with HIV by select transmission categories, 2006-2017, San Francisco\\x0c ▪ Among persons who died during 2006 to 2017, 20% were homeless at some point between time of  HIV \\n\\ndiagnosis and death.\\n\\n ▪ Among decedents who were ever homeless, a higher proportion of  deaths were due to liver disease, viral \\nhepatitis, accidents (including drug overdoses), mental disorders due to substance abuse, renal disease, \\nchronic obstructive lung disease, and assault.\\n\\nHousing status from HIV diagnosis to death\\nEver homeless\\nConsistently housed\\n\\nNumber (%)\\n\\nTotal\\nHIV\\n\\nAIDS Opportunistic illness\\n\\nAIDS Cancer\\n\\nHeart disease\\nNon-AIDS cancer \\nLiver disease \\nViral hepatitis \\nAccidents \\n\\nDrug overdose \\n\\nRenal disease \\nSepticemia \\nMental disorders due to substance abuse \\nChronic obstructive lung disease \\nDiabetes \\nSuicide\\nCerebrovascular disease \\nPneumonitis \\nDiseases of arteries \\nHyperlipidemia \\nAssault \\n\\n615\\n385 (62.6)\\n175 (28.5)\\n40 ( 6.5)\\n139 (22.6)\\n55 ( 8.9)\\n85 (13.8)\\n93 (15.1)\\n119 (19.3)\\n100 (16.3)\\n82 (13.3)\\n64 (10.4)\\n90 (14.6)\\n48 ( 7.8)\\n11 ( 1.8)\\n16 ( 2.6)\\n16 ( 2.6)\\n5 ( 0.8)\\n5 ( 0.8)\\n1 ( 0.2)\\n15 ( 2.4)\\n\\n2,439\\n1,585 (65.0)\\n624 (25.6)\\n167 ( 6.8)\\n682 (28.0)\\n495 (20.3)\\n292 (12.0)\\n265 (10.9)\\n262 (10.7)\\n202 ( 8.3)\\n237 ( 9.7)\\n236 ( 9.7)\\n205 ( 8.4)\\n160 ( 6.6)\\n131 ( 5.4)\\n103 ( 4.2)\\n102 ( 4.2)\\n38 ( 1.6)\\n30 ( 1.2)\\n28 ( 1.1)\\n16 ( 0.7)\\n\\n1\\nh\\nt\\na\\ne\\nD\\n \\nf\\no\\n \\ns\\ne\\ns\\nu\\na\\nC\\ne\\np\\ni\\nt\\nl\\nu\\nM\\n\\nl\\n\\n \\n\\n1  Includes underlying and contributory causes of  death. Individuals may have more than one cause of  death. See Technical \\nNotes “Death Ascertainment.” Deceased HIV cases that lack cause of  death information are not represented in this table.\\n\\n52  \\n\\nTRENDS IN HIV MORTALITY\\n\\nTable 5.11 Multiple causes of death among persons diagnosed with HIV by housing status, 2006-2017, San Francisco\\x0c6\\n\\nHealth Insurance Status at Time of \\nHIV Diagnosis\\n\\n ▪ Among HIV diagnoses in 2014 to 2018, 72% of  whites, 73% of  African Americans, 65% of  Latinxs, and \\n\\n56% of  Asians/Pacific Islanders (APIs) were insured at time of diagnosis.\\nLatinxs and APIs had higher proportions uninsured at diagnosis. APIs also had highest proportion missing \\nhealth insurance status information (15%).\\n\\n ▪\\n\\n ▪ By gender, trans women had the highest proportion uninsured at diagnosis.\\n ▪ Trend data suggest that access to health insurance improved for persons diagnosed with HIV in 2014 to \\n2008, with 65% insured in 2014 and 75% insured in 2018. This may be attributed, in part, to implementation \\nof  the Affordable Care Act in 2014 and MediCal expansion programs in California.\\n\\n75% \\n\\noF new diagnoSeS \\nin 2018 had health \\ninSUrance at time oF \\n\\ndiagnoSiS\\n\\n>25%\\n\\noF latinx, aPiS, and \\ntranS women were \\nUninSUred at time oF \\ndiagnoSiS, 2014-2018\\n\\n8% 11% 9%\\n\\n20% 16%\\n\\n26%\\n\\nMissing\\n\\n15%\\n\\n29%\\n\\nNo insurance\\n10% 6% 3%\\n15% 27%\\n\\n23%\\n\\nAny insurance\\n\\n9% 11% 11% 11% 8%\\n\\n26% 25% 22% 21%\\n\\n18%\\n\\n72% 73%\\n\\n65%\\n\\n56%\\n\\n79%\\n\\n70%\\n\\n66%\\n\\n65% 65% 67% 69%\\n\\n75%\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n100%\\n\\n90%\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\n1  Data on trans men are not presented due to small number and potential small population size. See Technical Notes “Gender Status.”\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  53\\n\\nFigure 6.1 Health insurance status at time of HIV diagnosis by race/ethnicity, gender1, and year of diagnosis, 2014-2018, San Francisco\\x0c ▪ Among whites, the proportion on public forms of  insurance increased steadily from 17% in 2014 to 41% \\n\\nin 2018; in 2018 similar proportions of  whites were on public insurance as private insurance.\\n\\n ▪ The predominant health insurance status for whites and APIs diagnosed each year was private insurance.\\n ▪\\n ▪ Beginning 2016 the proportion of  Latinxs with no health insurance declined while the proportion of  \\n\\nIn contrast, 47% or greater of  African Americans diagnosed each year were publicly insured.\\n\\nLatinxs with public forms of  insurance increased.\\n\\nWhite\\n\\nAfrican American \\n\\n100%\\n\\n80%\\n\\n60%\\n\\n40%\\n\\n20%\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\nPublic\\nPrivate\\nNone\\nMissing\\n\\n100%\\n\\n80%\\n\\n60%\\n\\n40%\\n\\n20%\\n\\nPublic\\nPrivate\\nNone\\nMissing\\n\\n0%\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n0%\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\nLatinx\\n\\nAsian/Pacific Islander\\n\\n100%\\n\\n80%\\n\\n60%\\n\\n40%\\n\\n20%\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\nPublic\\nPrivate\\nNone\\nMissing\\n\\nPublic\\nPrivate\\nNone\\nMissing\\n\\n100%\\n\\n80%\\n\\n60%\\n\\n40%\\n\\n20%\\n\\n0%\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n0%\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n54  \\n\\nHEALTH INSURANCE STATUS AT TIME OF HIV DIAGNOSIS\\n\\nFigure 6.2 Trends in health insurance status at time of HIV diagnosis by race/ethnicity, 2014-2018, San Francisco\\x0c ▪\\n\\nFrom 2014 to 2018, African Americans diagnosed with HIV had the highest proportion with publicly-\\nfunded insurance types compared to other racial/ethnic groups.\\n\\n ▪ Across racial ethnic groups, there were similar proportions using Healthy San Francisco for health care \\n\\ncoverage at time of diagnosis (3%-5%).\\n\\nWhite\\n\\nAA\\n\\nWhite (N=478)\\n\\nMedicare\\n\\n3%\\n\\nMediCal\\n\\n19%\\n\\nAfrican American (N=188)\\n\\nMediCal\\n\\n38%\\n\\nPrivate\\n44%\\n\\nMedicare\\n\\n2%\\n\\nPrivate\\n21%\\n\\nJail\\n<1%\\n\\nVA\\n1%\\nHSF\\n3%\\nOther Public \\n(not specified)\\n\\n3%\\n\\nMissing\\n\\n8%\\n\\nLatino\\n\\nNone\\n20%\\n\\nVA\\n1%\\nJail\\n2%\\n\\nHSF\\n3%\\n\\n5%\\n\\nOther Public \\n(not specified)\\n\\nAPI\\n\\nMissing\\n\\n11%\\n\\nNone\\n16%\\n\\nLatinx (N=377)\\n\\nAsian/Pacific Islander (N=159)\\n\\nMedicare\\n\\n1%\\n\\nPrivate\\n28%\\n\\nPrivate\\n38%\\n\\nMediCal\\n\\n26%\\n\\nJail\\n1%\\nVA\\n1%\\n\\nHSF\\n5%\\n\\nOther Public \\n(not specified)\\n\\n4%\\n\\nMissing\\n\\n9%\\n\\nHSF: Healthy San Francisco.\\n\\nNone\\n26%\\n\\nMediCal\\n\\n11%\\n\\nNone\\n29%\\n\\nVA\\n1%\\n\\nHSF\\n4%\\nOther Public \\n(not specified)\\n\\n1%\\n\\nMissing\\n\\n15%\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  55\\n\\nFigure 6.3 Health insurance status at time of HIV diagnosis by race/ethnicity, 2014-2018, San Francisco\\x0c ▪ Compared to men at the time of  HIV diagnosis, women and trans women had higher proportions with \\npublic insurance (including MediCal, Medicare, Healthy San Francisco, Veteran Administration, county jail, \\nand other unspecified public insurance).\\nFor 2014 to 2018 diagnoses, 50% of  women and 38% of  trans women reported using MediCal, a state-\\nsponsored insurance for persons meeting financial criteria.\\n\\n ▪\\n\\n ▪ Healthy San Francisco, the county-sponsored health access program for residents, was used by 3% of  men, \\n\\n5% of  women, and 11% of  trans women at time of  diagnosis.\\n23% of  men, 15% of  women, and 27% of  trans women had no health insurance coverage at time of  \\ndiagnosis.\\n\\n ▪\\n\\nMen\\n\\nWomen\\n\\nTrans women\\n\\nMen (N=1,113)\\n\\nWomen (N=108)\\n\\nTrans Women (N=37)\\n\\nMedicare\\n\\n5%\\n\\nPrivate\\n\\n8%\\n\\nNone\\n27%\\n\\nOther Public \\n(not specified)\\n\\n3%\\n\\nMissing\\n\\n10%\\n\\nNone\\n23%\\n\\nJail\\n<1%\\n\\nHSF\\n3%\\n\\nMediCal\\n\\n20%\\n\\nMediCal\\n\\n50%\\n\\nMedicare\\n\\n1%\\nVA\\n1%\\n\\nMediCal\\n\\n38%\\n\\nMedicare\\n\\n5%\\n\\nPrivate\\n15%\\n\\nPrivate\\n37%\\n\\nJail\\n1%\\n\\nHSF\\n5%\\n\\nMissing\\n\\n6%\\n\\nNone\\n15%\\n\\nHSF\\n11%\\n\\nMissing\\n\\n3%\\n\\n1  Data on trans men are not presented due to small number and potential small population size. See Technical Notes “Gender Status.”\\nHSF: Healthy San Francisco.\\n\\n56  \\n\\nHEALTH INSURANCE STATUS AT TIME OF HIV DIAGNOSIS\\n\\nFigure 6.4 Health insurance status at time of HIV diagnosis by gender1, 2014-2018, San Francisco\\x0c7\\n\\nHIV surveillance data\\n\\nHIV among Men who Have Sex \\nwith Men\\n\\n ▪ Among MSM newly diagnosed with HIV from 2009 through 2018, \\nwhites accounted for the largest number of diagnoses in San Francisco.\\n ▪ The number of  MSM newly diagnosed with HIV from 2009 to 2018 \\n\\ndeclined in whites and Latino persons. \\n\\n ▪ Annual number of  Latino MSM diagnosed exceeded the number of  \\n\\nwhite MSM in 2018.\\n\\n ▪ The  annual  number  of   Asian/Pacific  Islander  MSM  diagnosed \\nincreased from 36 in 2009 to a high of  46 in 2012 and then decreased \\nto 15 in 2018.\\n\\n ▪ Among MSM, whites made up 31%, African Americans 17%, Latino \\npersons 38% and Asian/Pacific Islanders 10% of new diagnoses in 2018.\\n\\nWhites\\n\\naccoUnted For the largeSt \\nnUmber oF newly diagnoSed \\n\\nmSm, 2009-2018\\n\\nLatino\\n\\nmSm diagnoSed with hiv \\nexceeded white mSm in \\n\\n2018\\n\\nWhite\\nAfrican American\\nLatino\\nAsian/Pacific Islander\\nOther\\n\\n400\\n\\n350\\n\\n300\\n\\n250\\n\\n200\\n\\n150\\n\\n100\\n\\n50\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1  Includes MSM and MSM-PWID with HIV by year of  their initial HIV diagnosis. See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\nYear of HIV Diagnosis1\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  57\\n\\nFigure 7.1 Number of MSM newly diagnosed with HIV by race/ethnicity, 2009-2018, San Francisco\\x0cHIV sexual behavior data\\n\\n ▪ Data from the STOP AIDS project show that the percent of  HIV-negative MSM who reported any \\ncondomless anal intercourse increased from 43% in 2012 to 63% in 2017, and decreased to 51% in 2018.\\n ▪ The proportion of  HIV-positive MSM reporting any condomless anal intercourse has generally remained \\n\\nabove 60%, with a high of 77% in 2017.\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\n63%\\n\\n60%\\n\\n33%\\n\\n32%\\n\\n56%\\n\\n48%\\n\\n43%\\n\\n38%\\n\\n68%\\n\\n57%\\n\\n64%\\n\\n58%\\n\\n65%\\n\\n57%\\n\\n63%\\n\\n51%\\n\\n77%\\n\\n63%\\n\\n64%\\n\\n51%\\n\\nHIV-positive MSM reported condomless sex\\nHIV-negative MSM reported condomless sex\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\nYear\\n\\n58  \\n\\nHIV AMONG MEN WHO HAVE SEX WITH MEN\\n\\nFigure 7.2 Percent of MSM reporting condomless anal intercourse in the last six months by self-reported HIV status, the STOP AIDS Project, 2009-2018, San Francisco\\x0cSexually transmitted diseases among MSM\\n\\n ▪ The last decade has seen an increase in reported cases of  male rectal gonorrhea irrespective of  HIV \\n\\nserostatus.\\n\\n ▪ The number of  reported cases of  male rectal gonorrhea has been higher among HIV-negative men than \\n\\namong HIV-positive men from 2009 through 2018.\\n\\n ▪ The number of  male gonococcal proctitis cases is notably lower, likely due to differences in how the data \\n\\nare reported, and has been relatively stable. \\n\\nMale Rectal Gonorrhea (HIV+)\\nMale Rectal Gonorrhea (HIV-)\\nMale Gonococcal Proctitis (HIV+)\\nMale Gonococcal Proctitis (HIV-)\\n\\n1200\\n\\n1000\\n\\n800\\n\\n600\\n\\n400\\n\\n200\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\nYear\\n\\n1  Data on male rectal gonorrhea and gonococcal proctitis originate from San Francisco Department of  Health STD case registry.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  59\\n\\nFigure 7.3 Male rectal gonorrhea and male gonococcal proctitis among MSM by HIV serostatus1, 2009-2018, San Francisco\\x0c ▪ The increase from 2009 to 2018 in early latent syphilis is dramatic, especially among HIV-positive MSM \\n\\nwho account for a greater proportion of  early syphilis cases than HIV-negative MSM.\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n1100\\n\\n1000\\n\\n900\\n\\n800\\n\\n700\\n\\n600\\n\\n500\\n\\n400\\n\\n300\\n\\n200\\n\\n100\\n\\n0\\n\\nEarly syphilis (HIV+)\\nEarly syphilis (HIV-)\\nPrimary (HIV+)\\nPrimary (HIV-)\\nSecondary (HIV+)\\nSecondary (HIV-)\\nEarly Latent (HIV+)\\nEarly Latent (HIV-)\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1  Data on early syphilis originate from San Francisco Department of  Health STD case registry.\\n\\nYear\\n\\n60  \\n\\nHIV AMONG MEN WHO HAVE SEX WITH MEN\\n\\nFigure 7.4 Early syphilis among MSM by HIV serostatus1, 2009-2018, San Francisco\\x0cSubstance use\\n\\n ▪ Data from the STOP AIDS Project show an increase, from 2009 to 2014, and then a decrease, from 2014 \\n\\nto 2017, in cocaine use.\\nPoppers use increased from a low in 2009 to a high in 2018.\\n\\n ▪\\n ▪ Methamphetamine use has remained relatively stable since 2009.\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n40%\\n\\n35%\\n\\n30%\\n\\n25%\\n\\n20%\\n\\n15%\\n\\n10%\\n\\n5%\\n\\n0%\\n\\nPoppers\\nCocaine\\nMethamphetamine\\n\\n34.8%\\n\\n35.0% 36.1%\\n\\n31.1%\\n\\n28.4%\\n\\n29.1%\\n\\n23.1%\\n\\n20.4%\\n\\n21.0%\\n\\n21.3%\\n\\n17.5% 17.9%\\n\\n24.9%\\n\\n21.6%\\n\\n15.5%\\n\\n13.6%\\n\\n16.0%\\n\\n12.0%\\n9.6%\\n\\n10.8%\\n\\n8.2%\\n\\n7.8%\\n\\n8.5%\\n\\n6.0%\\n\\n7.0%\\n\\n6.6%\\n\\n8.5%\\n\\n9.5%\\n\\n7.4%\\n\\n8.0%\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\nYear\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  61\\n\\nFigure 7.5 Substance use among MSM, the STOP AIDS Project, 2009-2018, San Francisco\\x0cHIV among People who \\nInject Drugs\\n\\n8\\n\\nWhites\\n\\naccoUnted For 43% oF \\nnon-mSm Pwid newly \\ndiagnoSed with hiv From \\n\\n2009-2018 \\n\\n ▪\\n\\nFrom 2009 to 2018, whites accounted for 43% of  non-MSM PWID \\ncases, African Americans 31%, and Latinxs 17%.\\n\\n ▪ The total number of  non-MSM PWID diagnoses each year decreased \\n\\nto 17 in 2015 and increased in 2016 to 2018 (21, 26, 27, respectively).\\n\\nWhite\\nAfrican American\\nLatinx\\nOther/Unknown\\n\\n30\\n\\n25\\n\\n20\\n\\n15\\n\\n10\\n\\n5\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1  Includes persons with HIV by year of  their initial HIV diagnosis. See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\nYear of HIV Diagnosis1\\n\\n62  \\n\\nHIV AMONG PEOPLE WHO INJECT DRUGS\\n\\nFigure 8.1 Number of non-MSM PWID newly diagnosed with HIV by race/ethnicity, 2009-2018, San Francisco\\x0c ▪ The majority of  non-MSM PWID newly diagnosed with HIV between 2009 and 2018 were over 29 years \\n\\nold and 33% were aged 50 years and older.\\n\\n ▪ Although numbers are small, annual diagnoses among PWID who were 30-39 years suggest a gradual \\n\\nincreasing trend from 2014 to 2018.\\n\\n ▪ The numbers of  annual HIV diagnoses among non-MSM PWID aged 18-24 years remained low.\\n\\n30\\n\\n25\\n\\n20\\n\\n15\\n\\n10\\n\\n5\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n18-24 years\\n25-29 years\\n30-39 years\\n40-49 years\\n50+ years\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1  Includes persons with HIV by year of  their initial HIV diagnosis. See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\nYear of HIV Diagnosis1\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  63\\n\\nFigure 8.2 Number of non-MSM PWID newly diagnosed with HIV by age group at HIV diagnosis, 2009-2018, San Francisco\\x0c9 \\n\\nHIV surveillance data\\n\\nHIV among Heterosexuals\\n\\n ▪ Among persons who acquired HIV through heterosexual contact in 2009 \\nto 2018, Latinxs accounted for 34%, African Americans accounted for \\n31%, and whites accounted for 22%. \\n\\n ▪ The number of persons who acquired HIV through heterosexual contact \\n\\nwas small; there were no clear temporal trends by race/ethnicity.\\n\\nLatinxs\\n\\naccoUnted For more than \\nnewly diagnoSed with hiv \\n\\n1/3 oF heteroSexUalS \\n\\nFrom 2009-2018 \\n\\nWhite\\nAfrican American\\nLatinx\\nOther/Unknown\\n\\n30\\n\\n25\\n\\n20\\n\\n15\\n\\n10\\n\\n5\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1  Includes persons with HIV by year of  their initial HIV diagnosis. See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\nYear of HIV Diagnosis1\\n\\n64  \\n\\nHIV AMONG HETEROSEXUALS\\n\\nFigure 9.1 Number of heterosexuals newly diagnosed with HIV by race/ethnicity, 2009-2018, San Francisco\\x0cSexually  transmitted  dis-\\neases among heterosexuals \\n\\n ▪ Overall,  the  number  of   early \\nsyphilis cases among heterosexual \\nmen  has  increased  over  time \\nreaching  a  peak  at  83  cases  in \\n2018.\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n85\\n80\\n75\\n70\\n65\\n60\\n55\\n50\\n45\\n40\\n35\\n30\\n25\\n20\\n15\\n10\\n5\\n0\\n\\nPrimary\\nSecondary\\nEarly Latent\\nEarly Syphilis (Total)\\n\\n41\\n\\n38\\n\\n29\\n\\n17\\n\\n8\\n\\n5\\n\\n4\\n\\n9\\n\\n4\\n\\n3\\n\\n2\\n\\n13\\n\\n13\\n\\n12\\n\\n13\\n\\n9\\n\\n7\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n20\\n\\n12\\n\\n9\\n\\n2013\\nYear\\n\\n83\\n\\n58\\n\\n47\\n\\n46\\n\\n41\\n\\n30\\n\\n25\\n\\n11\\n\\n10\\n\\n12\\n\\n28\\n\\n27\\n\\n17\\n\\n17\\n\\n14\\n\\n6\\n\\n5\\n\\n22\\n\\n15\\n\\n10\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1  Data on early syphilis originate from San Francisco Department of  Health STD case registry.\\n\\n ▪ Among women, syphilis cases are \\nlow relative to men, although the \\nnumbers of  secondary and early \\nlatent syphilis cases are increasing \\nin recent years.\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n85\\n80\\n75\\n70\\n65\\n60\\n55\\n50\\n45\\n40\\n35\\n30\\n25\\n20\\n15\\n10\\n5\\n0\\n\\nPrimary\\nSecondary\\nEarly Latent\\nEarly Syphilis (Total)\\n\\n16\\n\\n10\\n\\n5\\n\\n1\\n\\n2010\\n\\n18\\n\\n11\\n\\n7\\n\\n0\\n2011\\n\\n21\\n\\n11\\n\\n6\\n\\n4\\n\\n2012\\n\\n70\\n\\n38\\n\\n23\\n\\n9\\n\\n30\\n\\n30\\n\\n29\\n\\n21\\n\\n11\\n\\n8\\n\\n17\\n\\n13\\n\\n14\\n\\n13\\n\\n2\\n\\n2\\n\\n2\\n\\n3\\n\\n17\\n\\n16\\n\\n9\\n\\n4\\n\\n8\\n\\n5\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n2013\\nYear\\n\\n9\\n\\n5\\n\\n4\\n\\n0\\n2009\\n\\n1  Data on early sypillis originate from San Francisco Department of  Health STD case registry.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  65\\n\\nFigure 9.2 Early syphilis among heterosexual men1, 2009-2018, San FranciscoFigure 9.3 Early syphilis among women1, 2009-2018, San Francisco\\x0c10\\n\\nHIV among Women\\n\\n ▪ Among women newly diagnosed with HIV from 2009 to 2018, whites \\naccounted for 30% of  diagnoses, African Americans accounted for \\n32%, and Latinas accounted for 26%.\\n\\n ▪ Annual number of  diagnoses among African American women was \\n\\nhigher than white and Latina women for 2016 to 2018.\\n\\nAfrican\\n\\nAmericans\\n\\naccoUnted For a greater \\nnUmber oF women newly \\ndiagnoSed with hiv From \\n\\n2009-2018 \\n\\nWhite\\nAfrican American\\nLatina\\nOther/Unknown\\n\\n30\\n\\n25\\n\\n20\\n\\n15\\n\\n10\\n\\n5\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n0\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\nYear of HIV Diagnosis1\\n\\n1  Includes persons with HIV by year of  their initial HIV diagnosis. See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\n66  \\n\\nHIV AMONG WOMEN\\n\\nFigure 10.1 Number of women newly diagnosed with HIV by race/ethnicity, 2009-2018, San Francisco\\x0c ▪ Although African American women represent 6% of  the total female population in San Francisco (pie \\nchart on the right), as of  December 31, 2018 they accounted for 37% of  women living with HIV in San \\nFrancisco (pie chart on the left).\\n\\nWomen living with HIV\\n\\n(N=903)\\n\\nFemale population of  San Francisco1\\n\\n(N=396,773)\\n\\nLatina\\n22%\\n\\nAsian/ \\nPacific \\nIslander\\n\\n7%\\n\\nNative \\nAmerican\\n\\n1%\\n\\nOther/ \\nUnkown\\n\\n4%\\n\\nAfrican \\nAmerican\\n\\n37%\\n\\n1  United States 2010 Census data.\\n\\nWhite\\n28%\\n\\n ▪ Among women diagnosed and living with HIV \\nin San Francisco through the end of  2018, 46% \\nacquired HIV through injecting drugs and 49% \\nthrough heterosexual contact.\\n\\nLatina\\n14%\\n\\nAfrican \\nAmerican\\n\\n6%\\n\\nHeterosexual\\n\\n43%\\n\\nAsian/ \\nPacific \\nIslander\\n\\n37%\\n\\nWhite\\n40%\\n\\nNative \\nAmerican\\n\\n<1%\\nOther\\n3%\\n\\nN=903\\n\\nPresumed \\nHeterosexual\\n\\n1\\n\\n6% Other/ \\nUnknown\\n\\n4%\\n\\nTransfusion/\\nHemophilia\\n\\n1%\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  67\\n\\n1  See Technical Notes “Female Presumed Heterosexual Contact.”\\n\\nPWID\\n46%\\n\\nFigure 10.2 Women living with HIV diagnosed through December 2018 and female population by race/ethnicity, San FranciscoFigure 10.3 Women living with HIV diag-nosed through December 2018 by transmission category, San Francisco\\x0c11\\n\\nHIV among Children, Adolescents \\nand Young Adults\\n\\nLatinxs\\n\\naccoUnted For 36% oF \\nyoUng adUltS living with \\nhiv aS oF 12/31/2018\\n\\n ▪ Adolescents  (current  age  13-17  years)  or  young  adults \\n(current age 18-24 years) living with HIV in San Francisco \\nmake up less than 1% of persons living with HIV in the city.\\n ▪ As  of   December  31,  2018  there  were  fewer  than  ten \\n\\nadolescents and 98 young adults living with HIV.\\n\\n ▪ Among young adults living with HIV, three-quarters were \\nmen who have sex with men (either with or without a history \\nof  injecting drugs).\\n36% of  young adults living with HIV were Latinx, 27% \\nwere African American, 22% were white, and 8% were \\nAsian/Pacific Islander.\\n\\n ▪\\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\n2\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\nTotal\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nPerinatal\\nOther/Unidentified1\\nMen\\nWomen\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nMulti-race\\n\\n18 - 24 Years Old\\n\\nNumber (%)\\n98 (100)\\n66 ( 67)\\n4)\\n4 (\\n8 (\\n8)\\n7)\\n7 (\\n9 (\\n9)\\n4 (\\n4)\\n73 ( 74)\\n20 ( 20)\\n22 ( 22)\\n26 ( 27)\\n35 ( 36)\\n8 (\\n8)\\n7)\\n7 (\\n\\n1  Includes TWSM, TWSM-PWID and persons with no identified \\n\\nrisk factor.\\n\\n2  Data on trans women and trans men are not released separately \\n\\ndue to small numbers. See Technical Notes “Gender Status.”\\n\\n ▪\\n\\nFor the years 2014-2018 and compared to the U.S. data, San Francisco had lower proportions of adolescents \\nand young adults diagnosed with HIV. \\n\\n ▪ Annual diagnoses among persons who were age 20-24 years old show a declining trend from 2014 to 2017 \\n\\nand increased in 2018.\\n\\n \\n\\nn\\na\\nS\\n\\no\\nc\\ns\\ni\\nc\\nn\\na\\nr\\nF\\n\\n1\\n.\\nS\\n.\\nU\\n\\n All ages\\n   Age 13-19 years at HIV diagnosis\\n   Age 20-24 years at HIV diagnosis\\n All ages\\n   Age 13-19 years at HIV diagnosis\\n   Age 20-24 years at HIV diagnosis\\n\\n2014\\n\\n321\\n\\n1 ( <1 )\\n39 12 )\\n\\n(  \\n\\n40,888\\n1,786\\n4 )\\n7,486 18 )\\n\\n(    \\n(  \\n\\nYear of HIV Diagnosis\\n\\n2015\\n\\n281\\n5\\n2 )\\n36 13 )\\n\\n(    \\n( \\n\\n40,534\\n1,773\\n4 )\\n7,358 18 )\\n\\n(    \\n( \\n\\n2016\\n\\nNumber (%)\\n\\n234\\n4\\n2 )\\n29 12 )\\n\\n(    \\n( \\n\\n40,142\\n1,734\\n4 )\\n6,942 17 )\\n\\n(    \\n( \\n\\n2017\\n\\n2018\\n\\n4 )\\n8 )\\n\\n(    \\n(    \\n\\n227\\n8\\n18\\n38,739\\n1,748\\n5 )\\n6,416 17 )\\n\\n(    \\n( \\n\\n197\\n5\\n3 )\\n25 13 )\\n\\n(    \\n( \\n\\nN/A\\nN/A\\n\\n1  U.S. data are based on reported case counts from the 50 states and 6 dependent areas with confidential name-based HIV reporting in CDC HIV Surveillance \\n\\nReport, 2017 (volume 29).\\n\\n68  \\n\\nHIV AMONG CHILDREN, ADOLESCENTS AND YOUNG ADULTS\\n\\nTable 11.1 Young adults living with HIV by transmission category, gender1, and race/ethnicity, December 2018, San FranciscoTable 11.2 Number of adolescents and young adults newly diagnosed with HIV, 2014-2018, San Francisco and the United States\\x0c ▪ As of  December 31, 2018, there were 60 cumulative pediatric HIV cases (children less than 13 years old) \\n\\nwho resided in San Francisco at time of  diagnosis.\\n\\n ▪ The number of  pediatric HIV cases peaked between 1986 and 1995, and has declined over time, with zero \\n\\npediatric HIV cases diagnosed among residents of San Francisco since 2005.\\n\\n ▪ Of  the 60 reported pediatric HIV cases, 26 (43%) had died as of  December 2018 and 34 (57%) have \\n\\nsurvived beyond childhood (current age ≥13 years). \\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n25\\n\\n20\\n\\n15\\n\\n10\\n\\n5\\n\\n0\\n\\n21\\n\\n22\\n\\n4\\n\\n7\\n\\n6\\n\\n1980-1985\\n\\n1986-1990\\n\\n1991-1995\\nYear of HIV Diagnosis1\\n\\n1996-2000\\n\\n0\\n\\n2001-2005\\n\\n2006-2018\\n\\n1  See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  69\\n\\nFigure 11.1 Number of children diagnosed with HIV by time period of HIV diagnosis, 1980-2018, San Francisco\\x0c12\\n\\nHIV among Persons Aged 50 Years \\nand Older\\n\\n ▪ As of  December 31, 2018, 67% (N=10,691) of  persons living with HIV were \\n\\naged 50 years and older.\\nIn this age group, 75% were between the ages of  50-64 years old. \\n\\n ▪\\n ▪ Among those aged 50 years and older, 65% were white and 15% were Latinx \\n\\ncompared to 44% and 29%, respectively, among those under age 50. \\n\\n67%\\n\\noF Plwh were aged \\n50 yearS and older \\naS oF 12/31/2108\\n\\nAge ≥ 50 years as \\nof 12/31/2018\\n\\nAge < 50 years as \\nof 12/31/2018\\n\\nNumber (%)\\n\\n5,299\\n4,731 (89)\\n340 ( 6)\\n224 ( 4)\\n2,331 (44)\\n625 (12)\\n1,527 (29)\\n555 (10)\\n28 ( 1)\\n233 ( 4)\\n3,687 (70)\\n150 ( 3)\\n237 ( 4)\\n775 (15)\\n73 ( 1)\\n242 ( 5)\\n135 ( 3)\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nNative American\\nOther/Unknown\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n50-54\\n55-59\\n60-64\\n65+\\n\\n10,691\\n9,953 (93)\\n563 ( 5)\\n172 ( 2)\\n6,983 (65)\\n1,283 (12)\\n1,657 (15)\\n438 ( 4)\\n39 ( 0)\\n291 ( 3)\\n7,994 (75)\\n73 ( 1)\\n650 ( 6)\\n1,411 (13)\\n97 ( 1)\\n333 ( 3)\\n133 ( 1)\\n2,826 (26)\\n3,001 (28)\\n2,233 (21)\\n2,631 (25)\\n\\n1\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\nn\\no\\ni\\ns\\ns\\ni\\n\\n \\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n1  Data on trans men are not released separately due to small numbers. See Technical \\n\\nNotes “Gender Status.”\\n\\n70  \\n\\nHIV AMONG PERSONS AGED 50 YEARS AND OLDER\\n\\nTable 12.1 Characteristics of persons living with HIV by age group, December 2018, San Francisco\\x0c ▪ While the overall number of  new diagnoses decreased, the number of  persons aged 50 years and older at \\ntime of  diagnosis has oscillated and accounted for as much as 17% in 2009 and 2014, and as few as 11% \\nin 2015.\\n\\n81\\n\\n17%\\n\\n67\\n\\n16%\\n\\n67\\n\\n14%\\n\\n55\\n\\n12%\\n\\n48\\n12%\\n\\nChart1\\n\\n50 and older at time of HIV diagnosis\\n % 50 and older at time of HIV diagnosis\\n\\n25%\\n\\n20%\\n\\n17%\\n\\n54\\n\\n16%\\n\\n15%\\n\\n11%\\n\\n31\\n\\n35\\n\\n36\\n\\n15%\\n\\n13%\\n\\nP\\ne\\nr\\nc\\ne\\nn\\nt\\n\\n26\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n10%\\n\\n5%\\n\\n0%\\n\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n90\\n\\n80\\n\\n70\\n\\n60\\n\\n50\\n\\n40\\n\\n30\\n\\n20\\n\\n10\\n\\n0\\n\\n1  Includes persons with HIV by year of  their initial HIV diagnosis. See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\nYear of HIV Diagnosis1\\n\\nPage 1\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  71\\n\\nFigure 12.1 Number and percent of persons newly diagnosed with HIV at age 50 years and older, 2009-2018, San Francisco\\x0c ▪ Between 2009 and 2018, a higher proportion of women, whites, African Americans, PWID, and heterosexuals \\nwere diagnosed at the age of  50 years and older compared to those who were younger at time of  diagnosis. \\n ▪ Of  those diagnosed at the age of  50 and older, 47% were 50-54 years old, 26% were 55-59 years old, 17% \\n\\nwere 60-64 years old, and 10% were 65 years or older.\\n\\nAge ≥ 50 years at \\n\\ndiagnosis\\n\\nAge < 50 years at \\n\\ndiagnosis\\n\\nNumber (%)\\n\\nTotal \\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nOther/Unidentified2\\n50-54\\n55-59\\n60-64\\n65+\\n\\n500\\n414 (83)\\n81 (16)\\n5 ( 1)\\n273 (55)\\n102 (20)\\n75 (15)\\n26 ( 5)\\n24 ( 5)\\n284 (57)\\n82 (16)\\n47 ( 9)\\n55 (11)\\n32 ( 6)\\n237 (47)\\n132 (26)\\n83 (17)\\n48 (10)\\n\\n2,988\\n2,699 (90)\\n179 ( 6)\\n108 ( 4)\\n1,285 (43)\\n375 (13)\\n826 (28)\\n352 (12)\\n150 ( 5)\\n2,124 (71)\\n167 ( 6)\\n370 (12)\\n153 ( 5)\\n174 ( 6)\\n\\n1\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\n\\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n1  Data on trans men are not released separately due to small numbers. See Technical Notes \\n\\n“Gender Status.”\\n\\n2  Includes TWSM, TWSM-PWID and persons with no identified risk factor.\\n\\n72  \\n\\nHIV AMONG PERSONS AGED 50 YEARS AND OLDER\\n\\nTable 12.2 Characteristics of persons newly diagnosed with HIV in 2009-2018 by age at diagnosis, San Francisco\\x0cHIV among Trans Women\\n3%\\n\\n13 \\n\\noF all new hiv diagnoSeS \\nFrom 2009-2018 were \\n\\namong tranS women \\n\\n ▪\\n\\nFrom 2009 through 2018, there \\nwere 113 trans women newly \\ndiagnosed  with  HIV  in  San \\nFrancisco comprising 3% of all \\npersons diagnosed with HIV in \\nthis time period.\\n\\n ▪ Compared  to  all  persons \\ndiagnosed with HIV in this time \\nperiod, trans women were more \\nlikely to be non-white, persons \\nwho  inject  drugs  (PWID), \\nand  younger;  44%  of   newly \\ndiagnosed  trans  women  were \\n18-29 years old.\\n\\n ▪\\n\\n ▪ As of December 31, 2018, 31% \\nof  the 396 trans women living \\nwith HIV in San Francisco were \\nAfrican  Americans  and  36% \\nwere Latinas.\\n43%  of   trans  women  living \\nwith HIV were PWID.\\nSimilar to trans women newly \\ndiagnosed  with  HIV  in  2009 \\nto  2018,  trans  women  living \\nwith  HIV  were  more  likely \\nto  be  non-white,  PWID,  and \\nyounger ages when compared \\nto all persons living with HIV \\nin San Francisco.\\n\\n ▪\\n\\nTrans Women HIV Cases1 \\n\\nAll HIV Cases\\n\\n2009 - 2018\\nNumber (%)\\n\\nTotal\\nWhite\\nAfrican American\\nLatina\\nAsian/Pacific Islander\\nOther/Unknown\\nYes\\nNo\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50+\\n\\n113\\n18 (16)\\n31 (27)\\n43 (38)\\n13 (12)\\n8 ( 7)\\n35 (31)\\n78 (69)\\n1 ( 1)\\n28 (25)\\n22 (19)\\n38 (34)\\n19 (17)\\n5 ( 4)\\n\\n3,488\\n1,558 (45)\\n477 (14)\\n901 (26)\\n378 (11)\\n174 ( 5)\\n701 (20)\\n2,787 (80)\\n12 (<1)\\n448 (13)\\n614 (18)\\n1,049 (30)\\n865 (25)\\n500 (14)\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\n\\nl\\n\\ne\\np\\no\\ne\\nP\\n\\n \\n\\no\\nh\\nw\\n\\n \\nt\\nc\\ne\\nj\\nn\\n\\nI\\n\\ns\\ng\\nu\\nr\\nD\\n\\ni\\n\\n \\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\n \\nt\\na\\ne\\ng\\nA\\n\\n \\n\\n)\\ns\\nr\\na\\ne\\nY\\n(\\n\\n1  See Technical Notes “Gender Status.”\\n\\nTrans Women PLWH1\\n\\nAll PLWH\\n\\nNumber (%)\\n\\nTotal\\nWhite\\nAfrican American\\nLatina\\nAsian/Pacific Islander\\nOther/Unknown\\nYes\\nNo\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50+\\n\\n396\\n71 (18)\\n122 (31)\\n141 (36)\\n39 (10)\\n23 ( 6)\\n172 (43)\\n224 (57)\\n0 ( 0)\\n5 ( 1)\\n14 ( 4)\\n85 (21)\\n120 (30)\\n172 (43)\\n\\n15,990\\n9,314 (58)\\n1,908 (12)\\n3,184 (20)\\n993 ( 6)\\n591 ( 4)\\n3,243 (20)\\n12,747 (80)\\n4 (<1)\\n98 ( 1)\\n346 ( 2)\\n1,727 (11)\\n3,124 (20)\\n10,691 (67)\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\n\\nl\\n\\ne\\np\\no\\ne\\nP\\n\\n \\n\\no\\nh\\nw\\n\\n \\nt\\nc\\ne\\nj\\nn\\n\\nI\\n\\ns\\ng\\nu\\nr\\nD\\n\\ns\\nr\\na\\ne\\nY\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n)\\n8\\n1\\n0\\n2\\n \\nf\\no\\nd\\nn\\ne\\n \\nt\\na\\n(\\n\\n \\n\\n1  See Technical Notes “Gender Status.”\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  73\\n\\nTable 13.1 Characteristics of trans women compared to all persons newly diagnosed with HIV in 2009-2018, San FranciscoTable 13.2 Characteristics of trans women living with HIV compared to all persons living with HIV, December 2018, San Francisco\\x0c14 \\n\\nHousing Status among Persons \\nLiving with HIV\\n\\n ▪ Among  homeless  persons  newly  diagnosed  with  HIV  (See  Technical  Notes \\n“Housing Status and Current Address”) from 2009 through 2018, the number of  \\ndiagnoses peaked at 67 in 2010, and in 2018 the number was 40.\\n\\n ▪ The  proportion  of   new  diagnoses  among  homeless  individuals  fluctuated  but \\nshowed an overall increasing trend in the more recent years: 11% in 2016, 13% in \\n2017, and 20% in 2018 which was the highest during the 2009 to 2018 time period. \\n\\n20%\\n\\noF new diagnoSeS \\n\\nin 2018 were \\n\\nhomeleSS\\n\\nChart1\\n\\nHomeless number\\nHomeless %\\n\\n20%\\n\\n67\\n\\n14%\\n\\n57\\n\\n12%\\n\\n55\\n\\n12%\\n\\n14%\\n\\n44\\n\\n39\\n9%\\n\\n37\\n9%\\n\\n10%\\n\\n29\\n\\n11%\\n\\n25\\n\\n13%\\n\\n29\\n\\n40\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\ns\\ne\\ns\\na\\nC\\n \\ns\\ns\\ne\\nl\\ne\\nm\\no\\nH\\n\\n \\nf\\no\\n \\nr\\ne\\nb\\nm\\nu\\nN\\n\\n90\\n\\n80\\n\\n70\\n\\n60\\n\\n50\\n\\n40\\n\\n30\\n\\n20\\n\\n10\\n\\n0\\n\\n25%\\n\\n20%\\n\\n15%\\n\\n10%\\n\\n5%\\n\\n0%\\n\\nP\\ne\\nr\\nc\\ne\\nn\\nt\\n\\n1  Includes persons with HIV by year of  their initial HIV diagnosis. See Technical Notes “Date of  Initial HIV Diagnosis.”\\n\\nYear of HIV Diagnosis1\\n\\nPage 1\\n\\n74  \\n\\nHOUSING STATUS AMONG PERSONS LIVING WITH HIV\\n\\nFigure 14.1 Number and percent of homeless persons newly diagnosed with HIV by year of diagnosis, 2009-2018, San Francisco\\x0c ▪ Compared to all persons diagnosed with HIV in 2009 to 2018, persons who were homeless at time of  HIV \\ndiagnosis were more likely to be women or trans women, African American, persons who inject drugs \\n(PWID), and men who have sex with men and who also inject drugs (MSM-PWID).\\n\\nHIV Cases, 2009-2018\\n\\nHomeless\\n\\nAll\\n\\nNumber (%)\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n13 - 17\\n18 - 24\\n25 - 29\\n30 - 39\\n40 - 49\\n50+\\n\\n422\\n328 (78)\\n56 (13)\\n38 ( 9)\\n173 (41)\\n104 (25)\\n102 (24)\\n10 ( 2)\\n33 ( 8)\\n127 (30)\\n25 ( 6)\\n108 (26)\\n106 (25)\\n13 ( 3)\\n32 ( 8)\\n11 ( 3)\\n1 (<1)\\n67 (16)\\n82 (19)\\n117 (28)\\n89 (21)\\n66 (16)\\n\\n3,488\\n3,113 (89)\\n260 ( 7)\\n115 ( 3)\\n1,558 (45)\\n477 (14)\\n901 (26)\\n378 (11)\\n174 ( 5)\\n2,408 (69)\\n78 ( 2)\\n249 ( 7)\\n417 (12)\\n35 ( 1)\\n208 ( 6)\\n93 ( 3)\\n12 (<1)\\n448 (13)\\n614 (18)\\n1,049 (30)\\n865 (25)\\n500 (14)\\n\\n1\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nC\\nn\\no\\ni\\ns\\ns\\ni\\n\\n \\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ni\\n\\n \\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\n \\nt\\na\\ne\\ng\\nA\\n\\n \\n\\n)\\ns\\nr\\na\\ne\\nY\\n(\\n\\n1  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.” \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  75\\n\\nTable 14.1 Characteristics of homeless persons compared to all persons newly diagnosed with HIV in 2009-2018, San Francisco\\x0c ▪ A total of  7,849 persons living with HIV (PLWH) had residential housing status or address information \\n\\ncollected or updated in 2018. \\n\\n ▪ Eight percent of  PLWH with housing status or address in 2018 were homeless or lived in a Single-Room \\n\\nOccupancy (SRO) facility during 2018.\\n\\n ▪ Among persons who were homeless or lived in a SRO facility during 2018, there were higher proportions \\nof  women, trans women, African Americans, Latinx persons, PWID, MSM-PWID, and persons in younger \\nage groups (25-29 years, 30-39 years, 40-49 years), compared to all PLWH.\\n\\nPLWH as of 12/31/20181\\n\\nEver homeless or SRO in 2018\\n\\nAll \\n\\nNumber (%)\\n\\nTotal\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther\\nMSM\\nTWSM\\nPWID\\nMSM-PWID\\nTWSM-PWID\\nHeterosexual\\nOther/Unidentified\\n13-24\\n25-29\\n30-39\\n40-49\\n50-59\\n60-69\\n70+\\n\\n601\\n485 (81)\\n70 (12)\\n46 ( 8)\\n261 (43)\\n127 (21)\\n152 (25)\\n31 ( 5)\\n30 ( 5)\\n242 (40)\\n25 ( 4)\\n110 (18)\\n165 (27)\\n20 ( 3)\\n30 ( 5)\\n9 ( 1)\\n7 ( 1)\\n34 ( 6)\\n134 (22)\\n130 (22)\\n192 (32)\\n87 (14)\\n17 ( 3)\\n\\n7,849\\n7,142 (91)\\n509 ( 6)\\n198 ( 3)\\n4,516 (58)\\n970 (12)\\n1,548 (20)\\n505 ( 6)\\n310 ( 4)\\n5,723 (73)\\n117 ( 1)\\n456 ( 6)\\n1,055 (13)\\n74 ( 1)\\n309 ( 4)\\n115 ( 1)\\n69 ( 1)\\n224 ( 3)\\n899 (11)\\n1,522 (19)\\n2,781 (35)\\n1,830 (23)\\n524 ( 7)\\n\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\ny\\nr\\no\\ng\\ne\\nt\\na\\nc\\n \\nn\\no\\ni\\ns\\ns\\ni\\n\\nm\\ns\\nn\\na\\nr\\nT\\n\\ns\\nr\\na\\ne\\ny\\nn\\n\\n \\n\\ni\\n \\n\\ne\\ng\\nA\\n\\n)\\n8\\n1\\n0\\n2\\n/\\n1\\n3\\n/\\n2\\n1\\n \\nf\\no\\n \\ns\\na\\n(\\n\\n1  PLWH as of  12/31/2018 diagnosed in San Francisco at any HIV stage with residential housing status or address \\n\\ninformation in 2018.\\n\\n76  \\n\\nHOUSING STATUS AMONG PERSONS LIVING WITH HIV\\n\\nTable 14.2 Characteristics of persons who were homeless or lived in SRO facility during 2018 compared to all PLWH \\x0c15 \\n\\nPersons Co-infected with HIV and \\nSexually Transmitted Diseases\\n\\n>95%\\n\\noF Std diagnoSeS among \\nPlwh were mSm From \\n\\n2013-2017 \\n\\n ▪\\n\\nFrom 2013 to 2017, the number of  sexually transmitted disease (STD) \\ndiagnoses among persons living with HIV (PLWH) rose from 1,175 in \\n2013 to 1,365 in 2017. The majority of  cases (>95%) were among men \\nwho have sex with men (MSM).\\n\\n ▪ Overall, the increase coincided with the upward trend shown in early \\nsyphilis (Figure 7.4 on page 60) and in male gonorrhea (Figure 7.3 on \\npage 59) reported from 2006 through 2017 among MSM diagnosed \\nwith HIV.\\n\\nD\\nT\\nS\\n\\n \\n/\\n\\n \\n\\nw\\ns\\ne\\ns\\na\\nC\\n\\n \\nf\\no\\n\\n \\n.\\n\\no\\nN\\n\\n1400\\n\\n1200\\n\\n1000\\n\\n800\\n\\n600\\n\\n400\\n\\n200\\n\\n0\\n\\nNon-MSM/Non-TWSM Non-MSM\\nTWSM\\n\\n2\\n\\n39\\n\\n30\\n\\n26\\n37\\n\\nMSM\\n30\\n\\n26\\n\\n1,149\\n\\n1,188\\n\\n1,302\\n\\n1,342\\n\\n1,302\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\nYear of STD Diagnosis\\n\\n1  See Technical Notes “HIV and STD Co-infection.”\\n2  TWSM were included in MSM transmission category from 2013 to 2016 and were shown separately beginning in 2017.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  77\\n\\nFigure 15.1 Number of STD diagnoses1 among persons living with HIV by year of STD diagnosis, 2013-2017, San Francisco\\x0c ▪ The majority of  PLWH diagnosed with an STD from 2013 through 2017 were men, white, and aged 40-49 \\n\\nyears at time of STD diagnosis.\\n\\n ▪ There were small increases in the proportions of  Latinx and declines in the proportions of  whites who \\n\\nwere diagnosed with an STD.\\n\\n ▪ The proportion of  PLWH diagnosed with an STD at age 50 or older increased from 24% in 2013 to 34% \\n\\nin 2017, while the proportion of  those aged 40-49 declined during the same period of time.\\n\\n2\\nr\\ne\\nd\\nn\\ne\\nG\\n\\ny\\nt\\ni\\n\\ni\\n\\nc\\nn\\nh\\nt\\nE\\ne\\nc\\na\\nR\\n\\n/\\n\\n \\n\\nD\\nT\\nS\\n\\n \\nt\\na\\n\\n \\n\\ne\\ng\\nA\\n\\n \\n\\ns\\n\\ni\\n\\ns\\no\\nn\\ng\\na\\nD\\n\\ni\\n\\n)\\ns\\nr\\na\\ne\\ny\\n(\\n\\nMen\\nWomen\\nTrans Women\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n13 - 29\\n30 - 39\\n40 - 49\\n50 - 59\\n60 +\\nTotal\\n\\nYear of STD diagnosis\\n\\n2013\\n\\n2014\\n\\n1,147 (98)\\n6 ( 1)\\n22 ( 2)\\n690 (59)\\n104 ( 9)\\n269 (23)\\n80 ( 7)\\n32 ( 3)\\n141 (12)\\n291 (25)\\n471 (40)\\n230 (20)\\n42 ( 4)\\n\\n1,181 (97)\\n12 ( 1)\\n25 ( 2)\\n702 (58)\\n103 ( 8)\\n284 (23)\\n85 ( 7)\\n44 ( 4)\\n155 (13)\\n287 (24)\\n460 (38)\\n247 (20)\\n69 ( 6)\\n\\n2015\\n\\nNumber (%)\\n1,286 (96)\\n19 ( 1)\\n36 ( 3)\\n738 (55)\\n118 ( 9)\\n331 (25)\\n94 ( 7)\\n60 ( 4)\\n157 (12)\\n300 (22)\\n486 (36)\\n326 (24)\\n72 ( 5)\\n\\n2016\\n\\n2017\\n\\n1,312 (96)\\n14 ( 1)\\n46 ( 3)\\n728 (53)\\n119 ( 9)\\n366 (27)\\n107 ( 8)\\n52 ( 4)\\n166 (12)\\n312 (23)\\n440 (32)\\n361 (26)\\n93 ( 7)\\n\\n1,372\\n\\n1,311 (96)\\n16 ( 1)\\n37 ( 3)\\n715 (52)\\n114 ( 8)\\n366 (27)\\n112 ( 8)\\n58 ( 4)\\n135 (10)\\n326 (24)\\n433 (32)\\n356 (26)\\n115 ( 8)\\n\\n1,365\\n\\n1,175\\n1  See Technical Notes “HIV and STD Co-infection.”\\n2  Data on trans men are not released separately due to small numbers. See Technical Notes “Gender Status.” \\n\\n1,218\\n\\n1,341\\n\\n78  \\n\\nPERSONS CO-INFECTED WITH HIV AND SEXUALLY TRANSMITTED DISEASES\\n\\nTable 15.1 Demographic characteristics of persons living with HIV who were diagnosed with STD1, 2013-2017, San Francisco\\x0c16\\n\\nPre-Exposure Prophylaxis\\n\\n ▪ Key indicators of the PrEP continuum were evaluated from two population-based studies; 369 HIV-negative \\ntrans women from Trans*National Study, 2016-2018 and 399 men who have sex with men (MSM) from \\nNational HIV Behavioral Surveillance System, 2017\\n\\n ▪ Compared to MSM, trans women were less likely to be aware of  PrEP, less likely to have used PrEP in the \\npast 6 months, and less likely to report being PrEP adherent (defined as using PrEP daily or almost daily). \\n\\n \\n\\n100%\\n\\n100%\\n\\n100%\\n\\n97%\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n90%\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\nMSM (N=399)\\nTrans Women (N=369)\\n\\n79%\\n\\n40%\\n\\n35%\\n\\n15%\\n\\n10%\\n\\nTotal HIV-Negative\\n\\nPrEP Aware\\n\\nUsed PrEP\\n\\nPrEP Adherent\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  79\\n\\nFigure 16.1 PrEP Cascade among MSM and trans women, 2016-2018, San Francisco\\x0c ▪\\n\\nP r E P   u s e   a m o n g   M S M \\nincreased over time among all \\nraces. However, in recent years, \\nAfrican-American  MSM  had \\nlower proportions of  PrEP use \\ncompared to MSM of  all other \\nraces. \\n\\n ▪ Between  August  2016  and \\nMarch 2019, 2,095 clients were \\nscreened  for  PrEP  eligibility \\nat  selected  community  based \\norganizations in San Francisco, \\n56% (N=1,176) were scheduled \\nan appointment to discuss PrEP, \\n45%  (N=943)  initiated  PrEP, \\nand  23%  (N=489)  were  on \\nPrEP at six months follow-up.\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n100%\\n\\n90%\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n53%\\n\\n47%\\n\\n40%\\n\\n49%\\n\\n41%\\n\\n34%\\n\\n53%\\n\\n48%\\n\\n57%\\n\\n48%\\n\\n37%\\n\\n35%\\n\\n26%\\n\\n17%\\n\\n25%\\n\\n13%\\n\\n23%\\n\\n17%\\n\\n22%\\n\\n12%\\n\\nWhite\\n\\nAfrican American\\n\\nLatino\\n\\nAsian\\n\\n100%\\n\\n100%\\n2095\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n90%\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\n56%\\n1176\\n\\n45%\\n943\\n\\n23%\\n489\\n\\nScreened\\n\\nScheduled\\nAppointment\\n\\nInitiated PrEP\\n\\nOn PrEP at 6 months\\n\\n1  Community Based Organizations included API Wellness, Lyric, San Francisco AIDS Foundation, Instituto \\n\\nde la Raza, and Alliance Health Project. \\n\\n80  \\n\\nPRE-EXPOSURE PROPHYLAXIS\\n\\nFigure 16.2 Proportion of MSM currently on PrEP by race/ethnicity, San Francisco City Clinic patients, 2014-2018Figure 16.3 PrEP screening, appointments and PrEP initiation among clients being served by selected community based organizations1, San Francisco, August 2016 - March 2019\\x0c ▪ Of  the 2,905 clients screened for PrEP, white MSM were most likely to schedule an appointment (84%) \\nfollowed by Latino MSM (68%). Trans women (54%) and young MSM under the age of  25 (57%) were \\nless likely to schedule an appointment. PrEP initiation was highest among white MSM (72%) and Latino \\nMSM (56%) and lowest among trans women (43%) and young MSM (46%). White MSM (42%) were most \\nlikely to be on PrEP at six months and trans women (10%) were least likely to be on PrEP.\\n\\nt\\nn\\ne\\nc\\nr\\ne\\nP\\n\\n100%\\n\\n90%\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\n100%\\n\\n100%\\n\\n100%\\n\\n100%\\n\\n100%\\n\\n100%\\n\\n84%\\n\\n68%\\n\\n72%\\n\\n2\\n\\nAll clients\\nWhite MSM\\n2\\nAfrican American MSM\\nLatino MSM\\nTrans women\\nMSM <25 years\\n\\n2\\n\\n2\\n\\n2\\n\\n59%\\n\\n56%\\n\\n57%\\n\\n54%\\n\\n56%\\n\\n49%\\n\\n45%\\n\\n46%\\n\\n43%\\n\\n42%\\n\\n27%\\n\\n27%\\n\\n23%\\n\\n21%\\n\\n10%\\n\\nScreened\\n\\nScheduled\\nAppointment\\n\\nInitiated PrEP\\n\\nOn PrEP at 6 Months\\n\\n1  Community Based Organizations included API Wellness, Lyric, San Francisco AIDS Foundation, Instituto de la Raza, and Alliance Health Project. \\n2  These groups are priority populations and not mutually exclusive.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  81\\n\\nFigure 16.4 PrEP Cascade among clients being served by selected community based organizations1, San Francisco, August 2016 - March 2019 \\x0c17\\n\\nStigma among Persons with HIV\\n\\n ▪ Data  from  the  2015-2017  cycles  of   the  Medical  Monitoring  Project  (see  Technical  Notes  “Medical \\nMonitoring Project”) were used to measure prevalence of  four dimensions of  HIV stigma since HIV \\ndiagnosis: disclosure concerns, concerns with public attitudes about HIV, personalized HIV stigma and \\nnegative self-image.\\n\\n ▪ The  most  common  types \\nof   stigma  were  disclosure \\nc o n c e r n s   ( 6 8 % )   a n d \\npersonalized stigma (49%).\\n ▪ Trans  women  had  higher \\ndisclosure  concerns  and \\npersonalized stigma compared \\nto men and women.\\n\\n ▪ All four stigma dimensions \\nwere  lower  for  those  55 \\nyears of  age and older.\\n\\n ▪ Concerns  with  public \\nattitudes,  personalized \\nstigma  and  negative  self-\\nimage  were  lowest  in \\npersons  self-identifying  as \\nlesbian or gay compared to \\nother sexual orientations.\\nIndividuals  experiencing \\nhomelessness  reported \\nhigher levels of  stigma for \\nall four stigma dimensions.\\n\\n ▪\\n\\n \\nr\\ne\\nd\\nn\\ne\\nG\\n\\n6\\ny\\nt\\ni\\nt\\nn\\ne\\nd\\n\\nI\\n\\n)\\ns\\nr\\na\\ne\\ny\\n(\\n \\ne\\ng\\nA\\n\\ny\\nt\\ni\\nc\\ni\\nn\\nh\\nt\\nE\\n/\\ne\\nc\\na\\nR\\n\\n \\n\\n-\\nf\\nl\\ne\\nS\\n\\nd\\ne\\ni\\nf\\ni\\nt\\nn\\ne\\nd\\n\\ni\\n\\n \\nl\\n\\na\\nu\\nx\\ne\\nS\\n\\nn\\no\\ni\\nt\\na\\nt\\nn\\ne\\ni\\nr\\nO\\n\\nn\\no\\ni\\nt\\na\\nc\\nu\\nd\\nE\\n\\n \\n\\ny\\nr\\nt\\nn\\nu\\no\\nC\\n\\nh\\nt\\nr\\ni\\nB\\n \\nf\\no\\n\\n \\n\\ne\\nc\\nn\\ni\\ns\\n \\ne\\nm\\nT\\n\\ni\\n\\n \\n\\nI\\n\\nV\\nH\\n\\ns\\ni\\ns\\no\\nn\\ng\\na\\nD\\n\\ni\\n\\n Disclosure \\nConcerns2\\n\\n Public \\nAttitudes3\\n\\n Personalized \\nStigma4          \\n\\nNegative \\nSelf-image5    \\n\\nTotal\\nMen\\nWomen\\nTrans Women\\n18 - 34\\n35 - 44\\n45 - 54\\n55+\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nMulti-race/Other\\nLesbian or gay\\nStraight or heterosexual\\nBisexual\\nOther\\n\\nLess than college\\n\\nBachelors degree or higher\\n\\nUS or Puerto Rico\\n\\nForeign born\\n<5 years\\n5 - 9 years\\n≥ 10 years\\n\\nHoused\\n\\nNumber\\n\\n545\\n505\\n30\\n9\\n48\\n81\\n173\\n243\\n301\\n71\\n110\\n30\\n33\\n419\\n66\\n40\\n17\\n\\n297\\n\\n244\\n\\n438\\n\\n103\\n61\\n86\\n398\\n\\n452\\n\\n68%\\n68%\\n74%\\n88%\\n78%\\n74%\\n68%\\n64%\\n66%\\n72%\\n70%\\n87%\\n62%\\n68%\\n74%\\n58%\\n87%\\n\\n62%\\n\\n76%\\n\\n67%\\n\\n75%\\n76%\\n80%\\n64%\\n\\n67%\\n\\nRow %\\n\\n49%\\n48%\\n52%\\n55%\\n48%\\n60%\\n55%\\n39%\\n54%\\n41%\\n43%\\n41%\\n45%\\n48%\\n51%\\n49%\\n63%\\n\\n49%\\n\\n49%\\n\\n50%\\n\\n46%\\n36%\\n59%\\n48%\\n\\n46%\\n\\n44%\\n43%\\n56%\\n52%\\n55%\\n51%\\n42%\\n40%\\n37%\\n49%\\n51%\\n52%\\n57%\\n41%\\n52%\\n55%\\n58%\\n\\n46%\\n\\n41%\\n\\n41%\\n\\n56%\\n48%\\n51%\\n42%\\n\\n41%\\n\\n27%\\n27%\\n29%\\n20%\\n27%\\n40%\\n27%\\n22%\\n24%\\n23%\\n30%\\n25%\\n51%\\n25%\\n31%\\n34%\\n30%\\n\\n29%\\n\\n24%\\n\\n26%\\n\\n33%\\n25%\\n37%\\n25%\\n\\n25%\\n\\n \\n\\ng\\nn\\ni\\ns\\nu\\no\\nH\\n\\n7\\ns\\nu\\nt\\na\\nt\\nS\\n\\n \\n\\nl\\n\\ne\\nv\\ne\\nL\\n\\ny\\nt\\nr\\ne\\nv\\no\\nP\\n\\nHomeless\\nAbove poverty level\\nAt or below poverty level\\n\\n34%\\n24%\\n33%\\n1  Stigma prevalence counted as “agree” or “strongly agree” to each stigma dimension as outlined below.\\n2   “I am very careful who I tell that I have HIV” or “I worry that people who know I have HIV will tell others.”\\n3  “Most people think that a person with HIV is disgusting” or “Most people with HIV are rejected when \\n\\n74%\\n69%\\n68%\\n\\n56%\\n39%\\n55%\\n\\n62%\\n46%\\n58%\\n\\n93\\n375\\n161\\n\\nothers find out.”\\n\\n4  “I have been hurt by how people reacted to learning I have HIV” or “I have stopped socializing with some \\npeople because of  their reactions of  my having HIV” or “I have lost friends by telling them I have HIV.”\\n5  “I feel that I am not as good a person as others because I have HIV” or “Having HIV makes me feel unclean” \\n\\nor “Having HIV makes me feel that I’m a bad person.”\\n\\n6  Gender identity is measured by self-reported sex at birth and current gender identity. Data for trans men \\n\\nnot shown in order to protect confidentiality due to small cell count.\\n\\n7  Homeless defined as living in a single room occupancy hotel (SRO), in a shelter, on the street or in a car at \\n\\nany point in the past 12 months.\\n\\n82  \\n\\nSTIGMA AMONG PERSONS WITH HIV\\n\\nTable 17.1 Prevalence of stigma measures1 by demographic factors, Medical Monitoring Project, 2015-2017, San Francisco\\x0c ▪\\n\\nFigure 17.1 shows that disclosure concerns among persons living with HIV in San Francisco went from \\n70% in 2015 to 62% in 2017.\\n\\n ▪ Concerns with public attitudes about HIV and personalized stigma stayed relatively stable from 2015 to 2017.\\n ▪ The prevalence of  negative self-image was 33% in 2015 and 21% in 2017.\\n ▪ Trends for stigma are difficult to assess because these measures account for any stigma experienced since \\n\\ntime of  HIV diagnosis.\\n\\ne\\nr\\nu\\ns\\na\\ne\\nm\\n \\na\\nm\\ng\\ni\\nt\\ns\\n \\nf\\no\\n \\ne\\nc\\nn\\ne\\nl\\na\\nv\\ne\\nr\\nP\\n\\n80%\\n\\n70%\\n\\n60%\\n\\n50%\\n\\n40%\\n\\n30%\\n\\n20%\\n\\n10%\\n\\n0%\\n\\n70%\\n\\n72%\\n\\n Disclosure Concerns\\n Personalized Stigma\\n\\n Public Attitudes\\nNegative Self-image\\n\\n56%\\n\\n46%\\n\\n33%\\n\\n41%\\n\\n40%\\n\\n27%\\n\\n62%\\n\\n50%\\n\\n44%\\n\\n21%\\n\\n2015 (N=165)\\n\\n2016 (N=195)\\n\\nMMP Cycle Year\\n\\n2017 (N=185)\\n\\n1  Stigma prevalence counted as “agree” or “strongly agree” to each stigma dimension as outlined below.\\n2   “I am very careful who I tell that I have HIV” or “I worry that people who know I have HIV will tell others.”\\n3  “Most people think that a person with HIV is disgusting” or “Most people with HIV are rejected when others find out.”\\n4  “I have been hurt by how people reacted to learning I have HIV” or “I have stopped socializing with some people because of  their reactions of  my having HIV” \\n\\n5  “I feel that I am not as good a person as others because I have HIV” or “Having HIV makes me feel unclean” or “Having HIV makes me feel that I’m a bad \\n\\nor “I have lost friends by telling them I have HIV.”\\n\\nperson.”\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  83\\n\\nFigure 17.1 Prevalence of stigma measures1 by Medical Monitoring Project, 2015-2017, San Francisco\\x0c18\\n\\nGeographic Distribution of Persons \\nwith HIV\\n\\n ▪ Approximately 38% of persons living with HIV (PLWH) who resided in San Francisco at time of diagnosis \\n\\nhave since moved out of  the city.\\n\\n ▪ There were 12,754 current San Francisco residents living with HIV as of  December 31, 2018, regardless of  \\ntheir residence at HIV diagnosis. By neighborhood, Castro had the highest number of  PLWH (N=1,944) \\nfollowed by Tenderloin (N=1,562) and Western Addition (N=1,341). \\n\\n ▪ The Castro, Tenderloin, and South of  Market neighborhoods had census tracts with the highest numbers \\nof  PLWH (shown in the darker shades of  green). The South of  Market census tract along Market Street \\nhad the largest number of  PLWH (N=413) followed by four census tracts in the Castro. The Tenderloin \\nalso contains smaller census tracts with a high number of  PLWH, a reminder of  the higher density of  \\npersons in these areas.   \\n\\n1  The current address for PLWH was geocoded and displayed at census tract and neighborhood level on the map. The most current address is taken from the \\ndataset dated on April 15, 2019 and may reflect addresses after December 31, 2018. Last known addresses are obtained through chart review, laboratory reports, \\nand communications with other jurisdictions.\\n\\n84  \\n\\nGEOGRAPHIC DISTRIBUTION OF PERSONS WITH HIV\\n\\nPacificHeightsDowntownNobHillTenderloinWesternAdditionSouth ofMarketRichmondPotrero HillMissionCastroHaightAshburyNoe ValleyBayviewBernalHeightsDiamondHeightsTwinPeaksVisitacionValleyExcelsiorOuterMissionInglesideLakeMercedSunsetPresidioTreasure IslandGolden Gate ParkGolden GateBridgePacificOceanSan FranciscoBaySan Francisco-OaklandBay BridgeHomeless PLWH (N=506) and PLWH with unknown or invalid addresses (N=385) are not displayed*Data not shown (Censustracts with population totals less than 500)250 - 413170 - 25090 - 16940 - 892 - 39Number of Persons Living with HIVMap 18.1 Geographic distribution1 of persons living with HIV who resided in San Francisco as of December 2018\\x0c ▪ The Castro had the highest HIV prevalence of  8,174 per 100,000, followed by the Tenderloin (3,982 per \\n\\n100,000), South of Market (3,841 per 100,000) and Western Addition (3,312 per 100,000).\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  85\\n\\nData not shown for neighborhoods with populations less than 5004001 - 81742000 - 40001001 - 2000398 - 1000HIV Prevalence per 100,000 populationPacificHeightsDowntownNobHillTenderloinWesternAdditionSouth ofMarketRichmondPotrero HillMissionCastroHaightAshburyNoe ValleyBayviewBernalHeightsDiamondHeightsTwinPeaksVisitacionValleyExcelsiorOuterMissionInglesideLakeMercedSunsetPresidioTreasure IslandGolden Gate ParkGolden GateBridgePacificOceanSan FranciscoBaySan Francisco-OaklandBay BridgeMap 18.2 HIV prevalence per 100,000 population by neighborhood, 2018, San Francisco\\x0c ▪ The Tenderloin had the highest rate of  new diagnoses1 in 2017-2018 (138 per 100,000), followed by the \\n\\nCastro (126 per 100,000) and South of Market neighborhoods (91 per 100,000).  \\n\\n1  Two-year diagnosis rate numerators represent two years of  diagnosed cases.\\n\\n86  \\n\\nGEOGRAPHIC DISTRIBUTION OF PERSONS WITH HIV\\n\\nData not shown for neighborhoods with less than 15 cases diagnosed in the two-year period92 - 13857 - 9124 - 5613 - 23Number of HIV cases per 100,000PacificHeightsDowntownNobHillTenderloinWesternAdditionSouth ofMarketRichmondPotrero HillMissionCastroHaightAshburyNoe ValleyBayviewBernalHeightsDiamondHeightsTwinPeaksVisitacionValleyExcelsiorOuterMissionInglesideLakeMercedSunsetPresidioTreasure IslandGolden Gate ParkGolden GateBridgePacificOceanSan FranciscoBaySan Francisco-OaklandBay BridgeMap 18.3 Geographic distribution of rates of HIV diagnosis per 100,000 population per two years for persons newly diagnosed in 2017-2018, San Francisco\\x0c ▪\\n\\n Overall, 74% of  PLWH were virally suppressed in 2017. All but seven neighborhoods were above this \\noverall mark. These seven neighborhoods include Treasure Island (60%), Tenderloin (69%), Pacific Heights \\n(71%), South of Market (72%), Bayview and Nob Hill (73% each), and Downtown (74%). \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  87\\n\\nPacificHeightsDowntownNobHillTenderloinWesternAdditionSouth ofMarketRichmondPotrero HillMissionCastroHaightAshburyNoe ValleyBayviewBernalHeightsDiamondHeightsTwinPeaksVisitacionValleyExcelsiorOuterMissionInglesideLakeMercedSunsetPresidioTreasure IslandGolden Gate ParkGolden GateBridgePacificOceanSan FranciscoBaySan Francisco-OaklandBay Bridge38% of homeless PLWH and 46% of PLWH with unknown or invalid addresses were virally suppressed in 2017 (not displayed)*Data not shown (Neighborhoods with fewer than 15 cases)78.1% - 100%74.1% - 78%59.5% - 74%Percent virallysuppressedMap 18.4 Geographic distribution of proportion of persons living with HIV as of December 2017 and diagnosed through 2016 who were virally suppressed in 2017, San Francisco\\x0c ▪\\n\\n ▪\\n\\nFrom 2013 to 2017, 80% of  the 1,533 newly diagnosed San Francisco residents were linked into care within \\none month of  their diagnosis.\\nLake Merced had the lowest linkage to care proportion (67%) followed by South of  Market (71%) and \\nDiamond Heights (72%). \\n\\n88  \\n\\nGEOGRAPHIC DISTRIBUTION OF PERSONS WITH HIV\\n\\nPacificHeightsDowntownNobHillTenderloinWesternAdditionSouth ofMarketRichmondPotrero HillMissionCastroHaightAshburyNoe ValleyBayviewBernalHeightsDiamondHeightsTwinPeaksVisitacionValleyExcelsiorOuterMissionInglesideLakeMercedSunsetPresidioTreasure IslandGolden Gate ParkGolden GateBridgePacificOceanSan FranciscoBaySan Francisco-OaklandBay Bridge77% of persons who were homeless at diagnosis and 66% of persons with invalid or unknown addresses at diagnsis were linked to care within one month (not displayed)*Data not shown (Neighborhoods with fewer than 15 cases)85.1% - 94.6%80.2% - 85.0%66.7% - 80.1%Percent linked to HIV careMap 18.5 Geographic distribution of proportion of persons newly diagnosed with HIV in 2013-2017 who were linked to care within one month of diagnosis, San Francisco\\x0c ▪ Among newly diagnosed San Francisco residents from 2013 to 2017, 75% reached viral suppression within \\n\\n12 months after HIV diagnosis.\\nSeven neighborhoods had viral suppression below this overall level. The Visitacion Valley neighborhood \\nhad the lowest proportion virally suppressed (62%), followed by Diamond Heights (64%), Potrero Hill \\n(65%), and South of Market (67%). \\n\\n ▪\\n\\n ▪ Despite showing high linkage in care after diagnosis, newly diagnosed residents of  Potrero Hill did not \\n\\nsuccessfully achieved viral suppression.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  89\\n\\nPacificHeightsDowntownNobHillTenderloinWesternAdditionSouth ofMarketRichmondPotrero HillMissionCastroHaightAshburyNoe ValleyBayviewBernalHeightsDiamondHeightsTwinPeaksVisitacionValleyExcelsiorOuterMissionInglesideLakeMercedSunsetPresidioTreasure IslandGolden Gate ParkGolden GateBridgePacificOceanSan FranciscoBaySan Francisco-OaklandBay Bridge58% of persons who were homeless at HIV diagnosis and 60% of persons with unknown or invalid addresses achieved viral suppression within 12 months (not displayed) *Data not shown (Neighborhoods with fewer than 15 cases)81.0% - 90.0%75.3% - 80.9%61.6% - 75.2%Percent virally suppressedMap 18.6 Geographic distribution of proportion of persons newly diagnosed with HIV in 2013-2017 who achieved viral suppression within 12 months of diagnosis, San Francisco\\x0cT \\n\\nTechnical Notes\\n (in alphabetic order by topic)\\n\\nCD4-based Model\\n\\nThe CD4-based model uses HIV surveillance data and the first CD4 value after diagnosis to estimate HIV \\nincidence  (diagnosed  and  undiagnosed  persons  newly  acquired  HIV),  HIV  prevalence  (diagnosed  and \\nundiagnosed persons living with HIV), and percentage of  undiagnosed infections.\\n\\nThe date of  HIV acquisition is estimated for each person with a CD4 test by using a CD4 depletion model1. \\nTo account for persons without a CD4 test result, persons with CD4 test results are assinged a weight based on \\nthe year of HIV diagnosis, sex, race/ethnicity, transmission category, age at diagnosis, disease classification, and \\nvital status at the end of  the specified year. Then, based on the estimated time from HIV infection to diagnosis, \\nthe diagnosis delay distribution can be estimated by using standard survival analysis for right truncated data \\nand used to estimate annual HIV incidence, which includes persons with diagnosed and undiagnosed infection.\\n\\nHIV prevalence, which represents counts of  persons with diagnosed or undiagnosed HIV infection who were \\nalive at the end of a given year, is estimated by subtracting reported cumulative deaths from cumulative infections.\\nThe number of  persons with undiagnosed HIV infection is estimated by subtracting the number of  persons \\nliving with diagnosed infection from total prevalence. The percentage of diagnosed (or undiagnosed) infections \\nis determined by dividing the number of  persons living with diagnosed (or undiagnosed) infections by the total \\nprevalence for each year.\\n\\nThe CD4 model relies on a series of  assumptions: (1) the CD4 depletion model is accurate; (2) persons \\nreceived no treatment before the first CD4 test; (3) all data adjustments (e.g., multiple imputation for missing \\nvalues of  transmission category, weighting to account for cases without a CD4 test) are unbiased; and (4) a \\nperson’s infection, diagnosis, and death occur in a “closed” population (no migration) or balanced population \\n(approximately the same number of  infected people moved into or out of  the area under consideration).\\n\\nDate of Initial HIV Diagnosis\\n\\nThe date of  HIV diagnosis for newly diagnosed cases is determined based on the earliest date of  any of  the \\nfollowing: positive HIV antibody test, positive HIV antigen/antibody combination test, detectable viral load \\ntest, or physician-documented diagnosis in absence of  sufficient laboratory evidence. The date of  initial HIV \\ndiagnosis for assessing trends in new HIV diagnoses in this report takes into account patient self-report of  \\na positive HIV test as noted in the medical record that was prior to the confirmed HIV diagnosis made by \\nlaboratory or clinical evidence. However, CD4 or undetectable viral load tests prior to the confirmed HIV \\ndiagnosis are not used to determine date of  initial HIV diagnosis. Data for the most recent year should be \\ninterpreted with caution as the number of  cases diagnosed may be underestimated due to reporting delays. \\n\\n1  Song R, Hall HI, Green TA, Szwarcwald CL, Pantazis N. Using CD4 Data to Estimate HIV Incidence, Prevalence, and Percent of  Undiagnosed Infections in \\n\\nthe United States. J Acquir Immune DeficSyndr. 2017 Jan 1; 74(1):3-9.\\n\\n90  \\n\\nTECHNICAL NOTES\\n\\n\\x0cDeath Ascertainment \\n\\nDeath information among persons reported with HIV is obtained through the following mechanisms: (1) \\nmonthly matches with local vital statistics registry, (2) Social Security Death Master File (3) National Death \\nIndex (NDI), (4) medical record review, (5) notification from other health department, and (6) matches with \\nother disease registry databases. Matches to the NDI occur twice per calendar year, once through the NDI Early \\nRelease Program (https://www.cdc.gov/nchs/ndi/ndi_early_release.htm), and once through the NDI final file. \\n\\nCause of death information on death certificates is summarized and coded using the International Classification \\nof  Diseases, 10th revision (ICD-10) for deaths that occurred since 1999. A single cause of  death is identified \\nfrom all reported conditions that began the chain of events that resulted in death; this is known as the underlying \\ncause of death (https://www.cdc.gov/nchs/ndi/index.htm [accessed August 14, 2019]). All conditions (including \\nthe underlying cause of  death) listed on the death certificate are known as the multiple causes of  death (http://\\nwww.cdc.gov/nchs/icd/icd10.htm). We obtained the ICD codes from annual matches to the NDI from 1999 \\nto 2017. Decedents through 2017 have been matched to the NDI final file; cause of  death information in this \\nreport is available for deaths through 2017. NDI information for 2018 decedents was not available at the time \\nof  this report’s preparation. Data for deaths in 2018 are provisional.\\n\\nDeaths classified as B20-B24 and all AIDS-related opportunistic infections and cancers listed on the death \\ncertificate were included in the HIV-related classification. Deaths classified as R99 (ill-defined and unknown \\ncause of  mortality) were included in the non-HIV-related classification. Cause of  death information in the \\nNDI Early Release file may later be reclassified in the NDI final file. \\n\\nCause of  death information for racial subgroups such as Asian, Pacific Islander, Native American, and multi-\\nracial decedents was not displayed due to many small cells.\\n\\nEstimate of ART Use\\n\\nInformation on ART use is obtained from medical chart review. Using surveillance data to estimate use of  \\nART will most likely result in an underestimate of  ART use. The underestimate occurs because use of  ART \\nis collected at the time a person with HIV infection is reported (which is often close to the time that they are \\ndiagnosed), a time when some people have not yet begun treatment. The San Francisco Department of  Public \\nHealth (SFDPH) collects follow-up information from selected health care facilities. For persons who receive \\ncare at these sites, treatment data are likely to be more complete because it allows us to capture the use of  ART \\nafter diagnosis and the date the case report was completed. Follow-up information is not available for persons \\nwho have moved away from San Francisco or who receive ongoing care outside of  the city. Surveillance data \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  91\\n\\n\\x0cprovide information that indicates when a person was prescribed ART but does not provide information on \\nadherence. Persons whose medical records indicate that they were prescribed ART are assumed to have received it.\\n\\nThe lower level estimate of  ART use (Table 3.7 on page 26) was calculated among all cases living with HIV. \\nThe upper level estimate (Table 3.7 on page 26, Figure 3.4 on page 27) was calculated among cases who \\nhad follow-up information within the last two years, whose chart review was completed between January 2017 \\nand April 2019, and who were not known to have moved out of  San Francisco.\\n \\nFemale Presumed Heterosexual Contact\\n \\nIn 2010 the CDC HIV Incidence and Case Surveillance Branch accepted a definition for female presumed \\nheterosexual contact to reclassify the transmission category for adult female cases who would otherwise be \\nreported with no identified risk. The definition for female presumed heterosexual contact was first proposed \\nby the Council of  State and Territorial Epidemiologists2. Like other transmission categories, the definition \\nuses patient history variables collected on the HIV adult case report form. The female presumed heterosexual \\ncontact definition includes the following components: (1) the patient’s sex at birth is female, (2) the patient \\nhad sex with male(s), (3) the patient had no indication of  injection drug use, and (4) there is no other known \\ninformation that would suggest a likely alternative source of  HIV infection. \\n\\nGender Status\\n\\nAs part of  routine HIV case surveillance, sex at birth is collected. People who are classified as female at birth \\nand have no other gender identity noted are classified as women. People who are classified as male at birth \\nand have no other gender identity noted are classified as men. In September 1996, SFDPH began collecting \\ntransgender status when this information is contained in the medical record. Transgender individuals are listed \\nas either trans women or trans men. Due to the small number of  cases among trans men and small population \\nsize, data on trans men are sometimes suppressed in this report to protect confidentiality. We believe that our \\nreport likely underestimates the number of  trans women and trans men affected by HIV because data collected \\nfor HIV reporting are derived from the medical record. Consequently, information that may be discussed with \\nthe health care provider but not recorded in the medical record is generally not available for the purposes of  \\nHIV case reporting.\\n\\nGrouping of Data Categories\\n\\nData in certain racial/ethnic or risk categories are grouped together when the number of  persons with HIV \\nin that particular group is small and/or does not present significant trends. For example, “Other” in the \\nRace/Ethnicity breakdown in some tables or figures represents Asian/Pacific Islander, Native American, and \\n\\n2  Council of  State and Territorial Epidemiologists Positions statements 2007: Heterosexual HIV transmission classification. Available from http://c.ymcdn.com/\\n\\nsites/www.cste.org/resource/resmgr/PS/07-ID-09.pdf\\n\\n92  \\n\\nTECHNICAL NOTES\\n\\n\\x0cpeople of  multiple race. Whenever possible, this report presents the expanded racial/ethnic categories rather \\nthan aggregating into the group “Other.” The label “Other” in the Transmission Category breakdown may \\ninclude transfusion recipients, hemophiliacs, heterosexuals, persons acquiring HIV perinatally, or persons of  \\nunidentified risk.\\n\\nHIV and STD Co-infection\\n\\nThe diagnosis of  STD among PLWH was determined through a computerized match of  the SFDPH HIV and \\nSTD case registries. The data from the STD registry included persons reported with gonorrhea, chlamydia, \\nnon-gonococcal urethritis, or infectious syphilis. All STD occurred after the HIV diagnosis.\\n\\nHIV Care Outcomes and Definitions\\n\\nThe SFDPH monitors engagement in care and care outcomes among persons newly diagnosed and living with \\nHIV using reports of  CD4, viral load and genotype tests as indicators of  care, and viral load test results to \\nmeasure viral suppression, defined as a viral load less than 200 copies/mL. For new diagnoses, linkage to care \\nwithin 30 days of  diagnosis, retention in care 3-9 months after linkage, and viral suppression within 12 months \\nof  diagnosis were assessed. For PLWH, receipt of  care (one laboratory test), retention in care (two laboratory \\ntests) and viral suppression in the specified calendar year were assessed.\\n \\nComplete laboratory reporting of  HIV-related test results is critical to evaluating care outcomes and data-to-\\ncare activities (using HIV surveillance and other data sources to identify persons with HIV who may not be \\nin care, conduct outreach, and provide linkage to care and other support or prevention services). Incomplete \\ncare information may result for persons who received care outside of  San Francisco or participated in research \\nstudies in which the test results were not reported to SFDPH (Note California laws require laboratory to report \\nall HIV-related test results to the local health department where the provider is located). In addition, some \\npatients may be in care but do not have any laboratory tests performed in the time period assessed.\\n\\nHIV Case Rates and HIV Mortality Rates\\n\\nAnnual race-specific rates are calculated as the number of  cases diagnosed for a particular racial/ethnic group \\nduring each year divided by the San Francisco population for that race/ethnicity, multiplied by 100,000. Age-\\nadjusted mortality rates are calculated for persons 18 and over. For each race/ethnicity and sex group, the \\nnumber of  HIV cases who died each year was divided by projected San Francisco population estimates across \\nseven age groups (18-29, 30-39, 40-49,50-59,60-69,70-79, 80+) to generate crude rates applied to the standard \\npopulation, defined using the California population estimates from the Department of  Finance. These rates \\nare calculated separately for males and females. The annual populations are not available for transgender \\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  93\\n\\n\\x0cpersons. Population denominators by year are obtained from the State of  California, Department of  Finance, \\nDemographic Research Unit, in two sources: the California Intercensal Population Estimates3 and California \\nPopulation Projections4 (http://www.dof.ca.gov/Forecasting/Demographics/Projections/). \\n\\nHIV Disease Stage 3 (AIDS) Survival\\n\\nSurvival was calculated as the time between the date of  HIV stage 3 (AIDS) diagnosis and the date of  death. \\nThis analysis included persons who met the case definition for HIV disease stage 3 (AIDS). The follow-up \\ninformation for cases was obtained through retrospective and prospective reviews of  laboratory records and \\nmedical charts. Dates of  death were obtained through review of  local death certificates, reports from other \\nhealth departments, and matches with the National Death Index (NDI) and Social Security death files. The \\nmost recent NDI and Social Security death file matches included deaths that occurred through December 31, \\n2017. Survival reflects deaths that are HIV as well as non-HIV related. Persons not known to have died were \\ncensored on the date of their last known follow-up or on December 31, 2017, whichever was more recent.\\n\\nHIV Surveillance Methods\\n\\nSan Francisco HIV cases are reported primarily through active surveillance activities in which public health \\npersonnel review laboratory and pathology reports and medical records to identify cases and complete the case \\nreport forms. HIV cases are also identified through passive reporting, review of  death certificates, validation \\nstudies using secondary data sources such as hospital billing records or other disease registries, and reports \\nfrom other health departments. HIV cases are routinely de-duplicated with other California counties, states, \\nand U.S. territories. The surveillance system is evaluated regularly for completeness, timeliness, and accuracy. \\n\\nThe completeness of  case reporting of  HIV diagnoses in 2017 was evaluated (at 12 months after the diagnosis \\nyear) and found to be 98% (using CDC-developed reporting delay model). In terms of  timeliness, an estimated \\n97% of  2017 diagnoses were reported within six months of  HIV diagnosis.\\n\\nThe HIV data in this report include persons who were residents of San Francisco at the time they were diagnosed \\nwith HIV (all disease stages) including San Francisco residents who were diagnosed in other jurisdictions. Within \\nSection One and Three, this report also describes counts of  cases who resided outside San Francisco but were \\ndiagnosed by a provider or facility within San Francisco (out-of-jurisdiction, OOJ, residents) or cases who were \\ndiagnosed elsewhere but moved to San Francisco after their diagnosis. San Francisco started name-based case \\nreporting for HIV cases in April 2006, as mandated by California law. Beginning in 2009 case surveillance and \\nreporting of  OOJ residents newly diagnosed with HIV was conducted in the same manner as San Francisco \\nresidents. All cases included in this report were reported confidentially by name.\\n\\n3  State of  California, Department of  Finance, Race/Hispanics Population with Age and Gender Detail, 2000–2010. Sacramento, California, September 2012.\\n4  State of  California, Department of  Finance, Report P-3: State and County Population Projections by Race/Ethnicity, Detailed Age, and Gender, 2010-2060. \\n\\nSacramento, California, December 2014.\\n\\n94  \\n\\nTECHNICAL NOTES\\n\\n\\x0cHousing Status and Current Address\\n\\nThe housing status for HIV cases is determined through collection of  address at time of  diagnosis and current \\naddress through laboratory reports, passive case reports, medical record review, death certificates, and reports \\nfrom other health departments. A person is defined as homeless if: (1) the medical record states that the patient \\nis homeless or not housed or (2) the person’s address is a known homeless shelter or Navigation Center. \\n\\nPersons with missing address information are not classified as homeless. Persons are also considered “not \\nhomeless” if  they reside in (1) single room occupancy (SRO) facility, (2) transitional housing, (3) partner’s, \\nfamily member’s, or other non-family member’s residence, (4) institutional facility (examples: hospice, inpatient \\ndrug/alcohol recovery facility, facility housing physically/mentally disabled, residential treatment program, \\ncorrectional facility, long-term care facility). \\n\\nLinkage Integration Navigation Comprehensive Services\\n\\nLinkage Integration Navigation Comprehensive Services (LINCS) is a program maintained by SFDPH that \\nhelps PLWH re-engage with care. Since 2011, health care navigators on the LINCS team have worked at \\nSan Francisco City Clinic and other SFDPH sites to address patient needs, including difficulties in finding \\ninsurance, attending care appointments and adhering to medication. Patients may come to LINCS through \\ndirect referral by a provider or, more recently, through not-in-care lists generated from HIV surveillance or \\nmedical record databases. LINCS programmatic data were used to define patient’s gender, race/ethnicity \\nand housing status. Trans women were defined as either being transgender in HIV surveillance or in LINCS \\nprogrammatic data. Transmission category was determined from HIV surveillance data.\\n\\nMedical Monitoring Project\\n\\nThe  Medical  Monitoring  Project  (MMP)  is  an  ongoing  CDC-funded  national  HIV/AIDS  supplemental \\nsurveillance project. San Francisco is one of  23 project areas currently conducting MMP. Two-stage sampling is \\nused to sample adults with diagnosed HIV and a most recent address reported in the National HIV Surveillance \\nSystem of  San Francisco. Information about care utilization, clinical outcomes, resource needs, and HIV risk \\nbehaviors is collected through patient interviews and medical chart review. Interview and medical record \\nabstraction data from 545 participants from the 2015-2017 San Francisco MMP cycles were used in this report. \\nData were weighted for the probability of  selection, non-response and reporting delay. Prevalence estimates \\nare weighted percentages and might not sum to 100 because of rounding.\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  95\\n\\n\\x0cResidence and Receipt of Care for PLWH\\n\\nThe overall number of  PLWH in San Francisco is affected by 1) out-migration: San Francisco residents at \\nthe time of  diagnosis who later moved out of  San Francisco, and 2) in-migration: OOJ residents at the time \\nof  diagnosis who moved to and received care in San Francisco. Because in- and out-migration occur and the \\nresidence at time of  diagnosis may differ from the current residence among PLWH, SFDPH collects and \\nupdates information regarding current residence for PLWH who resided in San Francisco at time of  diagnosis \\nas well as PLWH who resided elsewhere at time of diagnosis but receive care in San Francisco. \\n\\nCare indicators (defined by using CD4, viral load, or genotype tests) were assessed for both PLWH who were \\nSan Francisco residents at diagnosis (Table 3.3 on page 22) and PLWH known to reside in San Francisco, \\nbased on their most recent available residence at the end of  the calendar year assessed, regardless of  their \\nresidence at time of  diagnosis (Table 3.4 on page 22). The latter excludes San Francisco residents at diagnosis \\nwho subsequently moved outside of  San Francisco and includes persons who resided elsewhere at time of  \\nHIV diagnosis and moved to San Francisco after diagnosis. \\n\\nThe extent of  care utilization and HIV case migration patterns cannot be fully understood until more complete \\nlaboratory and residence information is collected and shared between jurisdictions.  \\n\\nStage of Disease at HIV Diagnosis\\n\\nIn 2014, the United States surveillance case definition5 for HIV infection among adults and adolescents aged \\n≥13 years and children age<13 years was revised to expand the HIV infection classification staging system to \\nfive stages of  HIV infection as described below. With the new case definition, stages 1-3 are classified on the \\nbasis of  the first CD4 T-lymphocyte count and age on date of  CD4 T-lymphocyte test, unless there is a stage-\\n3-defining opportunistic illness. The CD4 T-lymphocyte percentage of  total lymphocytes is only used when \\nthe corresponding CD4 T-lymphocyte count is unknown.\\n\\n•  HIV infection stage 0: This stage is early HIV infection and is established by a sequence of  discordant \\nHIV test results indicative of  early HIV infection. The criteria for stage 0 infection can be established \\nby a testing history of  1) a confirmed HIV positive test that occurs 180 days or less after a negative or \\nindeterminate test for HIV infection, 2) a negative or indeterminate HIV antibody test is on or less than \\n180 days before a positive HIV virologic test and on or less than 60 days after a positive HIV antibody \\ntest, or 3) a negative or indeterminate HIV antibody test is on or less than 60 days after a positive HIV \\nvirologic test. This sequence of  discordant results may be based on testing history (previous laboratory \\ndocumented or patient’s self-report of  negative/indeterminate results), or by a HIV testing algorithm. \\nIf  the criteria for stage 0 are met, the stage is 0 (supersedes other stages) regardless of  criteria for other \\nstages (CD4 T-lymphocyte test results and opportunistic illness diagnoses).\\n\\n5  Selik RE, Mokotoff  ED, Branson B, Owen SM, Whitmore S, Hall HI. Revised Surveillance Case Definitions for HIV Infection -- United States, 2014. MMWR \\n\\n2014;63(No. RR-3):1-10.\\n\\n96  \\n\\nTECHNICAL NOTES\\n\\n\\x0c•  HIV infection stage 1-3: HIV infection stage 1-3 is based on age-specific CD4 T-lymphocyte count or \\n\\nCD4 T-lymphocyte percentage of  total lymphocytes.\\n\\nAge on date of  CD4 T-lymphocyte test\\n\\n<1 year\\n\\n1-5 years\\n\\n≥6 years\\n\\nStage  Cells/ μL\\n≥1,500\\n750-1,499\\n\\n<750\\n\\n1\\n2\\n3\\n\\n%\\n≥34\\n26-33\\n<26\\n\\nCells/ μL\\n≥1,000\\n500-999\\n<500\\n\\n%\\n≥30\\n22-29\\n<22\\n\\nCells/ μL\\n\\n≥500\\n200-499\\n<200\\n\\n%\\n≥26\\n14-25\\n<14\\n\\nData on persons with HIV infection, stage 3 (AIDS) include persons whose infection has ever been \\nclassified as stage 3 (AIDS).\\n\\n•  HIV infection, stage unknown: No information available on CD4 count or percentage and no reported \\ninformation on AIDS-defining conditions (every effort is made to collect CD4 counts or percentages \\nat time of  diagnosis).\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  97\\n\\n\\x0cD \\n\\nData Tables\\n\\nFigure 1.1  HIV disease stage 3 (AIDS) cases, deaths, and prevalence, 1980-2018, \\nSan Francisco  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 2\\n\\nYear\\nHIV disease stage 3 cases\\nHIV disease stage 3 deaths\\nPersons living with HIV ever \\nclassified as stage 3\\n\\nYear\\nHIV disease stage 3 cases\\nHIV disease stage 3 deaths\\nPersons living with HIV ever \\nclassified as stage 3\\n\\nYear\\nHIV disease stage 3 cases\\nHIV disease stage 3 deaths\\nPersons living with HIV ever \\nclassified as stage 3\\n\\nYear\\nHIV disease stage 3 cases\\nHIV disease stage 3 deaths\\nPersons living with HIV ever \\nclassified as stage 3\\n\\n1980 1981 1982 1983 1984 1985 1986 1987 1988 1989\\n1237 1636 1763 2158\\n807\\n1038 1279\\n\\n274\\n111\\n\\n557\\n273\\n\\n859\\n534\\n\\n26\\n8\\n\\n99\\n32\\n\\n878\\n\\n3\\n0\\n\\n3\\n\\n21\\n\\n88\\n\\n251\\n\\n535\\n\\n860\\n\\n1290 2048 2773 3652\\n\\n1990 1991 1992 1993 1994 1995 1996 1997 1998 1999\\n575\\n2042 2284 2326 2065 1777 1555 1069\\n1363 1512 1639 1603 1600 1485\\n994\\n353\\n\\n795\\n424\\n\\n690\\n401\\n\\n4331 5103 5790 6252 6429 6499 6574 6945 7234 7456\\n\\n2000 2001 2002 2003 2004 2005 2006 2007 2008 2009\\n324\\n552\\n350\\n209\\n\\n510\\n324\\n\\n487\\n322\\n\\n551\\n297\\n\\n480\\n307\\n\\n477\\n312\\n\\n451\\n288\\n\\n445\\n270\\n\\n435\\n227\\n\\n7658 7844 8009 8263 8436 8601 8764 8939 9147 9262\\n\\n2010 2011  2012  2013 2014 2015 2016 2017 2018\\n300\\n113\\n146\\n193\\n\\n252\\n190\\n\\n243\\n182\\n\\n190\\n192\\n\\n139\\n189\\n\\n126\\n203\\n\\n97\\n186\\n\\n128\\n202\\n\\n9369 9431 9492 9490 9440 9363 9274 9200 9167\\n\\nFigure 2.1  Number of persons newly diagnosed with HIV by race/ethnicity, 2009-\\n2018, San Francisco .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 13\\n\\nWhite\\nAfrican American\\nLatinx\\nAsian/Pacific Islander\\nOther/Unknown\\n\\n2009\\n227\\n63\\n114\\n41\\n27\\n\\n2010\\n224\\n63\\n108\\n41\\n31\\n\\n2011\\n220\\n65\\n85\\n36\\n19\\n\\n2012\\n228\\n50\\n113\\n52\\n22\\n\\n2013\\n181\\n48\\n104\\n49\\n17\\n\\n2014\\n135\\n33\\n94\\n44\\n15\\n\\n2015\\n113\\n41\\n75\\n35\\n17\\n\\n2016\\n90\\n34\\n69\\n35\\n6\\n\\n2017\\n82\\n38\\n65\\n29\\n13\\n\\n2018\\n58\\n42\\n74\\n16\\n7\\n\\n98  \\n\\nDATA TABLE\\n\\n\\x0cFigure 2.2  Annual rates of men newly diagnosed with HIV per 100,000 population \\nby race/ethnicity, 2009-2018, San Francisco   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 14\\n\\nWhite\\nAfrican American\\nLatino\\nAsian/Pacific Islander\\n\\n2009\\n118\\n191\\n149\\n30\\n\\n2010\\n115\\n203\\n148\\n29\\n\\n2011\\n111\\n191\\n108\\n26\\n\\n2012\\n118\\n150\\n151\\n40\\n\\n2013\\n89\\n163\\n142\\n33\\n\\n2014\\n65\\n130\\n122\\n32\\n\\n2015\\n53\\n126\\n95\\n26\\n\\n2016\\n41\\n97\\n82\\n26\\n\\n2017\\n36\\n114\\n79\\n19\\n\\n2018\\n27\\n145\\n89\\n11\\n\\nFigure 2.3  Annual rates of women newly diagnosed with HIV per 100,000 population \\nby race/ethnicity, 2009-2018, San Francisco   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 14\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\nWhite\\nAfrican American\\nLatina\\nAsian/Pacific Islander\\n\\n5\\n42\\n19\\n1\\n\\n8\\n39\\n12\\n3\\n\\n9\\n65\\n15\\n1\\n\\n2\\n30\\n17\\n1\\n\\n5\\n30\\n8\\n0\\n\\n4\\n4\\n7\\n1\\n\\n5\\n30\\n10\\n1\\n\\n4\\n43\\n8\\n2\\n\\n4\\n44\\n9\\n0\\n\\n2\\n35\\n8\\n0\\n\\nFigure 2.4  Number of men newly diagnosed with HIV by transmission category, \\n2009-2018, San Francisco  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 15\\n\\nMSM\\nPWID\\nMSM-PWID\\nHeterosexual\\nUnknown\\n\\n2009\\n315\\n14\\n72\\n8\\n11\\n\\n2010\\n293\\n24\\n63\\n20\\n14\\n\\n2011\\n294\\n12\\n53\\n9\\n3\\n\\n2012\\n348\\n15\\n50\\n10\\n7\\n\\n2013\\n299\\n11\\n46\\n6\\n3\\n\\n2014\\n233\\n15\\n39\\n8\\n2\\n\\n2015\\n206\\n6\\n24\\n7\\n4\\n\\n2016\\n160\\n9\\n22\\n7\\n3\\n\\n2017\\n136\\n16\\n28\\n6\\n8\\n\\n2018\\n124\\n21\\n20\\n4\\n5\\n\\nFigure 2.5  Number of women newly diagnosed with HIV by transmission category, \\n2009-2018, San Francisco  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 15\\n\\nPWID\\nHeterosexual\\nUnknown\\n\\n2009\\n11\\n17\\n2\\n\\n2010\\n14\\n18\\n4\\n\\n2011\\n16\\n21\\n4\\n\\n2012\\n\\n6\\n16\\n1\\n\\n2013\\n10\\n10\\n2\\n\\n2014\\n10\\n3\\n0\\n\\n2015\\n11\\n13\\n3\\n\\n2016\\n11\\n9\\n4\\n\\n2017\\n10\\n10\\n7\\n\\n2018\\n\\n6\\n6\\n5\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  99\\n\\n\\x0cFigure 5.1  Age-adjusted mortality rates among persons aged 18 and older with HIV \\nper 100,000 by sex and race/ethnicity, 2008-2017, San Francisco .  .  .  43\\n\\nWhite men\\nAfrican American men\\nLatino men\\n\\n2008 2009 2010 2011 2012 2013 2014 2015 2016 2017\\n94\\n95\\n194\\n148\\n65\\n76\\n\\n95\\n179\\n66\\n\\n98\\n163\\n64\\n\\n79\\n193\\n70\\n\\n92\\n163\\n69\\n\\n90\\n150\\n85\\n\\n86\\n178\\n78\\n\\n86\\n165\\n64\\n\\n85\\n169\\n50\\n\\nWhite women\\nAfrican American women\\nLatina women\\n\\n9\\n75\\n2\\n\\n5\\n50\\n2\\n\\n2\\n57\\n4\\n\\n3\\n55\\n4\\n\\n6\\n48\\n3\\n\\n7\\n75\\n12\\n\\n3\\n64\\n8\\n\\n6\\n58\\n7\\n\\n5\\n71\\n15\\n\\n6\\n43\\n10\\n\\nFigure 6.2  Trends in health insurance status at time of HIV diagnosis by race/ethnicity, \\n2014-2018, San Francisco  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 54\\n\\nWhite\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n17% 27% 29% 35% 41%\\n50% 45% 39% 40% 40%\\n25% 18% 18% 21% 14%\\n7%\\n5%\\n\\n10% 14%\\n\\n4%\\n\\nAfrican \\nAmerican 2014\\nPublic\\nPrivate\\nNone\\nMissing\\n\\n58% 51% 47% 53% 50%\\n18% 15% 21% 18% 33%\\n12% 20% 24% 13% 12%\\n12% 15%\\n5%\\n\\n16%\\n\\n9%\\n\\n2017\\n\\n2016\\n\\n2015\\n\\n2014\\n2018\\n32% 24% 41% 42% 49%\\n30% 36% 28% 26% 19%\\n30% 33% 25% 18% 22%\\n9%\\n14% 11%\\n\\n7%\\n\\n7%\\n\\nAPI\\nPublic\\nPrivate\\nNone\\nMissing\\n\\n2015\\n\\n2017\\n7%\\n\\n2018\\n2014\\n2016\\n23% 11% 20%\\n31%\\n39% 40% 40% 38% 31%\\n25% 31% 26% 34% 31%\\n14% 17% 14% 21%\\n6%\\n\\nPublic\\nPrivate\\nNone\\nMissing\\n\\nLatinx\\nPublic\\nPrivate\\nNone\\nMissing\\n\\n100   DATA TABLE\\n\\n\\x0cFigure 7.1  Number of MSM newly diagnosed with HIV by race/ethnicity, 2009-2018, \\nSan Francisco  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 57\\n\\nWhite\\nAfrican American\\nLatino\\nAsian/Pacific Islander\\nOther\\n\\n2009\\n205\\n36\\n88\\n36\\n22\\n\\n2010\\n192\\n29\\n78\\n35\\n22\\n\\n2011\\n199\\n34\\n68\\n32\\n14\\n\\n2012\\n211\\n29\\n93\\n46\\n19\\n\\n2013\\n164\\n33\\n93\\n42\\n13\\n\\n2014\\n119\\n25\\n76\\n40\\n12\\n\\n2015\\n96\\n26\\n64\\n32\\n12\\n\\n2016\\n78\\n19\\n51\\n30\\n4\\n\\n2017\\n64\\n19\\n48\\n22\\n11\\n\\n2018\\n45\\n25\\n55\\n15\\n4\\n\\nFigure 7.3  Male rectal gonorrhea and male gonococcal proctitis among MSM by \\nHIV serostatus, 2009-2018, San Francisco .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 59\\n\\nMale Rectal Gonorrhea (HIV+)\\nMale Rectal Gonorrhea (HIV-)\\nMale Gonococcal Proctitis (HIV+)\\nMale Gonococcal Proctitis (HIV-)\\n\\n2009 2010 2011 2012 2013 2014 2015 2016 2017 2018\\n430\\n170\\n212\\n1018\\n19\\n11\\n16\\n35\\n\\n174\\n246\\n5\\n13\\n\\n230\\n329\\n11\\n13\\n\\n299\\n447\\n10\\n14\\n\\n329\\n435\\n14\\n19\\n\\n299\\n513\\n16\\n22\\n\\n397\\n682\\n21\\n20\\n\\n429\\n863\\n20\\n50\\n\\n481\\n998\\n21\\n37\\n\\nFigure 7.4  Early  syphilis  among  MSM  by  HIV  serostatus,  2009-2018,  San \\nFrancisco  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 60\\n\\nEarly syphilis (HIV+)\\nEarly syphilis (HIV-)\\nPrimary (HIV+)\\nPrimary (HIV-)\\nSecondary (HIV+)\\nSecondary (HIV-)\\nEarly Latent (HIV+)\\nEarly Latent (HIV-)\\n\\n2009\\n305\\n163\\n\\n2010\\n397\\n181\\n\\n2011\\n410\\n175\\n\\n2012\\n545\\n221\\n\\n2013\\n550\\n288\\n\\n2014\\n555\\n313\\n\\n2015\\n570\\n367\\n\\n2016\\n513\\n396\\n\\n2017\\n589\\n508\\n\\n2018\\n496\\n465\\n\\n52\\n46\\n\\n114\\n67\\n\\n139\\n50\\n\\n78\\n56\\n\\n138\\n64\\n\\n181\\n61\\n\\n67\\n65\\n\\n144\\n55\\n\\n199\\n55\\n\\n90\\n72\\n\\n190\\n85\\n\\n265\\n64\\n\\n89\\n95\\n\\n161\\n79\\n\\n300\\n114\\n\\n75\\n80\\n\\n149\\n98\\n\\n331\\n135\\n\\n83\\n109\\n\\n147\\n85\\n\\n340\\n173\\n\\n89\\n116\\n\\n129\\n111\\n\\n295\\n169\\n\\n93\\n128\\n\\n132\\n141\\n\\n364\\n239\\n\\n73\\n132\\n\\n84\\n119\\n\\n339\\n214\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  101\\n\\n\\x0cFigure 8.1  Number of non-MSM PWID newly diagnosed with HIV by race/ethnicity, \\n2009-2018, San Francisco  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 62\\n\\nWhite\\nAfrican American\\nLatinx\\nOther/Unknown\\n\\n2009\\n10\\n9\\n5\\n1\\n\\n2010\\n19\\n14\\n1\\n4\\n\\n2011\\n11\\n11\\n5\\n1\\n\\n2012\\n\\n5\\n7\\n5\\n4\\n\\n2013\\n11\\n6\\n2\\n2\\n\\n2014\\n11\\n4\\n8\\n2\\n\\n2015\\n10\\n2\\n2\\n3\\n\\n2016\\n\\n7\\n7\\n3\\n4\\n\\n2017\\n10\\n9\\n5\\n2\\n\\n2018\\n12\\n7\\n6\\n2\\n\\nFigure 8.2  Number of non-MSM PWID newly diagnosed with HIV by age group at \\nHIV diagnosis, 2009-2018, San Francisco   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 63\\n\\nAge in years\\n18-24\\n25-29\\n30-39\\n40-49\\n50+\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n1\\n3\\n3\\n6\\n12\\n\\n3\\n2\\n10\\n12\\n11\\n\\n2\\n4\\n1\\n10\\n11\\n\\n3\\n0\\n3\\n10\\n5\\n\\n2\\n1\\n1\\n9\\n8\\n\\n1\\n3\\n5\\n5\\n11\\n\\n0\\n5\\n5\\n4\\n3\\n\\n2\\n3\\n7\\n4\\n5\\n\\n1\\n0\\n8\\n9\\n8\\n\\n2\\n1\\n8\\n8\\n8\\n\\nFigure 9.1  Number of heterosexuals newly diagnosed with HIV by race/ethnicity, \\n2009-2018, San Francisco  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 64\\n\\n2009\\n\\n2010\\n\\n2011\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\nWhite\\nAfrican American\\nLatinx\\nOther\\n\\n4\\n8\\n11\\n2\\n\\n7\\n11\\n14\\n6\\n\\n9\\n11\\n7\\n3\\n\\n7\\n6\\n10\\n3\\n\\n3\\n5\\n6\\n2\\n\\n3\\n2\\n3\\n3\\n\\n5\\n7\\n4\\n4\\n\\n3\\n4\\n7\\n2\\n\\n4\\n4\\n5\\n3\\n\\n0\\n6\\n4\\n0\\n\\nFigure 10.1  Number of women newly diagnosed with HIV by race/ethnicity, 2009-\\n2018, San Francisco .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . . 66\\n\\nWhite\\nAfrican American\\nLatina\\nOther/Unknown\\n\\n2009\\n\\n8\\n10\\n11\\n1\\n\\n2010\\n12\\n9\\n7\\n8\\n\\n2011\\n14\\n15\\n9\\n3\\n\\n2012\\n\\n2013\\n\\n2014\\n\\n2015\\n\\n2016\\n\\n2017\\n\\n2018\\n\\n4\\n7\\n10\\n2\\n\\n8\\n7\\n5\\n2\\n\\n7\\n1\\n4\\n1\\n\\n9\\n7\\n6\\n5\\n\\n7\\n10\\n5\\n2\\n\\n7\\n10\\n6\\n4\\n\\n3\\n8\\n5\\n1\\n\\n102   DATA TABLE\\n\\n\\x0cMap 18 \\n\\nGeographic distribution of persons with HIV   .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  .  . 84\\n\\nMap 18.2\\n\\nHIV prevalence \\n\\nper 100,000\\n\\n% of PLWH \\n\\nMap 18.3 Map 18.4 Map 18.5\\nTwo-year \\n% of new \\ndiagnoses \\nrate of new \\ndiagnoses \\nlinked to \\nper 100,000\\n\\nsuppressed\\n\\nvirally \\n\\nMap 18.1\\nNumber of \\n\\nPLWH\\n\\n369\\n280\\n1944\\n345\\n629\\n276\\n316\\n127\\n86\\n1168\\n294\\n249\\n206\\n310\\n196\\n16\\n464\\n763\\n354\\n1562\\n42\\n359\\n167\\n1341\\n\\n506\\n385\\n\\nNeighborhood\\nBayview\\nBernal Heights\\nCastro\\nDiamond Heights\\nDowntown\\nExcelsior\\nHaight Ashbury\\nIngleside\\nLake Merced\\nMission\\nNob Hill\\nNoe Valley\\nOuter Mission\\nPacific Heights\\nPotrero Hill\\nPresidio\\nRichmond\\nSouth of Market\\nSunset\\nTenderloin\\nTreasure Island\\nTwin Peaks\\nVisitacion Valley\\nWestern Addition\\n\\nHomeless\\nUnknown\\n\\n1028\\n1197\\n8174\\n2063\\n916\\n574\\n1495\\n794\\n517\\n2038\\n1608\\n2013\\n709\\n600\\n1618\\n495\\n504\\n3841\\n398\\n3982\\n1458\\n860\\n658\\n3312\\n\\nn/a\\nn/a\\n\\n53\\n13\\n126\\n24\\n39\\n23\\n38\\n63\\n18\\n56\\n22\\n16\\n48\\n14\\n66\\nn/a\\n13\\n91\\n21\\n138\\nn/a\\n19\\n35\\n84\\n\\nn/a\\nn/a\\n\\n73%\\n79%\\n79%\\n84%\\n74%\\n76%\\n77%\\n79%\\n78%\\n77%\\n73%\\n78%\\n81%\\n71%\\n78%\\nn/a\\n79%\\n72%\\n76%\\n69%\\n60%\\n83%\\n74%\\n79%\\n\\n38%\\n46%\\n\\nMap 18.6\\n% of new di-\\nagnoses virally \\n\\nsuppressed\\n\\n71%\\n84%\\n83%\\n64%\\n83%\\n81%\\n78%\\n90%\\n79%\\n82%\\n73%\\n76%\\n83%\\n83%\\n65%\\nn/a\\n80%\\n67%\\n84%\\n71%\\nn/a\\n86%\\n62%\\n81%\\n\\n58%\\n60%\\n\\ncare\\n82%\\n81%\\n83%\\n72%\\n76%\\n81%\\n95%\\n90%\\n67%\\n81%\\n85%\\n90%\\n77%\\n86%\\n88%\\nn/a\\n82%\\n71%\\n88%\\n80%\\nn/a\\n92%\\n81%\\n75%\\n\\n77%\\n66%\\n\\n \\n\\n2018 ANNUAL REPORT • HIV EPIDEMIOLOGY • SAN FRANCISCO  103\\n\\n\\x0cSan Francisco  \\nDepartment of Public Health \\n2018\\n\\n\\x0c'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
